Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Bacillus cereus ATCC 14579, ATCC 14579

>BC0667 Bicyclomycin resistance protein
MKYFIYFIVIVAFLDTFSQLPIMSTFAQSLGGTPLIIGLVVGMYSFANMI
GNIIAGAAVDKFGAKKILYISMGITSFIVLLYTVVQSGEQLLVVRFMHGF
SDGFLIPAAFTFLSKQTNAKRQGKAMALSGAAVGTAAIVGPAFSGIMKAT
AGVEWVFITISILMALGTIVSLFFLPNNVSRKDTSRTQMMNKEDMVELLK
SEPLLQAYIGAFTLMFSQGIVTYMLPVKVEALALKASTTGMMLSVFGITA
ILFFLLPTNRIYDRFNRSKLMLIGIAVMAFALSLLGLFATKGMLFIVMMI
YGIGFAILFPSINALLVENTTDDNRGKAFGLFYAFFSLGVVAGSFTVGAI
GASPSVSFIIGTAFLLTFAGMIYVRSKVKKTMMG
>BC4087 Phosphopentomutase
MNKYKRIFLVVMDSVGIGEAPDAEQFGDLGSDTIGHIAEHMNGLQMPNMV
KLGLGNIREMKGISKVEKPLGYYTKMQEKSTGKDTMTGHWEIMGLYIDTP
FQVFPEGFPKELLDELEEKTGRKIIGNKPASGTEILDELGQEQMETGSLI
VYTSADSVLQIAAHEEVVPLDELYKICKIARELTLDEKYMVGRVIARPFV
GEPGNFTRTPNRHDYALKPFGRTVMNELKDSDYDVIAIGKISDIYDGEGV
TESLRTKSNMDGMDKLVDTLNMDFTGLSFLNLVDFDALFGHRRDPQGYGE
ALQEYDARLPEVFAKLKEDDLLLITADHGNDPIHPGTDHTREYVPLLAYS
PSMKEGGQELPLRQTFADIGATVAENFGVKMPEYGTSFLNELKK
>BC2464 S-layer protein / Peptidoglycan endo-beta-N-acetylglucosaminidase
MINTMVEVFILMKHKLIATGILAGAILSYSSNILADTHKFPDVPTWADKS
VNYLVDKQVLNGYPDGTFGSNDSLDRASATKIMTKVLGIKIDPNAKPSFT
DSQNHWATPYIAAAEKAGIVKGEGNGIFNPSGKVTRAAMATMLVNAYKLQ
STANHNEQVRFEDLKGHWGEKHANILIDLKISNGTENGWQPNRFITRAEA
AQLTAKTDMLQQNLNDEKEVITATSYEDLNLTVASKITAQEIDSFIAKYH
SDSPLVGHGQDFINAQNQYGVSAHYLAAHAILESGYGKSEIAYQKHNLFG
LRAYDGDPFKYAKYLPSYGDSIAYNANYVRERYLEESGMYYNGSTLTGMN
VKYASDKGWAKKIAGIMERIKPFRVEDYTYAKKLPKNPETLDVDALSNEI
PYKMYADGSSSNVVSSATYYQVPYPFNLKIKSRPDVAVEENKVGTVTPGT
TIFIYREDPNGWVEFSFEANGEKYWTLKNKLSM
>BC3478 Phosphoglycerate mutase
MNKRETDSNENAVTLYVTRHGKTILNTNHRAQGWADSPLVEKGVEVATNL
GTGLKDIHFMNAYSSDSGRAIETANLVLKYSEQSKLKLEQRKDLRELNFG
IFEGEKLENMWDVVGKAAGVASSEELMKFSIQEVINLISVADPTKQAEDW
DLFSTRIKTEIDKISEEAAGNGGGNVLVVVHGLLITTLIEMLDSSKTKLG
VENASVTKIVYQDGTYTVESVGDMSYVAKGKESVEI
>BC4260 Glucokinase
MEEKWLVGVDLGGTTIKLAFINVYGEILHKWEIPTNTGEQGKHITLDVAK
AIDKKLEELGELKSKLIGIGMGAPGPVHVASGMIYEAVNLGWKNYPLKDL
LEVETGLPVVIDNDANLAALGEMWKGAGEGAKDLICMTLGTGVGGGVIAN
GEIVHGVSGAAGEIGHITVVTENAFPCNCGKSGCLETVASATGIVRVAMQ
KIQETNKESMLRSMLAEEGRITSKDVFEALGQGDELAGEVVEKVASYLGL
AVANLSSTLNPEKIVIGGGVSKAGDALLEPIQRYFEQYAFSRAVKSTKLA
IATLGNDAGVIGGAWLVKKHKYEAKMI
>BC2393 PTS system, diacetylchitobiose-specific IIB component
MKVLFVCSGGMSSAIVVNALKKEAEKNGVNMEVHAIGTNEVEEEVKNGWD
VVMVAPQIRHRFDSVKKFAEEESIPCGIIPPQAYTPLGGPTLLKTVNELI
S
>BC1910 holin
MFEMTVMIGIVVGLSQIGKTIGLQTKYVPLLNLTLGIMLGVLFMGGDIKT
NVFQGIIIGLSASGLFAHTKIMKKDVDAK
>BC5058 Chloramphenicol resistance protein
MSSYTVPSSEAQTSRRSMFALLALAISAFGIGTTEFISVGLLPSISKDLN
VSVTTAGLTVSLYALGAAVGAPVLTALTASMSRKTLLMWIMVIFIIGNGI
AAVATSFTVLIIARIVSAFAHGVFMSIGSTIAAAIVPENKRASAIAIMFT
GLTVATITGVPIGTFIGQQFGWRASFMAIVVIGIIAFIAHSILVPSNLKN
GVPVSFRDQFKLIKNGRLLLVFIITALGYGGTFVTFTYLSPLLQEVTGFE
ASTVTIILLVYGIAIAIGNMVGGKLSNHNPIRALFYMFLIQAIILFVLTF
TAPFKVAGLITIIFMGLFAFMNVPGLQVYVVILAERFVPSAVDVASAINI
AAFNGGIALGSYIGGLVTNSLGLIHTAWVGGLMVVAAVILTAWSMTLEKR
DQVK
>BC3212 Multidrug resistance protein B
MQICKRFKRINEIYNEGAIKYMSETLHKRKPPYLMLVILFIGAFVSFLNN
SLLNVALPSIMKDLNIQDYSTIQWLSTGYMLVSGILIPASAFLITRFSNR
SLFITSMVIFILGTALAAVAPNFGLLLTGRMVQAAGSSVMGPLLMNIMLV
SFPREKRGTAMGIFGLVMITAPAIGPTLSGYIVEYYDWRLLFEMILPLAI
ISLLLGIWKSENVMKQNKNAKLDYLSLLLSSVGFGGLLYGFSSASSDGWT
NKVVLTALIIGAIALIAFIIRQLKMDEPLLDLRVYKYPMFALASVIAIVN
AVAMFSGMILTPAYVQNVRGISPLSSGLMMLPGAVIMGIMSPITGKLFDK
YGPRILGIVGLSITAVSTYMLASLQIDSSHTHIILIYTLRMFGMAMVMMP
LMTNGLNQLPTRLNPHGTAVNNTAQQVSGSIGTAILVTIMNSVTKTKAES
LMSHIDPTTFTETTKAIVTQKALLSGIQYSFYVALGMNVVALLLVFFVKR
VDTSAEAVEKLNR
>BC2970 Tetracycline resistance determinant tetV
MKNVLKNRSFFFMWIGSAISELGGAFGTLCNSILVYELTGSEMALSSMWL
LYFIPSLILQLISGPFIDKWSRKWIMIFSQWIRASVFLLPLVMLVSGSIE
VWHIYVVQIVVGLITPLYTPASQAITPSIVRKEQLQDANAYIDGMTRLMM
FLAPVLGGVVIHFIGTELTLSFVCICLFVSGAFLLYIKENRTSQPIRKTW
LGQFLHGFTYFFTKPIIVWLGIFLTFVQFGVGVTMVTNLPYIKDELSAGY
AEFGYFMAGFPLGYVVGSILVGKVTYKSRRILMLGGLFIGGLTYISLGFN
HSIVMAVIIEIVAGVCIAFFNVYNTTICQQSVPNNMIGQIFSVRLFFIRS
AMPLGVLVGGILSEMWGVRALYFIIGSIICVTSLIGILLPYFKFLDEAIE
EKTA
>BC0842 PTS system, sucrose-specific IIBC component
MAKEISEQLGGIKNIRSIAHCMTRLRLTLHDESKVNMNLLKKVEGVMGVI
EDETLQVVVGPGTVNKVAAEMEGLTGLRIGEVADHHLEDIGQEMKSEIKK
KNNTPVKNFLRKIGSIFIPLIPGLVASGIINGVANFAKNAGADPNATWLQ
MLLLIGGGIFTFLGILVGWNTAKEFGGTPVLGAIAGILIFNPAMANVKLF
GEALVPGRGGLFAVIFAAWLMVVVERQVRKAVPNAVDIIVTPLITVLVVS
IVTMLAIQPLAGFLSDGITSGINAILNIGGAFAGAVLAGTFLPLVMVGLH
HGLTPIHMEFINQTHVTPLLPVLAMAGAGQVGAAIAIYVKTKNKRLRNVI
KGGLPVGFLGIGEPLLYGVTLPLGKPFITACLGAAVGGAFQAVMQTASLG
IGVSGLSLIPLIADNKYLLYFLGLVIAYAFGFIFTYFFGFKEEMAENI
>BC5217 PTS system, lichenan oligosaccharide-specific IIB component
MNILLCCAAGMSSSLIVTKMEKAAEARGIEVKIWAVSGSEVNSHIDKADV
LLLGPQVRYLLPKMKELCKDKGIPVDVIQSVHYGLCNGEAILQAALSMKP
>BC2435 Phosphoglycerate mutase
MIKLVLIRHGQSLWNLENRFTGWTDVDLSENGLSEAREAGAILKKNGYTF
DVAYTSVLKRAIRTLWIVLHEMDLTWVPIHKSWKLNERHYGALQGLNKDE
TAQKYGEEQVHIWRRSVDVRPPALTEDDPRYEATDPRYKTLKKGEFPLTE
CLEDTEKRVLAYWHSEIAPTLKSGNKVIISSHGNTIRSLVKYLDNLSSDG
VVSLNIPTSIPLVYELDENLRPIRHYYLSMDGEVPEGEIPKHISF
>BC4703 Transcriptional regulator, DeoR family
MKPTTTRMLTRIKSIYMYINENGTVTTKDLVDEFGITPRTIQRDLNVLQF
NELVYSPCRGKWTTTGKKVRMTS
>BC3965 hypothetical protein
MIGNGQLKVFRTINLGGNEKWEQSYAKYVKEQSDILKMRKRRYFTENAEQ
IVTVLEKIMRKLNDK
>BC1949 hypothetical protein
MKPTIKNYVFLHVAFLIYSIIMVYMKWAAKFPIASISFFVAYFGLVILLF
GYAILWQQVIKHFEISKAYSHRGIIILWSMLWSVFLFGDTIQWNHLLGAA
IIIVGIVVVTKDE
>BC3056 hypothetical protein
MKKFSVFSITLMTFGMLLFGLNRIIDSYSEPIILLGYISFLIGVVLSIIA
IARREDGRLKFISLISFFVLLFFITWFESFQVLRIITWLKNIY
>BC1049 Bis(5'-nucleosyl)-tetraphosphatase(asymmetrical)
MNHTADNCIFCKIIDGQIPCSKVYEDEHVLAFLDISQVTKGHTLVIPKVH
KQDIFALTPEIASHIFSVVPKIANAIKTEFNPVGFNLLNNNGEKAGQTVF
HFHLHLIPRYGEKDGFGAVWKSHQNEYTMENLQNIASTIANSVK
>BC0661 High affinity ribose transport protein rbsD
MKKHGVLNSEIAAVLASLGHTDTVVIADCGLPIPDGVKRIDLAVEIGKPS
FLEVLQVVADDMAIEKVTLAEEVIINNAEVNKEIERKLIEPAFEYVSHEQ
FKEHTKKAKAIIRTGEATPYANVILHAGVIF
>BC0662 Ribose transport ATP-binding protein rbsA
MGMHIEMKNISKAFNGNPVLKNAQFMIETGEVHALMGENGAGKSTLMKIL
TGVYKKDGGTIKIDGQERTFKNAKEAEEYGIAFIHQELNILPNLTVAENM
FLGKELMYGKTGILRTRQMNAIAQQQLAELGLHVRGAMLAEELSVGQQQI
IEIAKALMTNASVIIMDEPTAALTDREIETLFTVINKLRKEGVSFVYISH
RMEEIFSICDAITILRDGEYVGKRLIPETSFDEVVSMMVGRSIGERYPER
NSQIGDVIFEMRNGTKKGKFENVSFQVRKGEILGVAGLMGAGRTDIMKAI
FGYEPLDSGQIFINGQEVKIDSPIDAIRQRIAFITEDRKSEGLVLDFSIR
ENLALPNLENLSKGSVLSNELEQQFTEDMMKLLNVKASSGEQAVKSLSGG
NQQKIVIAKWLGIHPQLLILDEPTRGVDVGAKKEIYSIMNKLTEQGDAVI
MVSSELPEVLGMSDRVLVIHEGKVGGILGKDEASQESIMALATGGE
>BC0773 Fructokinase
MRNVFCIGELLIDFVCRNTNVSLVNGSDFEKKAGGAPANVAAAITKLGGH
ATFMGQVGNDPFGEFLEQTLQRAQVDTSMLIKDKQTTLAFVSIDQDGERD
FTFMRGADGEYQFNSIDLSKIQTNDLIHFGSATALLSSPLKETYFQLLQY
AKDKGHFISFDPNYRSALITNTEQFSQDCLTFIKHAHFVKVSQEEATMLS
KESDLQQAALKLLNYGAKVVAITLGKDGTLLATNEGQTIVSSISIQQVDT
TGAGDAFVGAMLYQIAQSEHTLSYHFKDLTAFISFANKVGAITCTNYGAI
ASLPSLTDIKAYD
>BC1074 hypothetical protein
MEAFSVMMRALRLNIKQAFCNRVSLIIMFSGFVLICIYHYYYVIRYLGDA
ANGPISTDIKWIGFRGNEMDVYLLLMPVIASLPFSTSYNSDKSDGFKPFV
SKEISLFSYSVTKYIVTFFCGGLLYTFPFILSLLFCKLTIPDGVPTAGSG
IINDNGMFANLYETSPITYIAVYIGINFLFAGLMALLGLAASAWSQKDYM
ALLFPFATTSIPYVLLNTVLPTIGGAPIHLYDPRQPLHGMSPYILTIQCA
FFLLVSLIMYIQGVKRDRKKYRRRLQKRERCRKAFQV
>BC2395 hypothetical protein
MNIKFSYKGVFLLLFGVICANLLFVPLLGMLNLSQMHSIWLVTSIAASVL
LTVVVSFIDGSFASKAQLFFRFILFSIGCTFVTYMIVF
>BC0441 Glucokinase
MKEYIAFDIGGTQIKYGIVSEIGRVLKRQTVATEIHLGGEQIIQKLIYVS
KKIMNEHTITGIGISTAGIVDINKGIVTGGADHIPGYSTIPIIDRLQEIL
KVPVSIDNDVNCAAFGEKWNGSGREKDNFIMLTLGTGIGGAIFIDGKLYR
GHSFSAGEWGNMLIEEKTFEEVASISGLIRLVSKYKGKGKWNGKRIFELY
DKGDREVAQAVGIFFKHLAIGISNLAYIFNPETIIIGGGITDRGNEFLKE
VKEEVSKYLNQEIYNNCEIELAQNGNCAGMIGAIYHFLHHHK
>BC3760 6-phospho-beta-glucosidase
MEVYTMKFPHDFLFGAASASYQVEGAWNEDGKGVTNWDEFSKIPGKTYNG
TNGDVAVDHYHRYKEDVRLMAEMGLESYRFSISWARILPTGDGKVNEKGI
EFYNNLIDECLKYGIVPFVTLYHWDLPLPLEKDGGWTNKRTAEAFVKYAE
TCFKAFGDRVKHWITFNETVMFCGLGYLKGAHPPGIQNDVPKYFQATHYV
FYAHAKTVAVYKQLKQYGEIGITHVFLPAYSVDDQKENIQAANHANEYET
YWYYDPILKGEYPSYVVQQLKEKGWTPNWTVEELEIIKQNAEENDFIGLN
YYQPIRVERYDMDIKSEEHSRENSTLAPGNPSFDGFYRTVKMDDKTYTKW
GWEISPEGFLEGLHMLKARYGDIKMYVTENGLGDEDPIIDGEIVDVPRIK
FIEAHLKVMKRAIEEGINLKRLLCMVSD
>BC1691 Phosphoglycerate mutase
MTTIYFVRHAHSTYTKEERERPLSEKGHCDAENVTHLLKDKHIDVVISSP
YKRAIQTVQGIANTYKLSIQTEEDLRERLLSTEPVSNFNDAMQNVWEDWS
FAYEGGESNDIAQRRAVICMQNILKQYEGKNIVIGTHGNIMVLLMNYFNS
KYDFEFWKTLHMPDVYKLNFDKNRFISAERIEKTGHRLNIL
>BC4707 Multidrug resistance protein B
MRKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLSGVELVSWVYAIYMLA
TAVSTPIYGKLADLFGRKKVLLIGATIFLVGSALCGVVTSMEQLIFFRAL
QGIGAGAVMPITMTIIGDLYSEAKDRAKAQGWMSAVWGVSGVIGPLVGGF
LVDSLSWRYIFFLNVPFGIIACLMIAIYYKESIKPAKHHIDYLGATVFSL
STIALLYALLTGSSKQNWGDMTIIGLLIFAAISFIIFLFIEKKSPEPLIP
LALFSNRTLSTINILTLIAGAMIISITMYLPIWSQGVLGKNATEAGLILM
PIPVMWTFGAIFSGNLVGKLKTKQIILLGASILSVATFLLFTLSTNSPSF
LIYVAVGLFGLGMGLVTPIYMVTIQAAVPAHTRGTAVGLNTFINTFSQTL
GAAIFGTIFNTMIHARGIKNLDLVSGGHGGTTANVVTESQSALASSVHVI
YMSTFVLAVFTLIIAWLLLKPATQTSEQQ
>BC0860 Multidrug resistance protein B
MGFWSMHRNIKIRIITSFLTRTVSTMIFPFMAIYFSIKLGSAVAGALLLI
NVIVSLVIGLYGGYVGDLLGRKKVMIIGQSIQVISIACMGVANSDYVDSP
WLTFIFMLVNSLGSGLMNPATEAMLIDVSTPENRKVMYSINYWAINLSIA
IGAIFGGLLFENYRLQLFIVLTLVAIITLYVMAVYMEEVYVARKTVEKKN
VLKGMADSYKVVMKDKAFLIFCAASICTLSLEFQINNYLGVRLQKEFETV
HFFFGNGVTFDLTGIRMLSWISAENTILVVLCSALLIKMLKSFNDLKILY
VGLFIYTIGFTILGTSNSLWILLIAGLFQTVGEMMYVPVRQSIMADMVPN
EARGSYMAINGMVFQVAKMNGALDVMLGSFIASWGMSALYFIVGMSSILL
FMKAIGKEKYEDERNVSQIG
>BC2540 hypothetical protein
MDRTLKITKLNMFLMIFLIPIIVGIIVGILTKLGQSILPGHWNSLANLGS
VWLVPSFFVASFSYSKRTAILSGILALFGMVLGYYGYAIVIKNIAHSIYF
ISVWIVCACIGGTIFGIAGFLWKDTTNPLHKFGSSLISGVFVTDGLHILL
NFEDYSHMLPVGYTEVIVGIILILVLERSNAHRISSFLMMIPITILGLIG
YKLLSLFT
>BC5204 Peptidoglycan N-acetylglucosamine deacetylase
MIKRVFQCIILFLTITMYVSSNTEATTVIPAEYHPNTETTSPTQKIAYLT
FDDGPNKYTTQILNILKEKNGKATFFVIGGKVPHYKKTMQRLIKDGHYIG
LHSMSHDVKRLYTGDPSTLIAEMEQTQSIVQQVTKLNTHLVRVPYGSMPY
LKKNYRDALVSAQYKMWDWTIDTYDWKSYDNPSAILERVRNQSDEQVEVI
LMHDSSVTVQILPKVIDYLQSQGYKLLPYNPSSHLKVNFWKDTRL
>BC1751 hypothetical protein
MGLLAMLFFLIYEWSNINPVEAIILLSVLLFIPMSFCIIDKRKRDGSQLL
FYKSVSFLYPIAAICAMLAFVTNHYLFALVWFVYTGIVALFGVSRLLERG
WKPLEEIAIDSAFIYLFLGGFWFSASVAKLSIMHFSFDIVLLTAAHFHYS
AFLLPLSAGLIGRKREKRSKVYDAIMFISMISPMTVAIGITYSRIFEFFA
VFLYLCAIYGYGFYVWRAKFNAISAKILLIVSSSTLMVTIMFSLIYSYGN
LKHVLTITIAQMVWIHGVVNGIGVALPAFIGWVIEKSVPNYKYYGKPMSK
LRGNVAIGEAYLYSNNLVDSKEYNGLVDKVNDFHSEAFDVTKVPLSMIHF
YENTTEYELQSNIKWTRWFRPFALCYEKMSKRVEQIHLGMGGNWETMHGS
IISVIDEKDGRENVRAWIRKNEAGESIFVALYSKHTNKNETYMNIALPLP
YSNMTGILRLCNDNHDLIITSKLRENGQGDEGIYLHTRFLTIRLPLAETF
IITEGKDKMLTAHHSMWLFGLEFLHIHYKIEKIAQK
>BC0691 hypothetical protein
MKIVKDERLMIEGLKHIRLVFILQNIFILGIVFYRYVLQDAGYESVSDLL
MVFMGGIVVINFLNLKNSVEVYEHTGGVSRSYFMKLLLIPVSIVIGILAI
CIVVTPDISIKEISMTGFIMFACFLVPSLFIYIYMKKIKSED
>BC5271 UDP-N-acetylglucosamine 4-epimerase
MKIAVTGGTGFLGQYVVESIKNDGNTPIILTRSIGNKAINDYEYRVSDYT
LEDLINQLNDVDAVVHLAATRGSQGKISEFHDNEILTQNLYDACYENNIS
NIVYASTISAYSDETSLPWNEKELPLPDLMYGVSKLACEHIGNIYSRKKG
LCIKNLRFAHLYGFNEKNNYMINRFFRQAFHGEQLTLHANSVAKREFLYA
KDAAKSVIYALKQEKVSGTFNIGSGDALTNYEVANTINNAFGNKDNLLVK
NPNANEGIHSSYMDSSKAKELLDFSTDYNFATAVEEIHLLMRGLDDVPLW
Y
>BC2230 Macrolide-efflux protein
MSSLYHDSRLYYILGANSLSAIGSGIVMITIPWLLIKESGGETTFGYVSI
IATLIMFLLTPFIGQSIDRFSRKSLLLCNEGIGIAVIGIMVIWGFAGQPY
HSIHYILIYIAGSFYYLLFYPTIFAFNQEIFQAEHYKSLSGTMEIQGQLT
QVISGAAASFLIEIVSLKWILLVDMLTFAGAFFLFLCIPYVKKKEVKRKI
TFKKQLFEGIHFMKKRPKLFWFLLATYMPFIGVMMANYLIPVYISDILKA
NASVYAIEGTMYGVGAVVAGICIPLIMKYVKTEVSIVMTMFIYVISITAM
IIEPSVIFLYGLAVFHAVGNAGTRVARNVLMMEEIPNEVMGRVDSLFRLI
GTGIRIVLLMLFTAGVSKAGVMLPFYVLSCILIFSLGIAIYYVLSQRKVA
ANVSNKSIV
>BC0768 Methylthioribose-binding protein
MKKLCSIVLIFLLFTLAACTNEQDTISSQKQQTVRKATTTVENQLQTEIP
SQMKKPLKIALIMQMSIGTFSSQYIEGVKKQVELFGGSVQVYNSDNDLAK
MAANLDTAINSKVDGILIDHGRSEALKPGVEKALQANIPVVAFDNDLRLP
GVTIIDQDDYSLAWKSLKTLAEDLNGQGNIAVVWVGGFAPMERRNVIIDA
FYKRYPNIKEVARFGTASNNTPLDTQTQVEALLKKYPKKGDLQAIFASWD
EFAKGTVKALEQAGRTDIKVYGIDLSNEDLQLMQKENSPWTATAATDPAE
VGKVQVRFLYKKIAGEQTPDIYSLEPYLVKKNSLPKENITMDQLSKYING
WGDSKDAYSPWMKKLEKEKK
>BC3038 Transporter, Drug/Metabolite Exporter family
MKRWQMEWLLVSVALVWGANYTIGKYGVAYMSSIQFNSLRFLVASPVLLL
ITFLMERSLRIDRKDWLRLVAVGIVGTTMYQTMFMLSVKYTSATNASLLI
AMSPIFTGILAVLHKQERFSMKVQIGSIVAFIGAAFVLLTGHTGGTTYEY
AWLGNIIGLVAAIAWGWYPILAQPLITKYSAMRVTSWSTLIGIVPLVVYC
LFNVNTLTWPVDMPSWGSLAYSIVFATIFGLAMWYVGISKIGSTKVMVYM
YLVPLFAVIFAAVTIGEQINMMQLVGGLIIFIGLYVVKKGGIQKPALNLK
KVS
>BC3682 Transketolase
MYKTFTNISEGKNSMSHSIEQLSINTIRTLSIDAIEKANSGHPGMPMGAA
PMAYTLWTQFMKHNPNNPTWFNRDRFVLSAGHGSMLLYSLLHLSGYDVTM
DDLKNFRQWGSKTPGHPEYGHTAGVDATTGPLGQGIATAVGMAMAERHLA
AKYNRDAYNVVDHYTYAICGDGDLMEGVSAEASSLAAHLQLGRLVVLYDS
NDISLDGDLNRSFSESVEDRYKAYGWQVIRVEDGNDIEAIAKAIEEAKAD
EKRPTLIEVRTTIGFGSPNKSGKSASHGSPLGVEETKLTKEAYAWTAEQD
FHVAEEVYDNFRKTVQDVGETAQAEWNTMLGEYAQAYPELANEFQAAMNG
QLPEGWEQNLPTYELGSKAATRNSSGAVINAIAESVPSFFGGSADLAGSN
KTYMNNEKDFTRDDYSGKNIWYGVREFAMGAAMNGIALHGGLKTYGGTFF
VFSDYLRPAIRLAALMQLPVTYVFTHDSIAVGEDGPTHEPIEQLAALRAM
PNVSVIRPADGNESVAAWRLALESTNKPTALVLTRQDLPTLEGAKDDTYE
KVAKGAYVVSASKKETADVILLATGSEVSLAVEAQKALAVDGVDAAVVSM
PSMDRFEAQTAEYKESVLPKAVTKRFAIEMGATFGWHRYVGLEGDVLGID
TFGASAPGEKIMEEYGFTVENVVRKVKEML
>BC0256 Multidrug resistance protein B
MDRNVWIRFIGETLNGIAMMMLMPFFALYLKDKVDSLLEVGVIMALSPIA
ASFGSLIGGRIADIYGRKPIMIFSMASNALLMLGFLFIEGFIPYAILSIF
LGLSNSLFHPAASAMVADVTAPEKRTEAYGLLRMGHNIGAAIGPIMGASV
VVLSKNLVFIIASSTMLFYALLVLLLIQETMPKRTDKEEHKEKEAGTVWK
IVMRDKVLMIYLLAGIIISMGFSQTEGMLPLHFDNEMKHIFGTNNPYPYL
MALNGLLVVLFQFQISKWATDKPVGKTMLYGACLFGIGLFFIGWLPKWFG
EFNTNATIILITLLFVYALYTLGEMIMSPVQMTFVANLAPEHLRGTYMGA
ASLQWITGSAFGPLLGGFLLDRLLGHFLFTILAVGCVVAGIVYVSLDRLV
EQRQKDTLTKQSS
>BC3393 Chloramphenicol resistance protein
MNSYTASSSEVQTNRRSIFALLALAISAFGIGTTEFVSVGLLPSISEDLH
VSVTTAGLTVSLYALGVAFGAPVLTSLTANMSRKTLLMWIMIIFIIGNGI
AAVATSFTVLLIARIISALSHGVFMSIGSTIAAALVPENKRASAIAIMFT
GVTVATITGAPIGTFIGQQFGWRTSFLAIVVIGIIALIANSILIPSNMKK
GASVSFRDQFKLITNGRLLLVFIITALGYGGTFVTFTYLSPLLQEVTGFK
ANTVTIILLVYGIAIAIGNVIGGKLSNHNPIRALFYMFFIQAIILFVLTF
TAPFKVAGLITIILMGLFAFMNVPGLQVYVVMLAERFVPSAVDVASAINI
AAFNAGIALGAYLGGIVTNSLGLIHTAWVGGIMVVGAVILTAWSMTLEKR
DQVK
>BC3031 Isoflavone reductase
MKILILGGTRFLGRAFVDEALQRGHEVTLFNRGTNKEVFPEVEQLIGDRN
NDVSSLKNRKWDVVIDTCGFSPHHIRNVGEVLNDNIEHYVFISSLSVYKD
WILHDIKEDYILQPEPTDDQIKAVENGEVSPYEYYGALKVLCEKEAEKYW
PGRVLHVRAGLLSGMFDYTDRLPYWIQRVAKGGKVLVPGRKDRPVQIVDI
KDVANWGLNMAENKNAGTFNVTGPNYDLTMEELLNTCKKVMNSDAEFVWV
EESFMNEHNVQPWTEMPLWLPEIFSLEGETKPWKGGFTISIENAVKEGLT
FRRIEETVTDVYEWMKSTDEWELKAGISGEREKELLERWYQ
>BC2962 Sugar transport system permease protein
MKHMLKMHETSIILLLLIYIAIVGMINPSFIQFNSLSLLMKSSVILVVLA
IGQSFVLFTKNIDVSVGSSMGLSAAVCGMMLTNGYSAFLSIFVAIILGAI
IGFVNGIGVAKFRVPAIIMTLGMLGIIRGTMLIFTGGKWIEDIPNDFKQL
SSIIILGLPITVWFVLIILLLLYFFLRKVPLGRYFYAVGDNEDGARLIGI
PVNKVKIYAFMISGISAALAGCIFVMNIGFVPNQTGTGLELQVIAAAVLG
GIHLKGGTGSLFGAALGALFLETISSSLVFLKIPAFWNNAISGFLLLLII
ILDSVMKKWKAERRMNL
>BC0766 Methylthioribose transport system permease protein
MNLVHKTKTKKLYLPTHLFYQFSTIAIIIGVTIFFSIVNDSFLTYNNISD
ILRSISIVTLLAIGVTFTLIVDGFDLSVGSTASLATIAAASCLVLYRQEL
LVTLLVPILCGLLVGLLNALLVIRIKLPDLLATLSIMYIVNGLHLTFSKG
SSIYEGMSGATGHFIPSFLFIGQGSVLGIPVPVIIMLTVVLIAHLFLEKT
TYGRFFYMTGGNREAARLAGIPTDRYRVYAYMISGLLASIGGIILCSRVG
TGQVSAGAPLLMDAVAAAYIGYAMFGAKKPNIVGTFLGSVLIGIILNGLT
MMNVPYYAQDIIKGSILITALAFSFIKKKRK
>BC1533 Methylglyoxal synthase
MKIALIAHDKKKNDMVSFAYAYKPIFEQHELFATGTTGLRIMEATGLVIT
RYQSGPLGGDQEIGAMIAKNDLDMVIFFRDPLTAQPHEPDVNALLRLCDV
YAIPLATNMASAEMLMHALERGDLDYRKLRK
>BC2287 Methylisocitrate lyase
MAWVVKKQSTQEELANRFRALVEANEILQIPGAHDAMAALVAKNTGFSAL
YLSGAAYTASKGLPDLGIVTSTEVAERARDLVRATDLPVLVDIDTGFGGV
LNVARTAVEMVEAKVAAVQIEDQQLPKKCGHLNGKKLVTTEELVQKIKAI
KEVAPSLYIVARTDARGVEGLDEAIERANAYVKAGADAIFPEALQSEEEF
RLFNSKVNAPLLANMTEFGKTPYYSAEEFANMGFQMVIYPVTSLRVAAKA
YENVFALIKETGSQKDALSNMQTRSELYETISYHDFEELDTGIAKTVLSE
DQ
>BC3146 Peptidoglycan N-acetylglucosamine deacetylase
MKESQNKKKISVVTKAILSLVVVLATTFFTFFLIGKWNSIPAKGVANESI
RLANTQQQGKKEDTSLAKQKRPDGKPVGKVVYLTFDDGPSEFTGKFLDVL
KEQHVASTFFMQGSNLQNTAFQENVKRAVKEGHYIGAHSMTHNSDKLYKK
GQFVTEMKETLALIHNITGTTPKLVRPPYGSAPGLKGQDIRNKIVEAGIK
VWDWTIDSNDWKLKGNPQQIIENVKRTTTEDVEVVLMHEKLQTLQALPEI
IKFYKEKGYEFGVYNEADHFQLNFQKDQRL
>BC3310 Transporter, MFS superfamily
MRFTFWIMVGIVAISGLSQGMLLPAIAMIFEQEGVSSSINGIHATALYIG
ILVISPFLEKPMQRFGMKPIIVIGGFLVIISLFFFTQTFSFWVWFILRFL
VGVGDHMLHVGTQTWITTTSDPSKIGRQVSIYGVFFGIGFAVGPYLASTV
QYGLATPFIISTILCLIGWLLLLPTKNAFPAQDEREVKSESSFSRYKQVV
GLGWIALLGPLAYGVLEAMLNSNLPVYALRKGWSVSDVSFLLPAFAVGGI
ITQIPLGILSDKYGRDRILTWTFSISTGIFLLAAVFDQYYWIVFACMLLA
GMVIGSCFSLGLGFMTDLLPRHLLPAGNILSGIAFSLGSIMGPVLGGVFI
EKIQYTSFFIAVMIIMGILAMLYMVYMKNQFASRKIESRLGHDKTT
>BC4660 Acetoin utilization protein acuA
MSNTLIHKKIYNARNLKTAKGTLIIEGPVSTHNLEMYEFHPDLIAFRPAE
QQYKAIVEISKLPEARLIIARHDQTIVGYVTYLYPDPLERWSEGKMENLI
ELGAIEVVPAFRGSSVGKNLLEVSMMDDYMEDYIILTTEYYWHWDLKQTG
LNVWEYRKVMEKMMNAGGLQWMATDDPEICSHPANCLMVRIGKRVDTDSI
QAFDRLRFHNRFMY
>BC2099 hypothetical protein
MRRKRNHHFKSGEKNEEYAAEISPAGIPIRHKRKEIANEIEGTNTGAMVG
YVALFLSLFSIAFYPVTLGSLAILVGLLAVNFGARTLGYTAIGFGSFSVL
FTLFYPLALSAF
>BC3804 Chitooligosaccharide deacetylase
MKVRILAYICIFSLYVSLGSYSVFAQDNLHEEIQKHAKKYEIAPQNAMID
KIWKATPGYNGRQVDIEASYNNMKKLKEFDQKYLEFKEVSPSVHLEDLSP
APIYRGHPNKKMVGLTINVAWGNEYLPRILEILKKHDVKATFFLEGRWVK
ENLRFAKMIVDANQEVGNHSYTHPNMKTLSSDEIREQLQKTNRMIEVVTN
QKVRWFAPPSGSFRDEVVKIADDFQMGTIMWTVDTIDWKRPEPDVLLQRV
MRKIHPGAIVLMHPTSSTAEALDTMIKKLKEQGYKVGNITELLDEKRVD
>BC5209 6-phospho-beta-glucosidase
MTGIKIATIGGGSSYTPELIEGFIKRYDELPVREIWLVDIEAGKEKLEIV
GNLAKRMVKKSGLPIEVHLTLDRREALKDADFVTTQLRVGLLEARAKDEA
IPLKYDVIGQETNGPGGLFKALRTIPVILDICKDMEELCPNAWLINFANP
AGMVTEAVLRYTNIQRVVGLCNVPIGIRMGLAKLLEVDASRVHVDFAGLN
HMVYGLDVYLDGVSVMDRVLELVTDPEKQITMENIAALNWEPDFIRGLRA
IPCPYHRYYYKTREMLEEEKEASVEKGTRAEVVKQLENDLFELYKDPNLD
IKPPQLEKRGGAYYSDAACSLITSIYNNKGDIQPVNTRNNGTIASLPHDS
AVEVNCIITKEGPKPIAVGDLPVPVRGLVQQIKSFERTTIEAAVTGDYHK
ALLAMTINPLVPSDKVAKQILDEMLEAHKEYLPQFFKKVEK
>BC2921 hypothetical protein
MKAIVIGILASFFFAFTFVLNRAMDLEGGSWIWSASLRYYFMVPMLLLIV
MYRGNLKQLFQYMKNNPKEWLVWSIVGFGLFYAPLSFAGAFGPGWLVAST
WQITIVAGILLTPFFAVDPLHKKLPMKELVMSGIILFGVVLMQVEHASSL
GIRETVLCVVPVLIAAFAYPLGNRKMMQVCKGELDVFQRVLGMTLASLPF
WFLLSGYEVSTGGLPSSSQVFQCFIVAVSSGLIATVLFFFATDLVKDDPQ
KLATVEATQSGEVLFALVGELIWLSAPIPSSLSWIGMSLVIIGMILHSYV
AVVVKKEEKITA
>BC3517 CDP-glucose 4,6-dehydratase
MLNQNFNNAFYGKTILITGHTGFKGSWLSLWLNELGATVIGYSLDPKNKN
DNFNITNLQNNIIDIRGDIRDFNKLNKVFTDYKPEIVFHLAAQPLVKYSY
EYPRETYEVNVVGTMNVLEAIRLHESAKIGIMVTSDKCYENKEWPWGYRE
IDPMGGHDIYSSSKGCCELLISSYRNSYFSVENFSQHKKIIASVRAGNVI
GGGDWSIDRIIPDCIRALESNKNIIIRNPTAIRPWQHVLEPLSGYLLLTE
KIINNGILYSGAWNFGPSLSNIVSVEKLVTSLLDIWGCGDWTAENIDPIN
FHEANLLNLDISKAKFNLNWQPKWSLQQTLENTIEWYKHYNSYTSSEMRN
LCISQIKQYCML
>BC2029 Phosphoglycerate mutase
MKTTIYVTRHGETEWNVAKRMQGRKNSALTENGIVQAKQLGNRMKDLPIH
AIYSSPSERTLHTAELIKGERDIPIIADEHFYEINMGIWEGQTIADIEKQ
FPEEVHLFWNEPHLFQSTSGENFEAVYERVIEGMQLLLEKHKGQNILIVS
HAAAAKLLVGHFAGIEIENVWDDPFMHSASLSIIEFEEGIGKVKQFADIS
HFQ
>BC0567 SN-glycerol-3-phosphate transport ATP-binding protein ugpC
MIELKNVSKVYKNAEETAVKGVSVHIKKGEFFVLVGPSGCGKSTLLRMIA
GLEEISSGDLIINERVANDLEPKDRNLSMVFQNYALYPHLSVEENILFGL
KVRKVQKEERQKRLMEAIEMIGLKEYVKMKPGQLSGGQRQRVALARAIVS
QAPICLMDEPLSNLDAKLRAQMRIEIREIQQRLGITMIYVTHDQIEAMTM
GDRIMVLNKGSIQQVGTPLNIYNEPANEFVASFIGSPSMNINDGEVNKEK
GVLHIGQLQIPLSIRQLKQLPEGTIRIGMRPEHIALSEEGQEVTLQSVEV
LGNESILNFAVNGTTWSAKVIGQLLLNKGDKVKLLFSQEKLCFFNENTNE
RLKVVAEEELKVVAK
>BC5170 Integral membrane protein
MSILAEYRWYFLIGAEIVFWLSAIGFFLLRYGFRLKKASFIMGIVLLVNE
VFILTLGVVDYYQTGKFSNFQIITVIILLYAVFYGKKDLKKLDIFAQKSV
AKWRNEPAPIIEEQVELIGMAYAKQEIKNWVLHLVLFVGVHIFFFFAYGF
IPFEQWGNWLESGIVLNKAASRVSQVWAIVFLVDTAISFSYVIFPKKEKG
KEKLLS
>BC2300 Oxalate/formate antiporter
MKKSTVNPWFVVLGTVIVQMGLGTIYTWSLFNQPLVSKYGWSLNAVAITF
SITSLSLAFSTLFASKLQEKWGLRKLIMIAGLALGLGLILSSQASSLILL
YVLAGVVVGYADGTAYITSLSNLIKWFPERKGLIAGISVSAYGSGSLIFK
YVNAQLIESVGVSQAFIYWGLIVTAMIVIGACLIHQAADQGAVHETKTKE
YTTKEMLGTKQVYLLFIMLFTSCMSGLYLIGMVKDIGVQLVGLSAATAAN
AVAMVAIFNTLGRIILGPLSDKIGRLKIVTGTFVVMASSVLVLSFVDLNY
GIYFVCVASVAFCFGGNITIFPAIVGDFFGMKNHSKNYGIVYQGFGFGAL
AGSFIGALLGGFKPTFMVIGVLCVVSFIIAILIQAPKQKKEQEEEYRSVA
>BC1970 hypothetical protein
MQKWLSMMGIIFILTGCKMSEAPTSLMEAPTNEKWINELKEQIDKDLPVN
YRLLTPMSNKDKQMIWSMNFKQDNKKEAILFYKLPNEDHSVYLAVYEEIG
NGWRIKSTHKFDGGDVDIVEVGDFTGNGKRELLIGISVNRESLEHVMYVF
SEENEEMKEIYNRSYTKLFIEDLNENGLKDISLVTFEKDEKLTVEFMEQF
KTLSEVSYDPFINSIQRIQMGRISKSLKAVVIDAGTGAHSGITYVAKFDQ
DHYEVLPMGWERRFI
>BC2391 hypothetical protein
MLFELVILFVILFLFLGYPISKAWDSFQSKKENSSSILKFEPQEILSICL
SYFIFGLGIMWNANDVRGGIPLHKFEKNGMMSDQYASLAHDHIAIVVLLV
ILGAVSYWRLTKGLTKLSPIFYIFYSTLMIVNIVYTFIYITHTGFAFYTE
LGGLRYIPVFCIQVGMLAFSLLFIAKLRNTLDYFIQSQNEKDYTQSNRII
LLLYRISFGYQKMATVWMISLFPVLLIIQFILILFGQKPDSFIRVFMETS
SFNYSKIPAPSPQIVSGDGHYLCTVSVKGHKNIVKPLRAGIRHGERITVN
RQLLIANAFENVIEERVPKCHKVIRNFYDKYGYPISKHINTKWSADFVYI
LMKPLEWFFLFVLYTVDKNPENRIHIQYSELRK
>BC2310 Multidrug resistance protein B
MKEKLNPKVVVSIVYITAMFMAAMDATIVNVALQTISRELQVPASAMGTV
NVGYLVSLAVFLPISGWLGDRFGTKRVFLIALFVFTIASALCGMANDITS
LNIFRIIQGAGGGLLTPVGMAMLFRTFSPEERPKISRFMILPIAVAPAIG
SIIGGFFVDQMSWRWAFYINLPFGIVALLFGLLFLAEHVEKSAGRFDSLG
FILSAPGFAMLIYALSQGPSKGGISPEIMSTGIAGGVFITLFIIVELKVK
QPMLDLRLLKEPVFRKMSLISLFSSAGLLGMLFVFPLMYQNVIGVSALES
GLTTFPEAIGLMISSQIVPWSYKKLGARKVISIGLICTVVIFVLLSFVNH
DTNPWQIRALLFGIGIFLGQSVGAVQFSAFNNITPPSMGRATTIFNVQNR
LGSAIGVAVLASILAGFGSNNAQSDFLPYQAALIGSAIFLLIALLFSLRI
SDKEVMSKKKEKTLSVSEKEKVLVNE
>BC2770 Transcriptional regulator, DeoR family
MFTEERREKILELLNTDGRVVAKDLAERFDMSIDSIRRDLSIMEKDGLLK
RTHGGAIELTRVRNLAAEPAKRYSDSSIYEDTIARVAVSYIQEGDSIFIG
GASVHNAMLKYLPEVSFTVITNSIEIAGYLREYKNIDTYLIGGKVKPSGN
ITDTLASELISRFSIDLYFSTGGGISLQGISTATPEVAYFSKRVSEIARR
NICLVPHNKLGIDCFIRGESLKEIDIIITDEEASKETVQDFEKQGKQVVI
APLYSFERSLT
>BC4912 hypothetical Membrane Spanning Protein
MEDQGVLAGFFALSFAFILVILIWAIISYLLTAFALYSMAKNDGATDGVL
AFIPFLNSKTWGDLAKDKLPDFLKEEAGWKVFGIYVACFIFNFVPIISLL
ATAVSIVLSIYLIYAILDRYGTNSILFTIIHVITFSVFLPIHLFIIRNEP
VRYKE
>BC3197 Tetracycline resistance determinant tetV
MKDSKRFNFHKLWLGQSISLLGTQFTIVALPLFALEVLQTSEANAAMLRG
IIFVPYLIFGLVAGALIDIFHRKNALLICSICQGVLFLSVFILTVTNILT
FPLLVFIMFLNGIFTTFYNIAVPSFLPEIVTDKDKLKKGNAQLALSESLS
VVIGPMLAGIIITLFGLTGSFTIDAVTYFVCFAFVLFISKFKPHTDGSLK
DVNIKSIYQNIYEGLVYFKKHPVLEPIVTCGAVYGFFKYILNSILVIFLY
KVMGLSELEIGFVVGSAAVGFLIGNTVLMKKSQQINNTKMLIYSATVSVT
GLAFIPIMGYMGTVYGIVAASIIHGMGEGVFGPYAATIRQLASPNHMLGR
VNAVQRTLNWGAWALGSFASAFLVSIFGLQTTLFIGGFGTTLCLVALLRR
GVSKGNDIEYTSSF
>BC0488 UDP-glucose 4-epimerase
MSKKCLITGGAGFIGSHLAEELMRRGYEVTVVDNFYKGKNKYHKELMKEI
RVIPISVLDKNSIYELVDQHDVVFHLAAILGVKTTMEKSIELIETNFDGT
RNVLQAALKGKKKVVFASTSEVYGKAKPPFSEEGDRLYGATSKIRWSYAV
CKTLEETLCLGYALEGLPVTIVRYFNIYGPRAKDGPYAGVIPRFIRAALQ
GEDILVYGDGKQTRCFTYVSDAVEATIRAMDEKVNGEIINIGSENEKSIK
EVAEVIKKLTNSSSKIVQVPFEEVYPHGFEEIPNRRPDVTKLKELVQFQA
KVTWENGLKETIKWFREQNNG
>BC2055 Macrolide-efflux protein
MRNLSLIYYLGSKICITLADIVYVMIITTHIYIATKSATITALFPLLQVI
TNLIANISAPLIINRFPSYTLLYTLQWLKTVFLLLLMILFPVLSTNIIAL
LTFIFVISLCSGWSAPLLYGILPRLTPKEKLVKVNSIFSFSTQIVQAVAY
SFTSIVVLLIGATSTLMINNILMIFGCIALHFSLRSIHTERIADSPSSKS
TVLLEGWKLLFQNPSLRTVTYMDLIETFAGTIWIGAITMAYVTTILHKGE
EWWGYINTSYYVGTLIGGLLAWKMSSYIQNNLIRSMSISSLIFSILTFLY
GMTSSGFIALFLCVLMGPCYQIRDISQTTVLQSSVAPSLLSKMYTAHGAL
LSTASGLSMLSIGIITDMFGVRTIYIIASILILCSACLSFSLLKYHKTEQ
NDISI
>BC4016 Cyclodextrin transport ATP-binding protein
MAELKLENIYKIYDNNVTAVTDFNLHIQDKEFIVFVGPSGCGKSTTLRMV
AGLEDISKGEFSIDGKLMNDVPPKDRDIAMVFQNYALYPHMSVYDNMAFG
LKLRKIPKDEIDRRVKDAAKILGLEQYLDRKPKALSGGQRQRVALGRAIV
RDAKVFLMDEPLSNLDAKLRVAMRSEISKLHHRLGTTTIYVTHDQTEAMT
MASRLVVMKDGKIQQIGTPKEVYETPENIFVGGFIGSPAMNFFRGKLTET
DFVIDNTIKIKVSEGKMKMLREQGYVNKEIVLGIRPEDIHDELLFLEASQ
STAFTTKIEVAELLGAESILYMKLGNQDFAARVDARHTFSPGDQIKLAFD
MNKAHFFDNQTEQRIR
>BC1157 Alpha-amylase
MGKIRTRKLFICFCLAFVLFVPIHTFADEKREWKDEVIYSIMIDRFNNGE
PKNDKQLEVGNLEGYQGGDIRGIIKRLDYIKEMGFTTVMLSPLFESGKYD
GLDVRNFKKVNEHFGTDNDVKELVKEAHAKGMKVVFQFPLGENERQVIDA
MKWWIKEVDLDGSYVIHSEKKPRSFWDNAQKDMQVIKKDFRIMTKEDSEY
NEKIVESFSEADVSVKSLYDVSKKEGEFVTFLDDQETKRYARIAKENMYY
PPSRLKLALTYLLTSPGIPNFYYGTEIALDGGSVPDNRRLMDFKSDEKFM
QHITKLGELRQARPSLRRGTFELLYDKSGMSILKRKYKDEVTLVAINNTK
ETQKVSLPASAIGEKQELRGLLQDEIIREENGKFYLVLKREESNVYKVNG
ETGVNWLFISLIVGVNVLFIAFLIAVKRKRR
>BC3725 Exochitinase
MLNKFKFFCCILVMFLLLPLSPFQAQAANNLGSKLLVGYWHNFDNGTGII
KLKDVSPKWDVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLKSKGK
KVVLSIGGQNGVVLLPDNAAKDRFINSIQSLIDKYGFDGIDIDLESGIYL
NGNDTNFKNPTTPQIVNLISAIRTISDHYGPDFLLSMAPETAYVQGGYSA
YGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGIGMDGNNYNQGTADYEVA
MADMLLHGFPVGGNPNNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMK
KALNYIIKGVPFGGKYKLSNQSGYPAFRGLMSWSINWDAKNNFEFSNNYR
TYFDGLSLQK
>BC0847 Transporter, Drug/Metabolite Exporter family
MPYFYVFLLLLTSLLWGGNFVVGKSLVDHASPMTLTNLRWMIAIVCLLPM
VWFKEKKILPPRTAILPLILMGISGVALFNIFQFLALEKTSATNVGLIST
LNAISIALFSVLFLKEKVNTLQILSMILSFFGVILVLLKGDFSLLFSLHF
NSGDLWMIAAVCIWGIYSVCSKWATKTTTPLMATLYSGIFGVILLLPFNI
GSFTVSNINTSFITSLLYTGLISTVLCMVFWNIGVQKLGATTSGIFLNFN
PIFTAILAFIFLGEELTWIQILGTIVVVTGCYLFSHFKTVAVQPVRPLMR
KHS
>BC2741 Transporter, Drug/Metabolite Exporter family
MVIFNYILVCIIFGTTFLTIKIGIEAGAPPLFSAGIRFFLAGIILMIIFK
LKRKEIMPHIFSKRIMYAGFCLTFMTFASLYWSEQYISSGLAAVLSATGP
MMILLIQAKRNREKLQKEQLVALVIALIGVIFVSLPGMHQQVSFIWSIAC
IVLVIGELFYGIGSIRSKEILSDLSNVSPFLINGIQMFYGGILLLIASII
VEQPNVTVLTSWSVQWPILYLIFIGSIGGHGLYYWLLSKTNPVFPSTWLY
VSPLIAIIVGYIILGEPLNPTMGMGACLILIGVFLANRSTLRTYFKKGRL
LEKEM
>BC4765 Transporter, Drug/Metabolite Exporter family
MRRWGIELLILSVVIIWGINYTIAKYGLLEFTAIEFTALRMMAAAPLLLL
LTFCIEKSVYMERTDIPRLIIVSVVGIVLYQTLFMETVKYTSATNASLLI
SISPIFTTAFAIFLKQEKFSSRKLIGSMTAFVGAALVLVAGHSLTSSFYG
NGIGLITSICWGLYPVLAGPLIKKYSALRVTAWSALVGAIPLLLLSGPHV
FVMPFHITHGMTLFALLYSIFFVTVFGLVMWYVGVQKIGASHTMVYMYIT
PLVAVLFAAVWANEYVSFQQIIGGIIIFVGLWFVKSEKVKVHSIAGEPIS
K
>BC2223 Gluconokinase
METRGRVIGIDIGTTSTKTVVFTEKGKVIASHAIDYPIIQPNVGWAEQDP
DVICAAVYKSVSVAIEKGNVLPEDISSIGISTAMHALIAVDENGAPLTRS
IIWADNRSTKQSEKLLQQMNGHEIYRRTGTPIHPMSPLSKLLWMKEEEPE
LYTSAYKFISIKEYVIYQLFSRYVVDYSIASATGLFNLETLNWDEDVLTM
LHMSSEKLSTPVPTTYILSGMKPELAQKMGISAETPIVIGASDGVLANVG
VGAISPGAAAITIGTSGAVRTISSNINTDEKGRTFCYALTDEHWVIGGPT
NNGGILLRWLRDEFGSPEQEVARKLGIDPYDLLIKYAESVPAGADGLLFL
PFLSGERAPYWNANARGTFFGINLQHKREHFIRAVMEGVCMSVYSVALAI
RDCTGPLTEIRVSGGFAKSAFWRQMLSDMMGKELLVPESHEASALGAAAV
ALYAVGKIDSLEEVKDWIDIVHHHVPNKENTAIYLEMFYMYERLYNRLKE
EFDCIAAFQRKQ
>BC1621 Macrolide-efflux protein
MSVSYSTLLKTNKNFNKLFYGQTLSVLGDWFHTVALLTFVYSITESPFMI
ALTFISKSLPQLLLSPFIGGIVDRFSKKNIMIFTDITRGILVLTYLLAGY
KIEIIFIANICLSVLSCVFEPAKQATLKNIVHQNHFVTANSLSSTINGFM
SIMGASLGGVIAQSLHIEFAFLVNSLSYFISAYFIYNMSIPAHDTCNKNK
AFFTDIKGGYTYILQTKIILTLILVGISWGIIGGAYQLLLTIYAEKIFHT
NIGILYTVQGAGLMIGSLLVNLYISHNKEKMKKVFGWAYLLQGIFFLGFI
LSDQLIIGIITLFCMRIAGGIIVPLDTTLLQTYTHENMIGKVFSFHYSIY
GSLIQLSMFFTGGLLEILSPQMIGSLLATCCIFVSFIWLFLFYRGDLSE
>BC4055 N-acetylgalactosamine-6-phosphate deacetylase
MKTQIVINAKIYTGQEIVENGFIRYAETIKEIGLMAQYVPQENETVFDAT
GKIIIPGMIDVHIHGGYDIDAMDANSDGLVTLGKEMLKEGVTTYFPTTMT
QAPEAIEAALTAAKEAKEKGAHFEYIHLEGPYVSKKRAGAQPLEHIVPAN
IEQFKQWQEASGNLIKLVTYAPEEEGALEFEQYLAETGVVGTMGHTDAID
AQLKNRKITHATHLYNQMRGLHHREPGVVGHVLLNPDVMVEVITDGIHIH
PDMVKLAYKLKGPKKVSVITDAMRAKGLEDGLYELGGQPVHVKDGSARLE
DGTLAGSILKMDQAFRNVIEFTGCSIEDAVLMTSVNQAEEFGLNNKGALA
VGKDADFVVMNEDLHVYDTVRLGIHMKEGK
>BC2716 Glucose dehydrogenase [pyrroloquinoline-quinone]
MTKVKVSLRPIVHNINLPTVLKTTILPGESTERLFIATQLGEIFYIGNGV
IKIFLDIRHLIIKLGTFEEGVSSSGYDERGLLGLAFHPQFYQNGLFYLHY
SVAGTQGPGAFSEQFKPNPCDPKTLNLKWVNRNTQYDHIDTVEEWTLQSN
GQAQKRRTLLNVRRPFFNHNGVNSLNFSPETGKLVFTNGDGGSGYDPFNL
SQDDLEIAGKIIEIDVSKNTFINNPPVVTRFDELPLSIQETLTVIAKGVR
NITGISFQRFYNQYIKYAGNVGQDIVESIFSFVQYKPIPVTELVQMHFMR
LTPNQDGVINFGWRGWEGDLPTSFIRHCSENQTLDERTMVYYDETIQTSV
KRILPLLSYFHKDSRTDKFGGTSLTGVQPYMGNAIPNLTGSVVFTDLAKK
EDSRPPVKGVLAYTRAGTDGKHADFHAIETNYDFGTQAAYYMSLGTNLNQ
TKLYLGVYSSMKVTDFNKGTIFEIIP
>BC4962 Fructose-1,6-bisphosphatase
MERELALEIVRVTEAAALASAQWMGRGKKNEADDAATTAMRDMFDSVNMA
GTVVIGEGELDEAPMLYIGEELGTGNGPEVDIAVDPLEGTNIVAKGLANA
MAVIAIADKGNLLHAPDMYMEKIAVGPKAAGKISLDDPIEKTIEIVAEAN
NKKIRDLTVIVQERERHQDIIDRVRAKGARVKLFGDGDVGASIATALPGT
GIDLFVGIGGAPEGVISAAALKCLEGEMQARLVPMNEEEEARCREMGLED
PRQLLMLDDLVSGDDAIFSATGVSAGELLDGVKFLGGDLAETYSIVMRYK
TRTVRFIKTHHHLDHKPHLNLDI
>BC2953 hypothetical protein
MKHMNQFEQMMYVGVIMSIVLSVMILGSLYYNPRLSLTDYPKDIQKVVFP
KSIHEKKQTIYFNIVYNTILFGTPFLSTYILHKHEKLMYMDAYLHTFGIL
MICNLVDLLIIDWLIFCWITPRFVVIPSTEGMKGYKDYKFHLRGAIVATQ
ILAIVSLFLAGIATTI
>BC3225 Macrolide-efflux protein
MDILKNRNFRLLFLGRIFTNIGDSLYYVAAMWLVYKLSGNPFYSGLAGFL
TLLPSALQFLTGPFVDRWSIKHTLVITQVLQCILILIIPITHYFDLLTVH
LLLIIMPIVAFIEQFAYPAQSKALPLLLHKTQLLKGNSLFSFAYQGIDLI
CTTLSGILVALFGAITLYVIDSFTFAITALLFFSLKIPKQTETGTSLSTK
QYFSDLKEGFSIVFRSLMGVFLIGSVVANFSIGMTMAILPSFADSLGGVK
SYGFFLAAISAGSLIGALFSSWVGKRNVGRVSIIGFATGATFWFLSTIVP
FQWLSILLFGLAWIPIGATNILFATISQIVIPNQYIGRINSVMRSMSTIA
MPIGSLIGGYTANVFSSQLIFALASIGILFISLVWLLHPKLRALPKADEI
TADTFGVQFKEERRKGAAL
>BC4843 2-dehydro-3-deoxygluconokinase
MINMRKKIAAFGEVMMRLQVPGYELLSQANTLNYSFSGTGVNVVAALSHL
GHEGLLISTLPENSVGDAAVSYIQKLGIQTSLVSRGGKYVGMYFLENGFG
ARASRVTYSNRLESSFNTASEEIYQFEEIAKEIDIVHFCGITLAMNDTVR
HHMKSLARAVKENGGTVVFDCNYRPSLWGEDGYEQAKPHYEEMLGLADIV
MMNEKDAMFVLGIKTEETEREAQLVDLIPKVAETYHIATIAGTHRSINSD
NTHSLRGFICKDGTFTFAKTLTFSVYDRIGAGDAYTSGIIHGEIKEFAPE
KAVSFASAAGMLAHTIVGDTPMSSEKDILRAMTASVGDVER
>BC2059 Phosphoglycerate mutase
MQILLIRHGESEADILHVHEGRADFELTDKGRQQVQRLVQKVKKDFAPDF
IWASTLKRARETGETLAEAIGCPIQLEEELMEFNNGVQAGLSFEEAKKYP
EPKFLHDRFENGESFIEFRMRIEGIFSKILTENTYDRIAIVAHGGVINSL
LRAFFKMPISMDYYFKMGDTGISLIEIEGEQKTVHFINDTNHLDGM
>BC4014 Neopullulanase
MFKEAIYHRPKDNYAYAYDEQTIHIRVRTKRDDIQSADLIYGDPYEWKDG
KWISASTPMKKTGSTALFDYWSISIEPKFKRLRYAFELKSETDTLIYAER
GFFSSIPNDDVGNFFCFPFIHADDVFKAPSWIKDTIWYQIFPERFANGDS
TLNPENTLPWGSANPTPTNFFGGDFSGVIQNLDYLVKLGISGIYFTPIFK
AHSNHKYDTIDYMEIDPQFGTKETFKELVEECHKHGIKVMLDAVFNHSGY
FFEKFQDVLENGEKSAYKEWFHIHEFPIITEPLPNYDTFAFTPYMPKLNT
AHPDVKEYLLEVGRYWVREFNIDGWRLDVANEVDHNFWREFRTEIKTLNP
EVYILGEIWHDALPWLQGDQFDAVMSYPVTNALLSYFANDSIKASEFMKQ
ITESLHSYSMNVNEAAFHLLDSHDTPRILTTCNGDKNKLKLLYVFHLSFI
GSPCIYYGDEIGMDGGMDPDCRKCMIWDTKEQDHALFTHIQTLILLRKQH
KAFGGHGTFQFIEANDEHNYISYTKTYEDETIFFVLNPTNSEVTVSLPLH
VTGKKIINIYTNEEFSAEASVLQVTLPPYGFSILKW
>BC2622 Macrolide glycosyltransferase
MMLKPQSGLNAFFHVHVQTSLYILEITKQLYESINFDFVIYDIFGAGELV
KEYLQVPGVVSSPIFLIPPEFLKTLPFHPNADMPFQPEEISEKLLNQMEH
KFGVKPKNNLQFMNNKGDVCLVYTSRYFQPNSESFGENNIFIGPSISKRK
TNIKFPLESLKEKKVIYISMGTLLEGLEPFFNTCIDTFSDFDGIVVMAIG
DRNDISKIKEAPDNFIIAPYVPQSEVLNEADVFITHGGMNSVHDAIHYNV
PFVIIPHDKDQPMIAQRLTELEAAHRLLKEHVNVHTLKEAVTDVLSNEKY
KYGIRKLNDSFLECGGSKEAIAVIESLLNKVKL
>BC4568 Multidrug resistance protein B
MSMPVENVNVKAVVAVLILGMFVSILNQTIINVALPPLMNEFNVSTSTAQ
WLITGFMLVNGILVPISAFLISRFTYRKLFVAAMLFFTVGSIICATSGNF
TMMMTGRVIQAVGAGILMPVGMNIFMTLFPPHKRGAAMGLLGVAMILAPA
IGPTVTGWVIENYSWNLMFYAMFIIGLIITFLSLKFFTLAQPVSKTKLDI
FGVVSSSIGLGSLLYGFSEAGNNSWTSAEVIISLVIGVIGLALFIWRELT
TDNKMLDLQVFKYPVFTFTLVINAIVTMALFGGMLLLPVYLQNIRGFTPI
ESGLLLLPGSLIMGIMGPVAGKLFDKYGIRPLAIIGLAITTYATYEFTKL
SMDTPYSVIMTDYIIRSIGMSFIMMPIMTAGMNALPMKLISHGTATQNTS
RQVAGSIGTAILITLMTQQTTAHVADYGNMLTTSNPILVDKVHGMGQSLA
ALAGSAQAGDAMSTQLLYGQISKLSAINGINDAFLIATILAGIAWVLSFF
LQSGNKPNRKAGN
>BC2734 Pullulanase
MMQITKRLINKTVLLLTLIVMLSSVFSFQSVKAVSNSKTTEIIIHYKEKL
GNTKDWNLWLWGENANGTSYQFTGEDEFGKYAKIKIDGDYNRVGFIVRTN
EWEKDGGDRWIENIKDGRAEVWILSGDEKVYNSKPSSDLSIQKATIDSFH
EITVTTNVPFHIKEKKIEIEGIKIKNITPYDINSGDITNKVKIITEQKID
LKQTYKVKIENLADTNTEIGKVIRSEEFDNLFYYGGNDLGNTYTPQHTKF
RLWAPTASEAKLVTYKKWNDKIGTEINMQQGEKGTWTAELKGNQKGLFYT
YKVKIGDKWTEAVDPYVRAASVNGDKGAVVNLEETNPKKWKANKKPKFKN
PEDAIIYELHVRDLSIQPESGIKQKGKYLGVTEKGTKGPEGVKTGLDHIK
DLGVTHVQFLPIFDYASVNEETLNEPQYNWGYDPKNFNVPEGSYSTNPYE
PTVRITELKQMVQTLHDNNLRVVMDVVYNHMYNAAESNFHKLVPGYYYRY
NEDGTFANGTGVGNDTASERKMMRKFMIDSVTYWAKEYNLDGFRFDLMGI
HDYETMNEIRKAVNQIDPSIILHGEGWDLNTPLAAELKANQKNAEKMKGI
AHFNDNIRDGLKGSVFEEKENGFINGKENMEDRIKKGITAGIDYDTNSST
YQDPEQVLTYVEAHDNHTLWDKLELTNPGDSDEVRTQMHKLSSSILLTSQ
GIPFLHAGQEFMRTKYGDHNSYKSPDSINQMDWLRRATFNNEVDYMKGLI
ELRKKYSAFRMTSAEQIKTHVSFIDAPKNTVAYIIEGNKHEYFTVAHNAN
REAVEITLPSKGPWKVLVDGKQARSKPLYVVHDNKIKVPALSSIVLKSEK
TIK
>BC2880 Multidrug resistance protein B
MGLLLGILMASMDNTIVVTAMGTIVGDLGGLENFVWVVSAYMVAEMAGMP
IFGKLSDMYGRKRFFIFGLIVFMIGSALCGTAENITQLGIYRAIQGIGGG
ALVPIAFTIVFDIFPPEKRGKMGGLFGAVFGLSSIFGPLLGAYITDYISW
HWVFYINLPLGILALIFITFFYKESRVHRKQKIDWFGAITLVGAVVSLMF
ALELGGQKYDWDSSFILSLFGGFAILIIAFIFIERKVEEPIISFEMFKQR
LFGMSTIIALCYGAAFMSATVYIPLFIQGVYGGTATNSGLLLLPMMLGSV
VTAQLGGFLTTKLSYRNIMIISAVIMLIGLFLLSTLTPETSRVLLTVYMI
IIGFGVGFSFSVLSMAAIHNFGMEQRGSATSTSNFIRSLGMTLGITIFGM
IQRTGFQDQLEEAFKGMSGGMNTNALGDSRAILSESARSQIPPQILDKII
DALSSSIVQTFMWALVPAGLAFIFIFFMGNERMVIKKQQTNKKSETSKA
>BC5333 Fructose-1,6-bisphosphatase
MERSLSMELVRVTEAAALSSARWMGRGKKDEADGAATSAMRDVFDTIPMK
GTVVIGEGEMDEAPMLYIGEKLGTGYGPRVDVAVDPLEGTNIVAAGGWNA
LAVIAIADHGNLLHAPDMYMNKIAVGPEAVGAVDIDAPIIDNLRAVAKAK
NKDIEDVVATVLNRPRHQEIIEEIRKAGARIKLINDGDVAGAINTAFDRT
GVDILFGSGGAPEGVLAAVALKCLGGEIHGKLLPQNEAELARCKKMGIED
INRILRMEDLVKGDDAIFAATGVTDGELLRGVQFKGSVGTTQSLVMRAKS
GTVRFVDGRHSLNKKPNLVIK
>BC2225 6-phosphogluconate dehydrogenase
MKLGLIGLGKMGFPLAEHLYEDKHEVVVYDVNKELVEKAGKLGITARHTL
KEMIAELEAPRTIWVMVPAGEVVESVLKDVYPLLDEGDIVIEGGNSFYKD
TLRRAEEAKSFGLHYVDIGTSGGVEGARYGACLMVGGEKEIYDQLEPLFK
DLAVENGYSYAGRVGSGHFLKMVHNGIEYGMMQAIAEGFEVLDKSDFDFN
YEDVAKVWANGSVIRGWLMDLTEKAFAEDPKLDGIKGVMNSSGEGKWTVE
TALELQAAAPVIAMSLFMRYRSQEDDTFHGKVVSALRNQFGGHEVVKK
>BC0981 Dihydroxyacetone kinase
MKKIINKPETLVMEMCNGMVMAHPELELLKKYKVIKKKEMNENKVTLISG
GGSGHEPAHAGLVGKGMLDAAVCGDVFASPSQIQVYQAIKETASKKGTLL
IIKNYSGDIMNFKNGAHLAKEDGIEVDYVKVDDDIAVEDSLYTVGRRGVA
GVILVHKIAGAAAEAGMDLGAVKAVAEKAAANVRTIGLALTSCTVPASGS
PTFTLAEDEMEYGVGIHGEPGIKREKMLSADELANRMTNDLVKDLGVKDG
EEIAILVNGFGGTPLQELYLFNNAVTRELAARNIKINRVFVGNYMTSIDM
AGMSLTVMKLDEELKTLLSKECNTPAFKVDGPVESVEYVNVLEETEEKEV
SFELETAEEHAVIKDNVITLNNMIYLVDKMSDIIIKNEVPFCELDTHAGD
GDFGMSVAKGFKQLKREWHSIVEQENVTIGSFLDGCSMIIMEHCGGASGP
IWGGAFRAASKAAAEKRELTVKEFAEMLQAALQGIQSIGERSFGRGAVVG
DKTLVDALAPCVDSWLDSASNEVDVKTAFEKGAEAAVKGAEYTKEIVARM
GRAGTVGERSLGYPDAGAHALGVIFTEIAGSLK
>BC1596 Transporter, Drug/Metabolite Exporter family
MSVKKEWIAPLALLFVSFIWGATFVVVQNAMSFVGPFTFNGIRFLFAGII
LLFVQIIFSQKTSKQELKHSSLAGLMVGFFLFVGYLLQTFGLLYTTSSKA
GFLTGLSIVMVPILSFIFLKQKATIFIILGIAVATTGLYLLTAADSFQLN
IGDILVLGCAVAFAAHILINGFFSKKISPLLLSTSQVLAVGIFSSICAFL
FEDWEKLFSVSLWTNQSFLFALFLTALFATSIAFFIQTSAQKHTSPTRVA
IIFAMEPVFAALTGVLVANEQLSISAIIGCLCIFLGMIFVELPSKTKKEA
QAA
>BC0582 Transporter, Drug/Metabolite Exporter family
MNNGRRIGLIMIITGATLWGLSGPMIQWLFQHTNVSSIDFLTIRLLLAGI
FILSFLLIKKQNIFQIWKHPRYSIQLIIFSILGMLGAQYAFIETVHISNA
VTATLFQFLGPVLITMYVAFEQRKFPASMQLFAIIAALIGTYFIITNGSI
ENIVLSKEAIIFGLLTAIGFAFYTLHPASLIKECGTTVVIGWGMLIGGIA
LLIYNRSFGWNQFSQTLTLKTFSMLILIIISGTLSFLLYIGSLKYLAATE
TSILSSIEPLVAAIVSITWLNESFGTYQLLGGVCIVLSVIFLTMPQKETE
PTYTTEQI
>BC5210 PTS system, lichenan oligosaccharide-specific IIA component
MMTTAEQIPFQLILNSGNARSFAMEALQFAKQGKMVEADEAMVKAKEAIN
EAHHFQTELIQSEARGEKTEVSVLLIHAQDHLMNAITVKELAAEFIDLYK
KLEAKGE
>BC3858 Ribulose-phosphate 3-epimerase
MIKIAPSILSADFSKLGEEIKDVEKGGADYIHVDVMDGHFVPNITIGPLI
VEAIRPITSLPLDVHLMIENPDNYILTFAQAGADIITVHVEACPHLHRTI
QLIKSHGIKAGVVLNPHTPVSVIEHVLEDIDMVLLMTVNPGFGGQKFIHS
VLPKIKQVADMVKERNLEVEIEVDGGVNAETARLCVEAGANVLVAGSAVY
NQKDRGEAIRVIRG
>BC2682 Chitosanase
MNGKRKIFTCISIVGIGLASFSNSSFAASVTDNSIQNSIPVVNQQVAAAK
EMKPFPQQVNYAGVIKPNHVTQESLNASVRSYYDNWKKKYLKNDLSSLPG
GYYVKGEITGDADGFKPLGTSEGQGYGMIITVLMAGYDSNAQKIYDGLFK
TARTFKSSQNANLMGWVVADSKKAQGHFGSATDGDLDIAYSLLLAHKQWG
SNGTVNYLKEAQDMITKGIKASNVTNNNRLNLGDWDSKSSLDTRPSDWMM
SHLRAFYEFTGDKTWLTVINNLSDVYTQFSNKYSPNTGLISDFVVKNPPQ
PAPKDFLDESEYTNAYYYNASRVPLRIVMDYAMYGEKRSKVISDKVSSWI
QNKTNGNPSKIVDGYQLNGSNIGSYPTAVFVSPFIAASITSSNNQKWVNS
GWDWMKNKRESYFSDSYNLLTMLFITGNWWKPVPDDKKTQNLINDAIYEG
YDN
>BC3720 Fructose repressor
MLTPERHQMILQLVKEQKVVKLQQLVERTESSESTIRRDLAQLEKQRLLK
RVHGGAAVLTGKGQEPTMVEKSSKNIQIKQQIAKYAASVIEQGDCIYLDA
GSTTFEMIPFLINKDVTVVTNGLMHIEALVENNIRAYLLGGMMKSRTKAL
IGAMAQESMQKYRFDKCFLGANGVHEQLGFTTPDPEEALLKQMALTLANE
GYFLIDESKFSEVAFAKIANVEDANIITNHLEIDLEKYKQQTNVIEADKQ
>BC2681 Transporter, Drug/Metabolite Exporter family
MHNKKWDLRIICAHAFTILIWGTAFPAIRMGLESYTPEHLTLLRLLIASF
ILLLFSFIYKLRLPDLKDIPAIFIFGALGFTIYHIALNYGEKTVNAGSAS
LIISVTPIVTAILASVFLNEKMKLNGWLGGVISFAGIALISFSQGDAIQL
NSGGLFILLAAISESLFFVFQTSYLKKYGFLPFTIYTILSSTVCMLIFLP
GVYQEILAAPLEVNLSVIYLGVFPTVLPYIALAYIISRAGASEATSSLYL
TPITACFIAWIWLGEVPTLVSIIGGGITILGIVIAHIPVLRKEKHRNLAN
NQSV
>BC4784 hypothetical protein
MDKRKETTVTVSMVKLNFSLFFIIIALSVGIGYLHIFLSGGVQVEVTLLT
MFLFIIAMIVLVCIHEAIHLIGFRYIGGVPWSELKWGVNWKLGVAYAHSK
QAVTVKQMKKVLMLPFLPTGILPIVLGLAMNLEPLSFLGILLTAGCIGDI
AVYQKVSKFPDDALVKDHPSKPQFTVYE
>BC4929 Macrolide-efflux protein
MEELQQNKTALEGSGKPLLKNTNFLFLWAATLFSSFALAFFTFSQTWYIA
KTLNLEASLGVVFVALSVPRLIFMIVGGAVADKFPKKNIMFYSNIIRAIL
VATILTWFIVGDITLYTFALFALFFGLADAFFWSADGSILPELVEKSRLT
QANSLTQMTNQASVILGPVLGGILIKFTNYETIFSITILLLIVAAILVQK
IQFTMPEQKDTDKGMFTSIKEGILYVKESPFLSTFLICSAFLNLFLIGPM
QVGFPLFVKNVLHGDSLQFSYLEASVGGGMAIGAVIVGLKNINRRRGLFC
IIMMLLSGVFFLSINFSTVLWQALLAGMFYGITIAMAIVPLMAMIQSTVK
EEMMGRVMSLLMLSSMGFIPLSYAFTSIALAIGIPIVTVMKSGAIAVIVF
VLFVAIRVPVVRKFD
>BC4651 Transporter, Drug/Metabolite Exporter family
MNKNQMLLGSFLCLLAVTAWGFMFPVMARALQFIDPFFFTTLRYGSAAII
FLILLLITEGKTSLRLEKRTLSLFFYGTVGFAGYGFLVFYGQQLAGPSGA
IHAAMIQSLMPLIALSLQWITQNRRPQNYTFLCMFVALLGVMLVISKGNI
ELLFGAASHLSTNILMLCGVTCWVIYTNGAARFQSWSPLRYTTLTCLFGS
ISLIVIVTFLTYTNIVTMPSLRTVVSVRFELFYMSIIAGVIAVFCWNMGN
RYISSINGILFMNLVPILALIGSIFRGYTVDKIEIAGAALTIIALLCNNL
WQRKVNIKIPTSVR
>BC5098 hypothetical protein
MNKKAKALSSVLLGFTLALTGCAGTKAEENHGKQKQEQVAKETKKENKLT
KGQKMANILSETNWQGTRVYDKDKNDLTKENANFIGLAKYDAKSGRYEFF
DAKTGASRGDKGTFFVTNDGKKRILISESMKYQAVIDMTKLNKNVFTYKR
MGKDANGKDVEVFVEHVPYKEKELSFTDPDKQLNTTTGDIIKNVDGDKIL
GGTLWHGTKVLDEAGNDVTQFNSNFISLAKFDDKSNKYEFFNSETGQSRG
DYGYFDVVHENKIRAHVSIGNNKYGAALELTELNKNKFTYKRTGKDQAGK
DITIFVEHEPYKGDMKPQFSF
>BC2113 hypothetical protein
MKTAQHETISNREFYFVLYMMLLYVTGWVIDVNGLFLSSYFNLAGEIMLP
LVGGIVGLFIMSVNKQQTK
>BC4015 Oligo-1,6-glucosidase
MEKQWWKESVVYQIYPRSFMDSNGDGIGDLQGIISKLDYLKELGIDVIWL
SPVYESPNDDNGYDISDYCKIMNEFGTMEDWDELLHEMHERNMKLMMDLV
VNHTSDEHNWFIESRKSKDNKYRDYYIWRPGKEGKEPNNWGAAFSGSAWQ
YDEMTDEYYLHLFSKKQPDLNWDNEKVRQDVYEMMKFWLEKGIDGFRMDV
INFISKEEGLPAVETEAEGYVSGHKHFMNGPNIHKYLHEMNEEVLSHYDI
MTVGEMPGVTTEEAKLYTGEERKELQMVFQFEHMDLDSGEGGKWDVKPCS
LLTLKENLTKWQKALEHTGWNSLYWNNHDQPRVVSRFGNDGMYRIESAKM
LATVLHMMKGTPYIYQGEEIGMTNVRFESIDEYRDIETLNMYKEKVIDHG
EDIEKVMESIYIKGRDNARTPMQWNDQNHAGFTKGEPWITVNPNYKEINV
KQAIQDEGSIFYYYKKLIELRKNNEIVVYGSYDLILNNDPSIFAYVRTYG
DEKLLVIANFTADESVFEMPKDISYSESELFIHNYDVEIGSIDNIPLRPY
EAIVFKLK
>BC4606 hypothetical Membrane Spanning Protein
MTMDVREHTFFSLLIISYFIAFGVILGGSLIGGFGAFLIGKPALTYINQF
AQNLRIWALVAAIGGTFDTFYSFERSFFGGDMKDIVKQILLIFFATGGMQ
TGLIIIKWLTQEHV
>BC1031 Oxalate decarboxylase
MKKRTVNEAGRNVPQPIRSDGAGAIDSGPRNVMRDIQNPNMLVPPITDAG
LVPNLKFSFSDTSMILKQGGWSREITARELPVSTTIAGVNMSLTAGGVRE
LHWHKEAEWAYMLLGRARITAVDQNGRNFIADVGPGDLWYFPPGIPHSIQ
GLEHCEFLLVFDDGHFSDLSTLAISDWFAHTPKEVLSANFGVPESVFRSL
PSDQVYIYQGEVPGSLESQEVQSPKGEVPLTFKHELLKQKPVKTPGGSVR
IVDSTNFPISKTIAAALVEVEPGGMRELHWHPNNDEWQYYLTGEARMTVF
LGNGTARTFDYRAGDVGYVPFATGHYIQNTGTETLWFLEMFRSNRFEDVS
LNQWMALTPKEIVESNIHVGPQVMDSLRKEKWPVVKYPGFSYSPKSDE
>BC3719 1-phosphofructokinase
MIYTVTLNPSIDYVVQVSSFDLGTINRAEKDMKFPGGKGINVSRVLQRLG
VKNIALGFTGGFTGQFIKEVLQTEGVTTNFVQVDEDTRINVKIKGEEETE
LNGQGPIVTKEQFEQLMKKIESMQPGDCVVLAGSVPVSIPSTFYESIAAF
GAEKGIRVVVDASGSALQHVIKNKPFLIKPNHHELGELFGVELSTVEDVL
PYGRKLIEQGVKHVIVSMAGEGALLFTAEGIYEATVPKGVVINSVGAGDS
LVAGFVGKYEQTKDIEKAFQYGVATGSATAFSADLCKKEKVEELLSQVIV
AKR
>BC4011 Cyclodextrin transport system permease protein
MNIKRQKMLRLSLSYLVIFVMCAIIFYPLLWIIGSSFNPGDSLSGSSIIP
QNATLDHYRKLLDLENSNYLLWYKNTLKVSVLTMIFSVLAISFTAYAFSR
YRFVGRKNGLLTFLILQMIPNFAALIALYVLAQLTGLIDTHLALILIYVG
GAIPMNTWLMKGYFDTIPKELDESARMDGAGHFRIFWQIIMPLAKPIVAV
VALFTFIGPFTDFILASIILRTPENYTLAVGLYEMVAKKFGNEFTTFAAG
SVLIAIPISILFLSLQKYFISGLTAGGTKG
>BC1598 LACX protein
MTATIQNEKVIVSISDKGAELQSVRLKEDNTEYLWQGDSTYWGRRAPILF
PIVGRLVDNTYYVDGKPYSLTQHGFARDLTFFVKEQSETKITYIVTSNEE
TLKKYPYEFELLVSYELNGQSVHITYEVNNPTSKEMFFSIGAHPGFNFPL
LDGESFTDYHLSFNGSERLETSVLEGPYLSNKKQLIAENTTELPLTYDLF
KNDALIFEHMNTNEISIRSHKHNKFVKVEFDGFPFVGVWTPGDNAPFLCI
EPWYGIADEVNPAKDFKNKKGIQSLQANETFTCRYSITIG
>BC0804 Quinolone resistence NorA protein
MGEAILVKREPLWTKEFVALIFANLCMFLGFQMLIPTLPVYVKEIGGTSS
NIGFVVGMFTVAALFVRPLTGNALQKFNKKIILMIGTAICLLAMGSYLFA
STIFLLLAVRILHGAGFGITTTTYGTVVSDLIPSARRGEGMGYFGLSGTL
AMALGPLIGLWLMQTYNFTILFLCALSCTIVSLILTKLLQIQKTKQPPQQ
SSSTFLDGFIERKALLPSLLILCITLMYGGIGSFITLFATEVGIADISLF
FLCNALAIAVTRPFSGKLYDAKGHTFVIIPGVIITFTGIILLSYTTTIPS
LIIAAACYGSGFGAIQPALQAWMIDRVAPHRRGVATATFFSAFDLGIGAG
AIIFGFIAHFTNYATVYRYSSLLLIAFLFIYITSIRKQKHGDKNTEKAAG
>BC2965 Sugar (pentulose and hexulose) kinases
MLMSHLLAFDAGTGSIRAVLFDLHGNQIAVSQKEWIHKSDLRYPGSMNFD
VVENWKLVQECTKEVLQKSNTPASSILAISATSMREGFVLYDQDGQEIWA
CANVDGRASVEVSELKEIRSHLEKDLYTKSGQTFSLGALPRLLWIKKHEP
DVYNNIHSFTMLNDWILYKLSGVLQIDPSNGCTSGIFDLQNRVWDNDVAK
ECGLSLPFSPTVNEAGTVIGNVTKECAALTGLREGIPVVAGGGDAQMASL
GTGIVKPNQTLICGGSFWQQEVNVTEPITDPHAAIRVNCHVVPNLWQYET
IAFFPGLVMRWFRDAFCQEEKKLADKLGVDAYELLEEQAKDVPVGSHGII
PTFSNVMNYISWRHAAPSFLNLSLDADKCGKKELFRAIEENAAFITLGNL
KLIKNLTGTFPSEVIFAGGAAKGKLWPQILSDVLGIPVKVPVVKEAAALG
TAIAAGVGAGIYSSMEETAEEFVQWEQTFEPVTENHELYKEFYETWKTVY
DSQLALADKGLPSHMWTAPGAL
>BC3482 Glucan 1,4-alpha-maltohexaosidase precursor
MFKRITIVGLSVVMFLPSIYEGSKAYADTVNNGTLMQYFEWYAPNDGNHW
NRLRTDVENLAEKGITSVWIPPAYKGTTQNDVGYGAYDLYDLGEFNQKGT
VRTKYGTKAQLKSAIDALHKKNIDVYGDVVMNHKGGADYTETVTAVEVDP
SNRNVEVSGDYEISAWTGFNFPGRGDSYSNFKWKWYHFDGTDWDEGRKLN
RIYKFRGIGKAWDWEVSSENGNYDYLMYADLDFDHPDVANEMKKWGTWYA
NELNLDGFRLDAVKHIDHEYLRDWVNHVRQQTGKEMFTVAEYWQNDIQTL
NNYLAKVNYNQSVFDAPLHYNFHYASTGNGNYDMRNILKGTVVANHPTLA
VTLVENHDSQPGQSLESVVSPWFKPLAYAFILTRAEGYPSVFYGDYYGTK
GNSNYEIPALKDKIDPILTARKNFAYGTQRDYFDHPDVIGWTREGDSVHA
NSGLATLISDGPGGAKWMDVGKNNAGEVWYDITGNQTNTVTINKDGWGQF
QVSGGSVSIYVQQ
>BC2144 5-methylcytosine-specific restriction enzyme A
MELNMLYLFTASNDSAIKNLEATIEKIYPISTCLADLDADTVTKLKDNEL
HENVCMWGATPGSSNVDRWEKLKEGDRILAYSKGEFKFFGTIFAKTHNPD
VARKI
>BC2967 Fructose-bisphosphate aldolase
MTWGFKNRLNTILPDGRAVMLAIDHGYFLGPIHGLEQPLETVKNLLPYTD
SLFLTRGVLSSCIPENCSTPMVMRVSGGATVVGKDLANETIVTPVKEAVK
QNAIGVGVSVFVGSDYETQTVSNLANVVSEAHDYGLPVLGITAVAKELQK
REARFLALASRVCVEMGADIIKTYYCEGFEKITSTCPAPVVIAGGPKLDS
IEDALNITYNALQEGAIGVDMGRNIWQSEHPAAMIQAIHGIVKNGLNVKE
ALELYDDVKN
>BC0896 S-layer protein / Peptidoglycan endo-beta-N-acetylglucosaminidase
MKTFSKGITAVALTGSLLLTPISSYAANDDITGHMFETNMRSLITKGVLM
GYGDNVYAPDKLVTRAEFATFIARALNLPKADSNFEDVPKTYGLYDGVSR
AYGAKIINGRTNETFSPNDVITREEMSIMVKRALDYKNIKVAVSPLTFTD
KDSINYKEHVQVMVATQIIKGYPEDNTFRPHLSATRGMASAMLDRMLQTI
EKNGNTNPVETKKYVVTNVRENGTEQEVERYNTYKEAVTAAQNKGMNAVK
YENEFLWIKDGFASAKRITGQNIINIYDENLATVYTYIQYGTELKVLEVG
EDRVKVQLSGLTGYVKKNEITLIPTNEMKQSSYYVKSDGYLYHKYYTYNT
SSPGYTEFRYGVAPSFMKQGQQMYSVDGKTFGDETFYQYFNYLSLRSKTD
YTAEQLDSYVKSIKPDSPLIGLGKKFKEVESKYNVNALFLYSLAIHESYY
GTSALAKDKNNLFGLKATDDSPYGNGEAFNSKEDCIEHAAKLYMNEGYLN
PGHWRYTATYTGDKAAGLNAKYASDANWGKKVAGHMNRFDSYLGKKEYNK
YKLARVMNNVEVKKNPSISNERLYRLNTNVVVTVTGEEIINGKAWVKVIS
DNPTVTEAYIAKESLEYVKH
>BC3209 hypothetical Cytosolic Protein
MYLATALKNLESLGFTFSEPLIEELQTLSVGAFTSFYKELVKHLKELVGA
HIQFTPMYPNFPQQMMDLSDADLYINAVIHYVTLRLPVSKVEERLPLLDS
VDLKVIDLGSEEDFNQMISQLIRANSSISSTDKTDVEWAITHTEDVSCFL
PNVIPHKENMSFIIGVLLINRKISADAAAKYFKTATDVLRLAVALSEGDV
SLASSVRFKKFNRVERRFLLGLLEQCGNITEDMIRYKKRWIRLGEILHPA
EYHTRFPKTHRAFEMLLFFH
>BC2961 Sugar transport system permease protein
MEGRKEDESMKYVYRWEGVLIVLLLVEFILFSLINSDFLNISNLLFSTND
FLFIAIAAIPMTFVIVTGGIDVSIGSIMGLTSILIGVLWMNGIPILFAVI
IALIISCLAGALNGLIIKMTDVEPLVVTLGTMFLYGGIALVISGGAGASG
YEGISGLPDTFVQLANGSFIGIPNLLWLLIVLTVLCTVLFHRTIYGRHVK
LTGANENTAKYTGIKTKKVVIIAYILSGLGGGLGGAFLTAYFGSARADMG
SETILPIITAVVLGGTLITGGKGSIIGTVLASIFIGLMQYGLQMTGLTNE
QSNVVIGIILILSVIMRHFKLHQFLAEKRKNLHKGEMS
>BC2787 HIT family hydrolase
MILYMKRMVMNMSTNDQVKLNCFICEKHKGNIIVPGGAIYEDELLYVGHV
HWDSEETYLGYVMIDIKRHVPGLAELTDEEAKAFGLITSRVSKALKESEG
AEHIYTFVSGNGVPHMHMHIIPRYANTPKEFWSPTEIAKWTGAPYGEAAK
IKKLCERIREYMVSEYAYNK
>BC2960 Sugar-binding protein
MKRKLGIVLIVCICLIGLIACSSQTADKKKVDDVKFAFIPKLTGVGFFTS
GGEGAKEMGDKLGVQVKYDGPSEASVSGQVKYINNFINQNYDALMVSSTS
VDGLSQSLQRAKKKGMTVLTWDSDVNPKDRSFYISQGTPDQLANLLIEMT
SKQIGDKGKVAFFYSSPTVTDQNQWVTKAKEIIKKKYPNWEIVTTQYGEN
NAQKSLSVGENILKTYPDINAVICPDATALPAMAQAAENLKMDKKVVVTG
FSTPNVMRDYVKRGTVAQFGLWDVKQQGALATYVANEIVVKGKKLKVGDS
FEVKGIGKVKVEPNSIQGYDYEAEGNGIIVLPERVVFTKDNIDKYNF
>BC2885 Peptide permease
MNYLLLRYNKPIFIRLCGELLTRTTESMLALIMIIYVNKMLNGNVIITML
IFGLQPLSDILFTLIAGGITDKYGRKKIMLLGLLLQGVAIGSFVFAQSVF
IFALLYVINGIGRSLYIPAQRAQIADLTKQEQQAEIFALLQTMGAIGSVV
GPLIGASFYNTHPEYLFIVQSVTLTIYAVVVWTQLPETVPPISKSKQTVE
ASSPKQFVFKHYAIFGLMVSTLPISFFYAQTETNYRIFAEHVFPNLVFIL
AFISTCKAILEIILQIFLVKWSERFSMAKIILISYACYTIAAVGFSYSTT
ILSLFFTLLFLVIGESIALNHLLRFVSEIAPHDKRGLYFSIYGIHWDISR
TCGPVIGAVILSKLNGSMLFYICASFLLVGGIVQALFVQSLERKKIVNHP
THNL
>BC4012 Cyclodextrin transport system permease protein
MQTSMEPANGLNHSKHRKMATMLSIIPGVGQMYNKQFVKGLIFLVLTGSF
IVAFADLLNMGLWGIVTLGTEVPRDHSVFLLVEGILALIVIAFGLGIYAF
NLYDAYQNGKKRDIGTPLNSVKEQYRNLLDQGFPYLMVSPGFLLLIFVVV
FPIIFVILIGFTNYDLYHSPPAKLVDWVGFKNFIDIFTLPMWRETFVSVF
SWTVIWTFVATTLQVALGIFLAIIVNQPGIKGKAIIRTIFILPWAVPAFV
SILVFSGMFNETFGAINNQVLALFGIEKIAWMTDPFWAKIALIMIQTWLG
FPFIFAMTTGILQSIPGELYEAATVDGATAWQQFRKITLPLVLYATAPIL
ITQYTFNFNNFSIIYLFNGGGPAVAGQDAGGTDILISWIYKLTMTSAQYG
KAAALTMILSLIVITVALWQFKRTKSFQEEDMM
>BC1199 ATP-NAD kinase
MKFTIMSKGDQSSDTLASTMKEYLLDFGFIMDEKEPDIVISVGGDGTLLY
AFHRYYNRLDETAFVGVHTGHLGFYADWLPTEVEKLVIAIAKTPFQVVEY
PLLEVIIRYVNGSKESQYLAMNEATVKSAEGTLVTEVEIRGEYFETFRGD
GLCISTPSGSTAYNKALGGAIIHPSIEAIQIAEMASINNRVFRTVGSPLV
LPKHHTCVLKPAAGMNLQITVDHLTMVHQDVKSIQYRVANEKVRFVRFRP
FPFWKRVRDSFVADK
>BC1171 Glucose epimerase
MFQRERVGGMERVLIVGALTFVGYHLVNKMIAEEVEVYGLDFDEFDSMTK
INEEKLLLIGRNALFTYYSIRDEDGWRSVEEERFDTVYFCLYEPNQQSGF
RNERVILQYLKRIIRMCEEQKVKLNLISSIEVGSTDESENKRLFLKVEEG
LKKGNLQYSVFRVPTLYGPWQPSFMMFHQLILSELGEKECRCTIEEKGND
LLYVEDVCEYLWENGTNGAHLGIYNLLSGKQSLWEKGMNLLRADDKVNKN
NNEVRDEAIEVISIKRNTPLEYGLNKQLAHMKKYKELYEG
>BC5136 Phosphoglycerate mutase
MRKPTALIILDGFGLREETYGNAVAQAKKPNFDGYWNKFPHTTLTACGEA
VGLPEGQMGNSEVGHLNIGAGRIVYQSLTRVNVAIREGEFDKNETFQSAI
KSVKEKGTALHLFGLLSDGGVHSHMNHMFALLRLAAKEGVEKVYIHAFLD
GRDVGPKTAQSYIDATNEVIKETGVGQFATISGRYYSMDRDKRWDRVEKC
YRAMVNGEGPTYKSAEECVEDSYANGIYDEFVLPSVIVNEDNTPVATIND
DDAVIFYNFRPDRAIQIARVFTNEDFREFDRGEKVPHIPEFVCMTHFSET
VDGYVAFKPMNLDNTLGEVVAQAGLKQLRIAETEKYPHVTFFFSGGREAE
FPGEERILINSPKVATYDLKPEMSIYEVTDALVNEIENDKHDVIILNFAN
CDMVGHSGMMEPTIKAVEATDECLGKVVEAILAKDGVALITADHGNADEE
LTSEGEPMTAHTTNPVPFIVTKNDVELREDGILGDIAPTMLTLLGVEQPK
EMTGKTIIK
>BC1694 hypothetical protein
MHFLVKVIVSALIIGIITEVAKHYSTIGGFIAALPLVSLLSLFWISFEGG
NKQELSQFALGVLYGFPASALLLFIVYIGLKNSFTLSTSVLLGIGVWCIV
FACQKLFQA
>BC4050 PTS system, glucose-specific IIABC component
MFKKIFGVLQKVGKALMLPVAILPAAGILLGFGNAFQNPQLTNVIPALKA
DWFVMVAKIMEQSGDIIFANLALLFAVGVAIGLAGGDGVAGLAAFVGYLI
MNKTMSVFLEVDKLVKVTSSGADPVKIGFADPAYANVLGIPTLQTGVFGG
IIVGIVAAYCYNKYFNIELPSYLGFFAGKRFVPIATATFSLIVGIIMCFV
WPYIQGGLNTFSHQMIDANRTIAAFIFGLIERSLIPFGLHHIFYSPFWFE
FGQYTNAAGELIRGDQKIFMAQLKDGVELTAGTFTTGKYPFMMFGLPAAA
LAMYHEARPENKKLAAGILGSAALTSFLTGITEPLEFSFLFVAPVLFGIH
AVFAGLSFMTMQILGVKIGMTFSGGLIDFLLFGVLPGRTAWWWVIIVGLV
LAVIYYFGFRFAIRKWNLKTPGREVANANDGAGKAEAGELPREVLVALGG
KENIASLDACITRLRVQVNEQKNVNKDRLKELGAAGVLEVGNNIQAIFGP
KSDTLKSQIHDIMSGRTPHVEKEDPVKVEETPQKVDENETIVSPIEGKIL
PITEVPDQVFSGKMMGDGFAIEPTEGTVVSPVNGEIVNVFPTKHAIGIQS
EGGKEILIHFGIDTVKLNGEGFEALVAQGDKVKQGQPLLKVDLAFVKENA
PSIITPIVFTNLQQGQQVELKKDGNVKKGETAIIDIQ
>BC4000 Multidrug resistance protein B
METQPLKKEANKTKFVVAGLLLGILMAAMDNTIVATAMATIVGDLGGFDK
FVWVTSAYMVATMAGMPIFGKLSDMYGRKRFYIGGLILFLFGSALCGTAS
SIEQLSIYRAIQGIGGGALMPIAFTIMYDIFPPEKRGKMTGLFGAVFGTS
SVFGPLLGAYITDYISWHWVFYINIPLGLISFFFITKYYSESLEFRKQKI
DWAGAITLVISIVCLMFALELGGKEYAWNSTVIIGLFTTVVITLIIFFFV
ERKATEPIISFHLFKKPLFAASQGVAFFYGAAFIICTVYIPIFIQGVLGG
SASNAGLILTPMMVGSVIGSQTGGQLASRTSYRNIMMVSGVFFVLGIYLL
STLTMDTPRLLVTLFMILAGLGVGFSFSVLSMSSIHKLEMRDRGSATSTN
SFFRSLGMTLGVTIFGTIQNHIFTDKLNSVFPPELAKLAPKGGDTSFLLS
PGATAKIPAEILAGIKEALATSIANTFFWALIPAVLSIICILLMGNERLF
TGPKKKEKQKQVS
>BC2929 Peptidoglycan N-acetylglucosamine deacetylase
MHNGIRMTTLVKRAMLVCAGVLFTYEVAFGSVHTALASTEDEAKSVQLVS
EIQTSLAPKEAPKHYNGQVRKVAYLTFDDGPGKYTAELLDMLKKENAKAT
FFLIGSNVKAFPDLVKREDAEGHYVGMHSMTHNYKKLYTEGHYVDEMKED
QGLIAGVLGKSPVLTRPSYGSMPGLNEALRNKVVENGLKVWDWTIDSLDW
KYNKMQVDAASAKIVENVLHGATNPTEVILMHDIHPQSVKAVPGIIKGLK
EKGYELEAYNENEHFPLNFWHDNRM
>BC4571 Deblocking aminopeptidase
MAMTKLDATLAMLKELTDARGIAGNEREPREVMKKYIEPFADELSTDNLG
SLVAKKVGEENGPKIMVAGHLDEVGFMITQIDDKGFLRFQTVGGWWSQVM
LAQRVTIVTRKGDVTGVIGSKPPHILPPEARKKPVEIKDMFIDIGASSQE
EAMEWGVRPGDQVVPYFEFQVMKNEKMLLAKAWDNRIGCAIAIDVLKQLK
DEKHPNVVYGVGTVQEEVGLRGAKTSANYIKPDIAFAVDVGIAGDTPGVT
SKEAQSKMGDGPQIILYDASVIGHTGLRDFVVDVADELQIPYQYDSVAGG
GTDAGAIHIAVNGIPSMAITIATRYIHSHAAMLHRDDYENAVKLIVEVIK
RLDKEAVHNITFN
>BC5211 PTS system, lichenan oligosaccharide-specific IIC component
MQKFIAFMEKYIVPVAGKIGSQRHLAAIRDGFIAVMPLILVGALASLING
FPSEAFQDFMKGLFGETWKQVGGGMWTGSFAILALIIAFTTSYNLAKSYG
VDGLSAGIISFGALIILTPTTPKEGGLNLAWTGAQGLFVAIIVALLVTEV
FRFFVQRNITFKMPDGVPPAVLRSFAAIVPAFVILTVVAGIQLAVKLAGT
SVHEFIFNTIQSPLQSLAGTLPSAIVIVLLVHLLWFFGLHGPNIVGGIIE
PLYLPALEKNMKLFQGGTSAFDVPNIVTKPFFDTFVYLGGSGATLAFLVV
VLLVAKSAQLRGVSRLSIGPGAFNINEPVIFGTPIILNPVLFLPFIITPI
VLVITSYTAISIGWGPKTVAMIPWATPPIISGYLVTGGHLSGAILQLFNF
VIAMVIYYPFVVLCDRSVVRTEKAAAQGNNNSVPM
>BC2796 Ribose 5-phosphate isomerase
MNLKQLAGEYAANFVNDGMKIGLGTGSTVYWTIQKLGERVKEGLSFQAVP
TSKETEALAQQLNIPLISLNDVQSLDLTIDGADEIDSNLQLIKGGGGALL
REKIVASSSKKLIIIADESKLVTHLGTFPLPIEIIPFSWKQTENKIQSLG
CQTTLRLKNNETYITDNNNMIIDCIFPNHISNPVHLHTQLKMITGVVETG
LFISMTSTAIIGTKNGIKKL
>BC2433 Indole-3-pyruvate decarboxylase
MKKQYTVSTYLLDRLHELGIEHIFGVPGDYNLAFLDDVVAHENLKWIGNC
NELNAAYAADGYARIKGIAALITTFGVGELSAINGIAGSYAENVPVIKIT
GTPPTKVMENGAIVHHTLGDGKFDHFSNMYREITVAQTNVTPEHAAEEID
RVLRACWNEKRPVHINLPIDVYNKPINKPTEPIINKPILSNKEALNKMLL
HAISKINSAKKPVILADFEVDRFHAKENLHQFVEKTGFPIATLSMGKGIF
PEKHPQFIGIYTGDVSSPYLRKRIDESDCIISIGVKLTDTITGGFTQGFT
KEQVIEIHPYTVKIIDKKYGPVVMQDVLQHLSDSIEHRNKDTLDVKPFIL
ESSPFTEEFIPKAQMVTQKRFWQQMYHFLQENDVLIVEQGTPFFGSSAIP
LPNNTAYVGQPLWGSIGYTLPALLGTQLANLSRRNILIIGDGSFQVTAQE
LSTILRQNLKPIIFLINNNGYTVERAIHGQNQLYNDIQMWDYNKLSMVFG
AEEKSLTFKVENEAELAAVLTNITFNKNQLIFIEVIMSQSDQPELLAKLG
KRSGQQNS
>BC4621 hypothetical protein
MNLIELTKDIKDQHKNFVVSNINSHCLRIAVFTGEYDWHYHSNSDELFIV
LEGELLIDFEDGETAVLKPNDSILIPACKIHRTRALKRTVNLCFEHIEAD
TIKVEQL
>BC0434 Macrolide-efflux protein
MKMNALFKNRAFMLVMASDILQQFAIWIRNMALLYFIMERTNNDPVSVSL
LSVMEYAPIFIFSFIGGALADRWNPKRTMVTGDVLSVLSIIGIVLLLKLD
YWQAIFFATLISAIVGQFSQPSSSRIFKRYVKEEQVANAIAFNQTLQSLF
LIFGPVVGSLVYTQLGLFTSLYSLIILFLLSAIALSFLPKWVEKEQVARD
SLKNDIKEGWKYVLHTKNLRMITITFTIIGLAVGLTTPLEVFLVIERLGM
EKEAVQYLAAADGIGMLIGGIVAAIFASKVNPKKMFVFGMGILAMSFLVE
GLSTSFWITSFMRFGTGICLACVNIVVGTLMIQLVPENMVGRVNGTILPL
FMGAMLIGTSLAGGLKELTSLVTVFCIAMALILLAIGPVLRMQIKKEDVA
NKEALTNSLASK
>BC1833 hypothetical protein
MLKGNNLIFKIRGGITMNINNLIVKNMDNPHELEKMYRKDPKAFKKAFSQ
AWDQNPDSQVLAAWYERLHFKEKVNKEKTSLFQKGFLFMGLLAILAGIST
RIIFHFVEQEAIAPINLAFGVIPFIAAYFVYNNTPKKSIIYSLAALFLIS
GYYLNTLPVNYKDSTILAYLHLPIFLWVLVGLAFTGNEYSKGSTRLAYIK
FNLEYCLLYGSMAVSGMILAVFTMRLFSFVDLDIGEFYFSNVVLFGAAAL
AIVTAYLVSMNLKLAKNITPYISKIFSPLVLITLLIYLITVIWIGKNPFL
DRNFLMAFNGILLGVLAVTIFSIVESDSDEKKNISDYINFSLIVLALIID
TVALSAIVFRLSSYGITPNRLAVLGVNILIWANLIWIMFAYMRFLQNKSG
LKAIQDAVTKYLPIYGLWAAFVIFTFPIIFN
>BC2104 hypothetical protein
MDRKLGMFLNTKHIEVNEGIQKAREWDLEYIQLYAMNKNFNLANISMVEW
NTLKKSLSFNGIKIPSLAISFGENGIMGIEAESAIDQFKYITDRGLGLGA
KIITAHIGKVPDDEKSAYYDKMLRVCNEIGDLAFRFGGFFAIETGSEKAI
VLKRFLETANSKGLAVNFDPANIISDVNENPGEGLLLLKDYIVQTHIKDC
KEVKNDRSTKYIEVAAGNGEVDFDIFFKVLDKIGFDGYNMIERNDYFDEL
DGMSQSINFAKKYIPTQKE
>BC1840 Transporter, Drug/Metabolite Exporter family
MTQLSRTKTAIILTFLVFMWGINWPLSKFALHYTPPVLFAGVRTLIGGFI
LLLFALPKYKELHLKETWHLYVISSLLNIIIFYGLQTVGLQYMPAGLFSA
IVFLQPVLLGIFSWIWLEESMYGLKIFGLVLGFIGVGVISSSSLTGHISV
IGILLALGCAIGWALGTVFIKKTGHRVNAIWMVTIQLLIGGLCLIGFGSE
FESWSSIAWSMPFVSVLLFISFFVIAMGWLAYFTLVGAGEASKVGAYTFL
IPLIAIIVSSIFLHEAITMSLFIGLLFIVVSICFVNIKPKTLAVRQQVEV
K
>BC4348 Phosphoglycerate mutase family
MKIVFVRHGEGEHTRDLPSSLKVLHPPLTDEGRNQAKLLQCNVPLQEADI
LIASPTLRTLQTATIWSAKVACQKIVHPYVSPRIFPYREEARTLPCDYIV
DQGMITKLFPHFSIEKSSNNQLWKEGINTISENSFQQIVDEFLLWCYELS
VERICIVSHDGTITAYRQYLQKVVLTRSDFLKETGIYEMDLSQKILIDKG
>BC2894 Macrolide-efflux protein
MWRNKNVWIVLIGEFIAGLGLWLGILGNLEFMQKYVPSDFMKSVILFIGL
LAGVLVGPMAGRVIDQYEKKKVLLYAGFGRVLSVIFMFFAIQFESIAFMI
AFMVALQISAAFYFPALQSVIPLIVREHELLQMNGVHMNVGTIARIAGTS
LGGILLVVMSLQYMYAFSMAAYALLFLSTFFLQFEDKKSTTPSKQAAKDN
SFMEVFRILKGIPIAFTALILSIIPLLFIAGFNLMVINISEMQHDPTIKG
FIYTIEGVAFMIGAFVIKRLSDHFKPEKLLYFFAVCTAFAHLSLFFSDIK
WMALTSFGLFGFSVGCFFPIMSTIFQTKVEKSYHGRLFSFRNMFERVMFQ
IVLLGTGFFLDTIGLQYMVLIFGVVSLLIISISLSKQKHYEKQHSQSANL
>BC3618 Peptidoglycan N-acetylglucosamine deacetylase
MLLRKELEPTGYVTWEVPNNEKIIAITFDDGPDPTYTPQVLDLLRQYKAE
ATFFMIGFRVQRNPYLVKQVLKEGHEIGNHTMNHLYASNSSDEKLENDIL
DGKKFFEKWVKEPLLFRPPGGYINDAVFKTAKEAGYQTVLWSWHQDPRDW
ANPGVESIVNHVVKNAKSGDIVLLHDGGNDRSQTVAALAKILPELKKQGY
RFVTVSELLRYKH
>BC2963 Sugar transport ATP-binding protein
MPKGYKQKEKIEVVQETVKTKKILEVVDINGHAFENISFTVHAGEVVGVA
GIIGSGRTELAEAIFGLKTIKSGSILLGGKSIDTCSLHKRLDEGLVYVPE
DRARNGIFSIASVKENIAAASLYQNNRFFINKEKESALVNSFIEQFRIVV
QDMNKELASLSGGNQQKVVLAKYLACNPKIIILDEPTRGIDAKARLEVYE
TIKKMKREGLAILLISSDVEEIVQLVNRVYVMRNGRFVSHMEKEQLSVNE
VTRLAYGGVAE
>BC3718 PTS system, fructose-specific IIABC component
MKITELLKRDTVIMDLTASNKEAVIDELVEKLNGANRLNSKTEFKEAILK
REAQSTTGIGEGIAIPHAKTKAVKQPSICFGRSVSGINYESLDGQPAHLF
FMIAASEGANNTHLETLSRLSTLLMDEGFRKQLLEAKDESELLQLFDEKE
NEKEEEIEVAKPEGNEPYVLAVTACPTGIAHTYMAADSLKAKATELGIAI
KVETNGSTGIKNGLTKEDIERATAIIVAADKQVEMNRFAGKHVIQVPVAD
GIRKTENLLKRAVKQDAPIFKGVKEDGKSESIEGEKGLGIYKHLMSGVSN
MLPFVVGGGILIALAFSFGGIKAEGPLAELFMSIGGGKTGAFLFLVPILA
GFIASSIADRPGFMPGVVGGFLAANANAGFLGGLIAGFLAGYVVLGLKRL
FSGLPVQLEGIKPVLLYPVFGLLITGVVMQKVVIPPVVALNEMLTGWLNG
LNGTNAILLGLILGGMMAIDMGGPINKAAFTFGIAAIEAQNFGVHSAVMA
GGMVPPLAIAFATTFFKSKFTEAERKSGLTNYIMGASFITEGAIPFAAAD
PVRVIVSCVVGSSIAGALSMLFQITLPAPHGGLFVIALVNKPLLYIFSIL
IGTIVSAVTLGVWKKKVQ
>BC2689 Oxalate/formate antiporter
MKQTSINSLLIVLGTIIVQIGLGTIYTWSLFNQPLVSKFGWNLNAVAITF
SITSFSLSFSTLFAAKLQKKLGLRKLIATAGIVLGLGLILSSQVSSLPLL
YLLAGVVVGYADGTAYITSLSNLIKWFPNRKGLISGISVSAYGMGSLIFR
YINGNLIDNLGVSQAFLYWGIIVLLLVLIGSFFLREAIVSNAVTETLHND
YTPREMMRTKQVYLLFFMLFTSCMGGLYLISMVKDIGVQLVGLSAATAAN
AVAMIAIFNTVGRIILGTLSDKIGRMKIVSATFIIIGLSVFTLSFIPLNY
GIYFACVASVAFCFGGNITIFPAIVGDFFGLKNHSTNYGIVYQGFGFGAL
AGSFIGAILGGFQPTFIIIGVLSVISFIISILIRPPNVEKKKELKHLHRK
VA
>BC3359 CDP-glucose 4,6-dehydratase
MASSSFWNKKKVFITGHTGFKGSWLTLFLSSLGAEVVGFSSHPPSIPNIF
EQGNVAKECTTMKGDITDYHSLFHAMKQHKPDIIFHLAAQPIVTASYKNP
IDTFKTNVLGTVHVLEAAKSVESVRAIINVTSDKCYENDGSGDRAFVEND
RLGGFDPYSASKACAEIVATSYQKSFFRTNTQKLASVRAGNVIGGGDWAE
DRLFPDIIRAYLHNHTLYIRNKYAVRPWQHVLDPLHGYILLAEKLWNDDK
YAEAWNFGPMNEPNRTVHDVIESVIKLWNNPLTIISSSTNTPYESPVLTL
DSTKAVNKLGWTPKLSTDDAIAWTVDWYKKYASGENIESFTRQQIDVFKN
L
>BC4196 hypothetical protein
MKALKISLTVVVELALIYLFSLLVGWSFIETFFLGSLAIFAIMWLIIMSN
HRNNITDHAISKTLTGVETGEIKPFQIVLTPSIMGTLSLVLVSFIITAIY
YLPYFL
>BC4069 Stage V sporulation protein AB
MPMIESGFVILIGLAGGIAVGSGYVAFLAVLGIIPRLAQLTRSGKHIQYF
EWAVIAGTLTGAWCSLKNITFQTSQYWLVILGIFCGTFIGMLAAALTEVL
NVLPILAKRVGVEGKIIVLLVALVLGKVIGSLFHWIYFVK
>BC3371 Transaldolase
MRFFIDTANLEDIKKAYKLGVLAGVTTNPSLVAKEGVKFEDRIAEICQAV
PKVESVSAEVTPDAVTAEEMIAQAEELIKINGGDKNVTIKLPMTLAGLEA
CRYLTEKGVKTNVTLIFTVNQALLAARAGATYVSPFLGRLDDISEDGVLL
VAKIAELFDVHQLDTQIIAASVRHPDHVTRVAMAGAHIATIPYKVIEQLA
MHPLTDQGIEKFAADWAKAPKL
>BC5140 Glyceraldehyde 3-phosphate dehydrogenase
MDLDVSGRNVFRAALNNSEVEVVAINDLTDAKTLAHLLKYDTVHGTLNAE
VSANENSIVVNGKEIKVIAERDPAQLPWSDYGVEVVVESTGRFTKKSDAE
KHLGGSVKKVIISAPASDEDITVVMGVNHEQYDAANHNVVSNASCTTNCL
APFAKVLNEKFGVKRGMMTTIHSYTNDQQILDLPHKDLRRARAAAENMIP
TSTGAAKAVALVLPELKGKLNGGAVRVPTANVSLVDLVVELDKEVTVEEV
NAAFKAAAEGELKGILGYSEEPLVSIDYNGCTASSTIDALSTMVMEGNMV
KVLSWYDNETGYSNRVVDLAAYMTSKGL
>BC5276 Phosphotyrosine-protein phosphatase (capsular polysaccharide biosynthesis)
MIDLHCHILPGIDDGAQTVTDSLAMAQKAASEGIHTIVATPHHQNGKYVN
ERTPIIHHVKQLNDELQQHNIPLTILPGQEVRLYGDLLEDYEAGKIVTLN
ETNKYIFIEFPSNHVPRYAEQLLYELRVKGMIPIIVHPERNAELIERPDK
LYNIVNKGALTQVTAGSLLGKFGKKIKKFSLQLVEHNLTHMIASDAHNTT
SRGFHLAESYELIEKEFGMNVMGDLKENPYLVISGKTIYKEDPEQIRRKK
LFGIF
>BC0962 Lincomycin resistance protein
MNMTTKSPASGKVDTSNLKHTPILIALLLGAMVALLNETLLGNALTVLMK
EFDVTASTIQWLSTAYMLVVGVLVPITALLQQWLTTRQMFLIAMVTFLVG
TLIAGFAPTFSVLLIGRIVQAVATGLITPLLMNTILIICPPEKRGATMGL
IALVMMAAPAIGPTLSGVIVDSLNWRWLFYIVIPIVIISIMIGMKYIQNV
SELTRPKVDYPSILLSTLGFGGLVYSFSASGDLGWSDAKVYGTLIVGLIS
LCIFAVRQLKIENPILELRAFKVPMFTLSVGLIVIVMMSLFSTMTLLPMF
LQTVLLVTAFKSGIIMLPGSVISAIMGPIAGKLFDKFSPKVIIVPGIVLV
GIAMFLFKGITPDTSMVQIIIMHSVLMVGLMFVMTAQTYGLNQLTPDLYP
HGTALFSTLQQVAGAIGTAIFISKMSSGTTKYMESSANPLDPLEKLNGLT
SGFQGAFALGLVFIIVAFIVSLFLKEEKEGVKEARVLQNEH
>BC3089 Integral membrane protein
MMKHIVALLIKYTAITAVLLIILSIFQGISIPRVLLISLFLTGAAYLIGD
LFILPKYGNMIATMADFGLSFFGTWLLTSLFTNLDATRNIGFSSFLAALI
IGGIEVFFHIYMQKLVLRNDNELREHNHIPHDKYAMEISDEYMDSSTINK
SKLEDTPKK
>BC4599 Pyruvate kinase
MRKTKIVCTIGPASESIEKLEQLIEAGMNVARLNFSHGSHEEHGARIKNI
REASKKTGKTVGILLDTKGPEIRTHDFVDGQAELVTGAEVVLSTEQVLGT
AEKFSVSYAGLYDDVDPGSRILIDDGLIELEVIEKADGNIRTKVLNSGTV
KNKKGVNVPNVSIKLPGITEKDVKDIIFGIEQKVDFIAASFVRKASDVLE
IRELLEEHNAQYIQIVPKIENQEGIDNIDSILEVSDGLMVARGDMGVEIP
PEEVPLVQKRLIKKCNVLGKPVITATQMLDSMQRNPRPTRAEASDVANAI
FDGTDAIMLSGETAAGQYPVEAVTMMANIAVRVEKSLQYEDMFKKRIKEF
TPTITDAISQSVAHTALALDVAAIVAPTESGYTAKMISKYRPKSPIVAVT
SDEQVGRRLALVWGVQAFMAEKRAASTDEMLDTAIQTGMDAGLIGLGDTV
VITAGVPVAETGTTNLMKIHVVGEEIAKGQGIGRKAAKGKVVVAKTAAEA
VANVNEGDILVTTSTDKDMIPAIEKAAALVVEEGGLTSHAAVVGVSIGIP
VIVGVNGVTATLKNGQEVTVDAARGIVYNGHAEVL
>BC3349 Transporter, MFS superfamily
MKSFSTPIRFMLISSFFMSFGYFAVYAFLAIYLLTFLHFSAVQVGTVLTV
MTITSRVIPLFSGLIADKIGYIIMMIAGLFLRGIGFIALGICSDFYTISI
SSALIGFGTAFYEPAARAIFGSQPAHLRKNLFTYLNLSFNCGAIIGPIAG
GFILLLDPIYAFSLTGSLMLLFAFIFYLLKNHFQVTTENTSITLGIQAIL
QNKSFLLFSFIMIFFYIMFTQLTVALPLHMKNISSSNQLATLVITINAIT
GVIFMVLFRKLFHKYNTLSIIKYGVLLMSISFLLIPLFQHPYWLFICVIL
FTIGETLVLPNADITIANYSNESYTATFFGFYQLSLAFGFIIGNYTGTSS
TSNLSGMYTPWLIFGGIGLIGFISLHILNIKKVASKEDIHLCNTSDL
>BC5030 Transporter, Drug/Metabolite Exporter family
MEKFKYSLLVLFGACSYGILSTIFKLGFINGFSAHQLLGGQYVFGWIGLF
LLVLFFSRHKVTKKQFFSLLTVGTTMSMTGIFYAISVEELPASIAVVLLF
QFTWIGVIIEAIANRTFPSRDKIISILILFAGTLFAGGVFEGLGQSFSTK
GIIFGLLAAVSFSFYVFASGRVATDVPPYTKSFLMTTSATLIVCLFFPPT
FLTDGALQAGLWKYAFFLGLFGVVVPVICFSIGVPKVGTGLGTILGAAEL
PTAIIASITLVHEVVTFMQWIGIIFILVGIFIPQLLTARKERKQNRVHSA
>BC0855 Multidrug resistance protein B
MKKPIKEQKMVLVILLSNIFIAFLGIGLIIPVMPSFMNDMHLTGKTMGYL
VAVFAMAQLITSPITGRWVDLYGRKKMIIIGLFIFGVSELLFGLGKDVWM
LYVARVLSGISAAFIMPGVTAYVADITSIQERPKAMGYLSAAISTGFIIG
PGIGGFIAEYGIRVPFFVAAAIAFIACVISIFILKEPLTKEELAEISSNT
KESSFIGDLKKSLHPMYAIAFIIVFVLAFGLSAYETVFSLFSDHKFGFSP
KDIAAIITISSIFGVVVQVFMFGKLVDMFGEKVLIQICLIVGAVLAFVST
VVFNYWIVLLVTCFIFLAFDLLRPALTTFLSKAAGKEQGFVAGMNSTYTS
LGNIAGPAMGGILFDMNIHYPYAFSGVVLIVGLGITFMWREKQLAESFAK
>BC4959 4-nitrophenylphosphatase
MYKGYLIDLDGTMYRGEEQIEEASDFVKALGERGIPYLFVTNNSTRKPEQ
VAEKLVRFDIPAKAEQVFTTSMATANFIYERKQDATVYMIGEEGLHDALV
EKGFELVDENPDFVVVGLDRDITYEKLAKACLAVRNGATFISTNGDIAIP
TERGLLPGNGSLTSVVAVSTGVDPIFIGKPESIIMEQALKVLGIEKNEAL
MVGDNYDTDILAGINAGMHTLLVHTGVTTVEKLTEYEVQPTQVVHNLTEW
IEKM
>BC3162 Bicyclomycin resistance protein
MSNFKNKAIDKDISSGLIILLATACGIIVANLYYAQPLIGLISNEIGLSN
SSAGLIVTLTQIGYVVGLLFLVPLGDIVENKKLILILLFLSAFALISMVF
VKSATLLLIASFFIGLGSVAAQVLVPLVSYLSSENARGRVVGNVMSGLLL
GIMLARPISSLVADMWGWNAIFALSATVIIVLAFVLSKVLPTRKPKAKTN
YIALLNSMWQLLRTTPILRRRAIYHACVFGAFSLFWTTVPLLLFSPAFHF
SQTAIALYALVGITGAIAAPIGGRLADLGWTRPATGIALTVVIISLILPL
FIQSSSSFGIAVLVIAAILLDMGVSANLVLSQRLIFSLSPEIRSRLNGLF
MAIFFLGGAVGSFIGGWAYALGGWNLTLWIGIAFPTIALLYFAREE
>BC2450 Macrolide-efflux protein
MKTTDSKGLLGNRVYLQVFSAYSLLMLGVFIDMLAIMTIVGFEWEVDPTM
IGLIPVAYALPGIIFGSWAGVIADRFRKIPIMMFCNLMVGLITIALLFVQ
DIHWLLVALMIRSIFIVFYYPAQQTLTRQIVSPDLLTKAVSINGIVEQGT
KIVGPLIGGMLLSWFQPEFCLIIRAISCLLATLVLIPTIKFKETISKEFV
EQQKQSTWTAWVQGWGYVLSNRIILSTMIFVTIAMAVLQLVDSQFPTLFK
SLFPHDKSKMGYIISIIGLGGILGALLTQKLKQFQYGWVVCGGMVLMGIG
FGGIGLITPGTVFVLAYLISFIAGIGSGLMLVSNQVILQIESDQDQVGRV
FGIQSSLTNAVLIISPAMSGPLVHLFGVTQLYVYGGIGLVIIGVIGVSLQ
KYLWAKHKHEPIRANNF
>BC4898 Glucose-6-phosphate isomerase
MSTHVTFDYSKALSFIGEHEITYLRDAVKVTHHAIHEKTGAGNDFLGWVD
LPLQYDKEEFARIQKCAEKIKNDSDILLVVGIGGSYLGARAAIEMLNHSF
YNTLSKEQRKTPQVLFVGQNISSTYMKDLMDVLEGKDFSINVISKSGTTT
EPALAFRIFRKLLEEKYGKEEARKRIYATTDKARGALKTLADNEGYETFV
IPDDVGGRFSVLTPVGLLPIAVSGLNIEEMMKGAAAGHDDFGTSELEENP
AYQYAVVRNALYNKGKTIEMLVNYEPALQYFAEWWKQLFGESEGKDQKGI
FPSSANFSTDLHSLGQYVQEGRRDLFETVLKVGKSTHELTIESEENDLDG
LNYLAGETVDFVNTKAYEGTLLAHSDGGVPNLIVNIPELNEYTFGYLVYF
FEKACAMSGYLLGVNPFDQPGVEAYKKNMFALLGKPGFEELKAELEERLK
>BC0414 PTS system, glucose-specific IIBC component
MKITSFDFWQKFGKALLVVVAVMPAAGLMISIGKLIGMSAGDVNAVHTIA
RVMEDIGWAIITNLHILFAVAIGGSWAKDRAGGAFAALLAFVLTNRITGA
IFGVNAEMLADSKAKVSSVIAGDLIVKDYFTSVLGAPALNMGVFVGIITG
FLGATLYNRYYNYDRLPQALAFFNGKRFVPFVVILWSTVTAIVLSLLWPF
IQSGLNEFGRWIAASKDSAPVVAPFVYGTLERLLLPFGLHHMLTIPMNYT
ELGGTYTMLTGSKVGQVVAGQDPLWLAWITDLNNLLANGDTKAYNDLLNN
VVPARFKAGQVIGSTAALMGIAFAMFRNVDKEKRAKYKPMFLSAALAVFL
TGVTEPIEFMFMFIAPVLYVVYAITTGLAFALADLINLRVHAFGFIELIT
RTPMMVNAGLTRDLINFVIVSLVFFGLNFTLFNFLIKKFNLPTPGRAGNY
IDNEDEASEGTGNVQDGSLATKVIDLLGGKENIADVDACMTRLRVTVKDL
DVVAPEAQWKQNGALGLIVKDKGVQAVYGPKADVLKSDIQDMLGA
>BC3622 Multidrug resistance protein B
MKGKLQHIHPLGMSIILGTLFARFATSMSIPFLAIYLTTVKGVSAGMTGA
IIGTSALVGVFASFIGGNLSDRFGRKTIMLWSMIVWIFVFIGFSLADHVL
SFFLLNALNGLCRSFFEPTSRALLSDLTKPEYRLLVYNLRYGAINVGVAI
GPIVGLQIGSAKSTIPFLVAAGVYILYTAILAFQFKKYPMEKKKVSTEKP
VTMLNAMRILRKDIVFLVALVGIILSNCGFSHLTTTVSQYFANAHIFEDG
VKLFSYMLALNAIVVVIIQYPVIQMCKKYTPLTSIMVGTLFVSGGLFGFG
IVESMLGAAVCTIIFTIGEVLMFSMTDVFIDDIAVAHLKGTYFGAMGFSG
IGAVIGPWFGGVLLDYYGYQNGFAVFSALAIFSTVAFPVLLVTKGLSKKR
YDRNSNIEMHAK
>BC0568 SN-glycerol-3-phosphate transport system permease protein ugpA
MIEVSKLPVQTKVSKKKKLWERTKDLRIGLLFLAPSILLFSIFLFYPLFR
TIYYSFYLTDIHGEANLFVGLENYQYLFSDPAFYKSIKSTLLFVLYTVPT
SIIFALFLALIANGKVRGIGLFRVLFSSTMGISVAASAVIWLFLFHPSVG
LFNNILASMNLPAIAWLTSPDWALFSVSVTTVWVNTGFAFLVILGGLQNI
DTSLYESASIDGASYLYKLRRVTLPMLSPTLFFIVTVTLISAFQSFGQID
ILTHGGPNDATNLIVYSIYKEAFVNHQFGTASAQAMVLFVFIFVATLLQF
KFAERKVHYK
>BC1329 Transcriptional regulator, DeoR family
MSVVGEERKRTILEKVEFKGKVKVSELAREFAVSTETIRRYLEELDREKK
LKKVYGGAVQLPGAGVEAPMLEREMLHIEEKKRIGYKAATFVEDGDVIAI
DDGSTPLQMVPYLVHRKNLTIVTSSFPVATQLISSINKKMFHGEVLFIGG
KVSPKHSRVSGSISQQVIQQFHFHKAFVSIDGLLPSFGVSSFELEKAKLS
EAMMKLAEKTYILCDHTKVGVKGNYRIAAISRIQHVICDKKMPYSFEEEL
MKHNIQWTVC
>BC3323 Pyruvate kinase
MVTKMTIDRICTIGPASNNKETLAQLIKNGMKIVRLNLSHGTHESHKDII
RLVKSLDDSIKFLGDVQGPKIRLGEVKGEQITLQAGDSFILHTQPVTGSN
TEASVDYEGIANDVKVGSRILINDGEVELIVEKISTDKIETKVKTGGNIS
SHKGVNLPDAAVRLPAITEKDKKDIQFLLEENVDFIACSFVRKPSHIKEI
RDFIQQYKETSPNVIAKIETMEAIENFQDICKEADGIMIARGDLGVELPY
QCIPLLQKMMIQECNRTNTYVITATQMLQSMVDHSIPTRAEVTDVFQAVL
DGTNAVMLSAESASGEHPIESVRTLRLVSEFAEHVKKDGPFAMKDVLQLL
RESLDE
>BC0935 Citrate-proton symporter
MAQVKSNRVAGNIFKGSVGNLIEWYDWYVYSAFAVYFSAEFFPKGDPTSQ
LLNTAAIFAVGFLMRPIGSLLMGRYADRHGRRAALTLSITVMAGGSLIIA
CTPSYESIGIMAPIILVLARLLQGLSLGGEYGTSATYLSEMASSGRRGFY
SSFQYVTLVAGQMVALGVQIVLQQLLSEPDMKAWGWRIPFIIGAMGAVAV
LWLRRTMDESEQFSNIKSQKRESAGTIRALMKHPKAVLTVIGLTLGGTVA
FYTYTTYLQKFMVNTVGLPKEVVSWINFVALLIFVVLQPIAGLLSDKIGR
RPLLMAFGILGTLLTAPIFFFMEKTTEPIVAFLLMMVGLIIVTGYTSINA
IVKAELFPTEIRALGVGLPYALTVAIFGGTAEFIALWLKSIGMESLFYFY
VAGCIAISFITYWRMDESSKTSQIEAELGGGDKLVNNKSS
>BC0665 Transaldolase
MKFFIDTANINEIKEANELGVLAGVTTNPSLVAKEGVDFHERIREICNVV
EGPVSAEVISLEADKMIEEGKELAKIAPNVVVKVPMTTEGLKAVKAFSDL
GIRTNVTLVFSAVQALLAARAGATYVSPFLGRLDDIGHNGMDLIRQIAEI
FAIHGIETEIIAASVRHSVHVTDAALNGAHIATIPANVIASLVKHPLTDQ
GIEKFLADWEKTQEK
>BC1063 Transporter, Drug/Metabolite Exporter family
MLQKSFKQEKTVPALKMIASMVIFGSVGFFSVQTNLPSFELVFVRCIFAT
IFLSVCWLLTGQYKQDKWERKEVIQVLICGFFLVFNWVFLFKAFENMSVT
IAISVYHLAPVIVLLIGSIVFKEKLTFISIISIIVCFAGALLIAGIDGSF
SVGSLMSSGMIWGFLAALFYAFTTLFGKGINKMSAYAMTFLQTFLGIFLL
IPFIDLDAFSGLTQSNWTYIIATGFIHTGIVYYLFFDSLRYLSTKTISIL
VFLDPAVAILLDTVLTGFRPTLMQITGILFIFIGMTLTLKKSKDKKLSQK
EKRIESDASISQQ
>BC1757 Multidrug resistance protein B
MEQSKGIKIVFLMCLGIFLCMIDTTIMNIALPAIQSSVNTSLEKMSWVLN
VYTMTIAVLAIPLGRIADIFGKAKMYILGLVIFGGGSVLCAFANTGDFLI
FSRFIQSIGAAILFPTSMVIGVSAMPLAKRHVALAILGVTQGLSAAMGPV
IGGIITQHLGWRWVFFVNVPVCIIGIVLCCIMLQIKNEERIISKIDWIGL
LLSSTAIFSFTLILVKGNTWGWQSNIALSCYAISTISLILFVLVERKIHN
PMVNLKLFQDRMFVGASIVVILSNLFLIGVTVLLPTFLTKLQGRTEIEAA
FLVTPISAMIFFVSPVAATLIKKLGKVTIILSGFLIMGLSYYWLQMIDVH
STNIEIIIPCMILGVGYGLVVGPITVLSASSFEGELLTASQSVVSMLRQV
GIVLAVAIFVSNLTHNLTVNKEKVYRYAEEKVRTIHVNSTEQTEILQMTK
EKIENQSLESNINKKQNAMTMGLSKEKKEELIRDKTDEILRKVPVEYRDV
KREEVMRQVTKEVEKQEESIKKEVLTFSNDVNHYAKNQMAMSFTDLYKAS
VPIILICAFVSLLFWEGKALSKKRKGRIVEEA
>BC5147 Stage V sporulation protein AC
MASKDKNLTPVQQEYKKFEQEREPKRPVLKNCIKAFFVGGFICFIGQLIS
TFYITYFDFTERSAGNPTVATLIFISMLLTGFGIYDRFGQFAGAGTAVPV
TGFGNSVIAACIEHRTEGFVLGVGGNMFKLAGSVILFGVFSAFVIALIKT
ILVQWGGL
>BC4566 hypothetical Membrane Spanning Protein
MFSIIWMLFTPLLLLCGIAGGIFLIVTGIKYRKLLVGLMGLLSLSFVTLP
FVLLSVGIHIDTIFPIPTALYWTLFSLTGLLAGVSGVQAKIKSIRNMGFI
IFTIGILGVIFWELMSVGDSFYI
>BC2066 Macrolide glycosyltransferase
MANVLVINFPGEGHINPTLAVVSELIQRGETVVSYCIEDYRKKVEATGAE
FRVFENFLSQINIMERVNEGGSPLTMLSHMIEASERIVTQIVEETKEEKY
DYLIYDNHFPVGRIIVNILQLPSVSSCTTFAVNQYINFHDEQESRQVDEM
DPLYQSCLAGMERWNKQYGMKCNSMYDIMNHPGDITIVYTSKEYQPRSEV
FDESYKFVGPSIATRKEVGSFPTEDLKNEKVIFISMGTVFNEQPALYEKC
FEAFKDVDATVVLVVGKKINISQFENIPKNFKLYNYVPQLEVLQHADVFV
THGGMNSSSEALYYGVPLVVIPVTGDQPFVAKRLTEVGAGITLNRNELTS
ELLRETVKKVMDDVTFKENSLKVGESLRNAGGYQRAVEEIFKLKMKPYVK
IK
>BC0388 hypothetical protein
MYITIEETAEYLNLPKSYIEELIQQKKIRALFDGEQYLVNKEQFNTHLEQ
MEKYKQLVEEILNEPIPEDMDVKDED
>BC0219 Glucose uptake protein homolog
MDILLALLPAIAWGNILLVSVKMGGGAYSQTVGMTIGALFFATIMYVFTQ
PALTMTILIVGFISGLFWALGQVNQLKTVEKLGVSTTVTISTGMQLVATS
IFGVIAFREWTTTTTIILGTIAILLIVVGVVFTSLDDKENAQPPGQLKKG
LLTLIVSTFGYLVYVIIIRWYNIDGWSAILPQAVGMFVGAVVLTSKHKPF
NKYAIRNALSGLLWGTGNLFLLLSLPRVGVATSFPLSQTGIVISTFGAIV
FLGEKKTKRQLIFIALGSVLIIGGAVLLGMTKA
>BC3492 Permease
MNSTYKWVMLIFATVAQTTATLITYGVGAFALFWKEEYALTNTEIGLLVS
VVNIGPLFCMLFVGRLLDQYNEKLLISISSFLLGGSFLLTNMVNGFNGLL
FVLLLVGTFYSVSQPGGSKVIMKWFSKENRGLAMGIRQAGIPIGGTLAGV
LIPFLTIKYNMAYAVNSIACICIIGGFLFFIFYKEPYIQEKVKQERSKLS
FWMQLKEVMCKKELYAIYITGICMISLQMVLVAHFIKFLVLEQSITPILA
GKVFSVMFFSGMVGRVILAATSDLFYKGNRRTPLFITVCISIFFILILVM
SIHTITNVLYGVSALLGFFSIGWFSLFITEVAESASEESVGMTVSFALTL
NQIAIIVAPALFGYIVDKKGYTYAWLCIVVLLTISAVSLYRKYRK
>BC0767 Methylthioribose transport ATP-binding protein
MMTFSLQNITHSYHVATPVLEDVSIHIQKGKVHALLGMNGAGKSTLLKIA
TGEIQPVVGDIKIDTQSVSFTSPRDAKKHGISFVTQEVDHGLIPGLSVLE
NVLIDHLAMQNKVLFSKSKLVALAKQHLQTVQVNLNVSEDVSNCSLHEKQ
LLLIARALSNNTNYLLLDEPTSSLGPKEVETFGKLLKDLTSKGIGILLVS
HRLSEIRNFADDVTVLHNGQVALSETITTITDQQIVEAMTGKQLTLPINT
APKTGSEELFKVQELLLHEGHSPLSLTIRKGETVVIYGLIGSGKTTLAET
LFGALHTYHAEIAGQKLTIKTPRDAIKAKIALVPEERRKQGVFLSEDIIS
HTNLHQSGWKRKQTELNDATTAISSFGISPNDPKALIHSLSGGNQQKVSI
AKWSGFKPNLFLLDEPTKGVDIAAKQDIFQFIRNITENGSSVIYFTGEQD
EALHIADRILILANGEFVGEYLPSELSPEQLLHLSEGSYSIESRS
>BC5012 Chloramphenicol resistance protein
MNFRVYILAIAAFVVGTVELIIGGTLDLIANDLGVSISAAGQLITIFSVV
FALSGPVLLAVTGKFERKTLYVGALSIFLIGNIISAFSVNYGMLMFSRVI
CAASGSLIIALSVTLASSVVEPHFRARAIGIIFMGISGSLVLGVPLGLVL
GNAYGWRAPFVLISVLTVMAIACISLFLTKVPPTSVLSIKEQLATLKDKK
IVSAQLTSFLFLTGHLTLYAYLTPFLKDVMHVEANWISVFYFIFGIAAVI
GGGFGGWLADKWGSKKSIISIIIVFACAIFILPLMTFSFPLFIIMMGLWS
MLSWAISPAQQNYLIEIAPESAGIQQGLNNSALHLGIALGSTVGGVVIEK
SSVMYNAWVGGGFIILALLCAIFSITRGRSTQFVKEESIV
>BC4049 Phosphocarrier protein HPr
MEKIFKVTSDSGIHARPATLLVNTASKFGSDINLEYNGKNVNLKSIMGVM
SLGIQQNAEIKITANGDDAAQALAAIEETMKNEGLGE
>BC5320 PTS system, glucose-specific IIA component
MFKKLFGLGSKTNEETIVAPLTGAVKNIEEVPDPVFAGRMMGDGVAIDPT
EGVVVSPVDGEIVQLFHTKHAIGIKAKNGTEILIHVGLETVKMEGEGFEA
HVSEGQAVKAGDKLISFDLELIREKAKSTITPIVITNTDAAESIKTTVGV
AATKGSTEVMKVTMK
>BC1753 Tetracycline resistance determinant tetV
MQGEIQKEKSLGYIGKLLLPVKVSTHFKFLWIGQLLSALGSSITMVILPV
VVYSLTGSTVVMGMTMAMYMLPNILALPFAGLIVDRIDRVRLMLFTDIIR
CILMLLLASLIFMDLLTITILYILVAIYGLMEGIFQPAYSAVRAKVFVPE
IRNAANALTQMSNQGIRLIGPALGGLIVSVASAGIGFGLDAATYLLSFLC
LLFLKEIKFKKVKPIEKSKLNYKQEFMEGVFVLKSHPWLWITILVFSFIN
ICYAGIIVVLIPWLFNVHHHFEAYVYGLGMAFSGGGAVIAALIFGGKELW
HKRGLLAYGGVLMSGIALLIMPFISWAPALIFLMAIEGFGMMIFGLIWET
SLQELVPEEAFGRVASLDMLGSFALLPLGYVVVGWLATVIGGEITIITLA
SLVILTIGIALSVPSIRRFN
>BC2061 Multidrug resistance protein B
MAFVNMYTVLGNYLSSPTYNLTAEQILYFRLAGLFGMLLSPLAGRLTKRF
EVRKVLQGGLLIAIFSLSSIGFVSYLSLLVMMSVCFVIGIAISVPSLVSL
VGQLGGEIRNDTFYWFCSFSIYN
>BC2411 Macrolide-efflux protein
MKDVMRMPASIQSSLKDFHLMVSGQIITILGSTLLRFALSLYVLDITGRA
DIFAGLYAVTSIPFLLAPLGGAIADRFNRRNVMVIFDFINAAIVLSFIVL
LLTESVSILLIGTIMFLLAVISAMYAPVVMASIPQLVPEKKLEQANGIVN
GVQALSNIVAPVLGGILYGIIGLKMLVITSCLAFFLSAILEMFITIPFIK
RIQEGHIVPTIVKDMKEGFLYVLKQPFILKAMLLAALLNLILTPLFVVGG
PIMLRVTMQSSDTMYGIGMGLIDFATILWALSIGFFAKKLQMRTLYNWML
IIALLVMPVALSVTPFILNLGPYPPFILFILSSLLIAMIMTIVSIYVITV
VQKKTPNENLGKVMAIITAVSQCMAPIGQVVYGFMFEGFSTKIYLPIFAI
SFIMILIAIVTKKILRNEGN
>BC4497 Tetracycline resistence protein TETA(L)/TETK
MGKDIRNHSKWFVFTLCFIVLLGPMNAVLFNVALEDIANDLSISQSKVSW
VVVGYSLVVGIGSIIYGKLADRYSVKRLLIISIIIFVAGSIVGFVNQSYE
IIIFARLVQASGGAAFIALSMIAVAKLVAPAKKPGALAMISSSIALAVGI
GPLVGGAITNTLGWPYLFLFMVISMIGIFLLVKFMPEEARHTDEVFRFDF
IGAVLLFVLITTILLGVNINSWLFVLSVVFLFLFKAHMKRTESPFIDIEL
FTNKPLLRLIAVGFIINVALCASLLLLPLLLGRGHGLSPFVIGIVLFIAS
LFGIVSSFITGKIIPSFGNVKMMYVASVVMIIGFLILGIIPDGNLLFILF
AVILTFMSYSAIQVSLNTFIPKTLNPAKVGVGLGLYNLINFFGMAFGPAV
ASKIMESTNSYRLNFILIVILIAAHFFLLMGMSSFQKKMEQ
>BC2350 Transporter, Drug/Metabolite Exporter family
MKSPILSYFILFFGVFALSTSAIFVKLADAPATIIAFYRLFFATLILLPL
LLFNKNSRNELKTLTKKQWTFGFISGLFLAAHYVLWFESLQYTSVASSTV
IVTLQPLFSMIGGYFLFKERFTKGAVIGCLIAISGSIIIGWQDFQISGEA
LYGDILAFIAAGIITAYFFISQHVRKDLSLIPYSVISYGSSAGFLGIFAF
TQQESFIHYFTQTWLCFIGLAFIATILGQTIFNWLLKWMSATVISMSILG
ETIGTCILAYFILHETISLQQGLGITVIFIGLVLFLLQPSSNKKA
>BC4866 Glucose-1-phosphate adenylyltransferase
MAQKQKCVAMLLAGGKGSRLSALTKNLAKPAVPFGGKYRIIDFTLSNCAN
SGIETVGILTQYQPLELHNYIGIGNAWDLDRVSGGVTVLPPYAESSGVKW
YTGTASAIYQNLNYLSQYEPEYVLILSGDHIYKMDYSKMLDYHIEKESDV
SISVIEVPWDEASRFGIMNTNEEMEIVEFEEKPQFPRSNLASMGIYIFNW
SILKEYLEMDARNPESSNDFGKDVLPLLLDEGKKLMAYPFEGYWKDVGTV
KSLWEANMDLLRDETSLNLNDRNWRIYSVNPNEPPQYIAEKAKVEESLIN
EGCVIEGDVKHSVLFQGVTVEEGSMVIDSVVMPGAKIGKNVVIERAIVGS
EMVIEDGTIIRPEKNVDDVVLIAEGK
>BC4600 6-phosphofructokinase
MKRIGVLTSGGDSPGMNAAIRAVVRKAIFHDIEVYGIYHGYAGLISGHIE
KLELGSVGDIIPRGGTKLYTARCLEFKDPEVRLKGIEQLKKHGIEGLVVI
GGDGSYQGAKKLTEQGFPCVGVPGTIDNDIPGTDFTIGFDTALNTVIDAI
DKIRDTATSHERTYVIEVMGRHAGDIALWAGLADGAETILIPEEEYDMDD
VIARLKRGSERGKKHSIIVVAEGVGSAIDIGKHIEEATNFDTRVTVLGHV
QRGGSPSAQDRVLASRLGARAVELLIAGKGGRCVGIQDNKLVDHDIIEAL
AQKHTIDKDMYQLSKELSI
>BC0202 Multidrug resistance protein B
MMAGSMVFPFYILLLRNVGNSFSQFGWAYGLFALTSALVYPLVGKISDQV
GDKKLLIIYAWSMAILMLCFPIATEVWHVYILQIVMGILGAVQRNTEKTS
LARKVAQEKAGYEIGKYHVWTSIGGAVAVIATGYLVDFFTIGTIFYIASI
LYVVSGIVLSSKKI
>BC2515 Macrolide-efflux protein
MKFVQERRLTVKTTFSKEYKIFIFGLLISRIGDSLYTFALPWIAYQLTGS
AVIMGSLFAVNVLPIVLFGPLVGVLVDRYDRKKLLWMADIINIILVSLVP
ILHALHLLEVWHLYVITFILAVMSMLFDVTTVTVIPHIAGASLTKANSLY
QMVNQLASLFGPIIAGLFISFIGGFQVLWINVLSFIATLIAVIILPSMKN
LNKKNTDKKTLQNVLNDLFDGFKWLINDRLNIALSLQAMVGNFGASAVLG
VLMYYLLSTLNLTSAQSGYNYTLIGIGGLLGSLIAVPLEKKFRRGILIPL
LLFFGALGLTFALWSTYWLAPGIAFGIAMTCNITWNTIVTSIRQETVPSN
LQGRVLGFSRVLTRLSMPLGALVGGIISAYNPVFIFALAAFTKIIEVFIA
LCSPIRKL
>BC3502 IG hypothetical 17676
MQKRIVHFEGMVVFLATIYMYSIYEFSWIIFFVFLLAPDLSMLAYGINNH
VGAKIYNVCHTYIISILIVLIGVYFKIDTVIMIGLIWTAHIGMDRMFGYG
LKYETGFKDTHIQRL
>BC1227 Transporter, Drug/Metabolite Exporter family
MKQEKSIALPLAISIIAISFAAVFVKMSSAPSSILSMYRLWIIVLIMLPI
VWKKREEFNRIQMKDWGFLIGSGFFLALHFLLWFESLKHTTVASSTIILA
LQPIVSLVGGFFLFKERTTYSAIATMGIAILGVMCIGWGDLGLSKQAIYG
DILSFLSVIAVVGYLFIGQTTVKKVSHWIYSFTVFAFAGLFMGIYNVILQ
VPFTGYTRWDWTVFLLLAIVPTVSHVINTWLLNYVNATPISMSILGEPVG
ASILAFCLLGEKLNAMQIIGSMLVLFGVSVFLLQQQKRTAKNVVNEPVYT
QEL
>BC2402 Tetracycline resistance protein
MSIFRLKNERGTEKSIDKHALLFGLISVFLCGIGFSIIMPVVPFLVQPYT
SNPEEQALVVTLLTSVYAACVFLTAPVLGALSDKYGRRPLLLICLFGSAI
GYLVLGIGGALWVLFAGRIIEGITGGSISTIFAYFADIIPKEQRTKYFGW
VSAVVGAGTIIGPTIGGILAKFGDTVPIYFGAIITLINVVYGIKYMPESL
EKNNRLKEITFVRLNPFVQLANILSMKNLKWLLVSAFLLWIPNGSLQAIF
TQFTMDTFSWKPALIGLMFSILGFQDIVSQSFIMPKLLIKLSDKQIAILG
MVSEIIGYSFIAASALFSLYPLLIAGMLMYGFGDSIFGPSFNGMLSKSVS
SSEQGRIQGGSQSIQALARMIGPILGGQIYVSLGHAAPAFMGMILIVAAI
AVLYKGTHETV
>BC3364 Transporter, Drug/Metabolite Exporter family
MKQTILGAICLSLAASIWVGMYVVSKYVLDFIPPLTLVWLRFIIAFVVLY
GILKLAEKKQKKKVTIRKKDWLLFAWIGFIGYFISITCQFIGTKLSDAHT
GSLVTSATPAFMVIFAALILKEKLTARRLLSTIIATIGVIIVIGWDIEIG
SYFIGTIILVGAAITWALLSIYVKIASIQFSSLVITTYAIFFSLFFITPF
MIWELQAASIGTVNTYVILGVLYLGIVSTAGAFFLWNKGLKLLDASIGSL
FFFFQPIVGSLLGWLLLNETLNSNFFIGGILIICSVLITTFEKK
>BC2325 Macrolide-efflux protein
MNRFDRQRICTVSNICCSLCNIGILISLYYGMIILVFIFLFLENACIQFF
SPSEQSMIQGVVESDQYGAAAGINQMVNSLYALFGVGIATMVYWTFGIYG
SILVNTLTFITSGILIQTISIPEKVRVPNGRTKWKEVNLKMLITEFKEGI
RYIYQNETLKKLLLGFIVFG
>BC3934 Phosphoglycerate mutase
MTEICLVRHGQTDWNFQEIIQGREDIPLNEVGKKQASQSAAALQEETWDI
IISSPLIRAQETANEIAKTVGLQSILLDERFVERNFGEASGKPVAAVREL
IAEGKVEGMERDEEIVARCFAALEDVATTHFGKRIIIVAHSHAIKAILHA
IEPDEITFKTPLKNACISYVKQNSGKWDVLKYNIAEHINV
>BC0570 Glycerol-3-phosphate-binding protein
MSLVKKGAALLMVATMALSSAACSNSKTEGKPEVQAKVAPVEKNGDKTVI
RFWHAMGGKTQGVLDGLVADYNKSQNKYEIKAEFQGTYEESLTKFRTMSA
TKEAPALVQSSEITTKYMIDSKKITPIDSWIKKDKYDTSKLEKAITNYYS
VDGKMYSMPFNSSTPVLIYNKDAFAKAGLDPEKAPKTYAELQEAAKKLTI
KEGGNVKQYGFSMLNYGWFFEELLATQGALYVDNENGRKDAAKKAVFNGK
EGQKVFGMLDDLNKAGALGKYGASWDDIRAAFQSGQVAMYLDSSAGVRDL
IDASKFNVGVSYIPYPEDSKQNGVVIGGASLWMTNMVSEETQQGAWDFMK
YLTKPDVQAKWHTATGYFSINPDAYNEPLVKEQYEKYPQLKVTVDQLQAT
KQSPATQGALISVFPESRDAVVKALEAMYDGKNSKEALDEAAKATDRAIS
ISARTSQK
>BC1681 Tetracycline resistance determinant tetV
MKIATRNIILMMIGKMTSLLGAGIYTFAMGLYVLKTTGSGMGFAITLVCG
SLPRMICGPIAGAVADRVNRKWLVIGTDLLSSLTMLSMFILATIFGPSLL
FIYISAALLSICASFYSVALTSSIPSLVDEGRIQKASALNQTAASLSNIL
GPIIGGVVYGFFSIKSFFLLNSITFFLAVILQLFIVFDLYKKEVAESTEH
FLTSIKEGFLYVKRQREIYGLMKIALWVNFFACGLTVALPYIIVHTLHLS
SKQLGTVEGMLAVGMLMGAIALSVRKEVNNPFRSIYTGLFLFAGLSLCTA
FPLLVIIPKVASFIYYIAFMMLTGIAIMIVNIPMQVHMQKTTDPSYLGRV
FGLLETIATAIAPLGMIVYGLLLDMLPTSIVMMTIGGGLLLVVLVGVKQH
MAKKQVDVSA
>BC3252 hypothetical protein
MIGEMNDDQIQLFKANGDFIWHEHPNTDKLFIVLEGEMFIDFRDGQVKIS
KGEMFIVPRGVEHKPFTEKESHIMLVEPKREMD
>BC0204 Bicyclomycin resistance protein
MNEVNHEIYKPVKANRLWMILVLGTLTAIGPLSIDMYLPSLPKLTDDLQT
GASLAQLTLTACLLGLSVGQLFVGSISDIYGRRKPLIIALIIYVASSLLC
AVAPSIWTLVLLRFLQGASGSAGIVISRAMVRDMYSGSEMTKFFSLLMLV
NGAAPILAPIIGGQLLQFTTWRGVFIVLGAISVFMLISATFVLRETLPPE
ERETGGLSGTLATYGKLLKDRLFMGYALSQGLVTAAMFAYISGSPFVLQN
IYGASPQQFSLFFAINGIGIIIASQVTGRLAGKVNEKTLFVAGIIIAAVG
GLSLLLTIVLGIGLIGVLCSLFLVVSSVGVVSTTGFSLAMRNQKQAAGTA
SALLGLLQFISGALVAPLVGIGGSNTALPMGVVIALCEVGAVLCYLFMAR
RSEKQFELQQKQNLEA
>BC0429 Endochitinase
MRSQKFTLLLLSLLLFLPLFLTNFITPNLALADSPKQSQKIVGYFPSWGV
YGRNYQVADIDASKLTHLNYAFADICWNGKHGNPSTHPDNPNKQTWNCKE
SGVPLQNKEVPNGTLVLGEPWADVTKSYPGSGTTWEDCDKYARCGNFGEL
KRLKAKYPHLKTIISVGGWTWSNRFSDMAADEKTRKVFAESTVAFLRAYG
FDGVDLDWEYPGVETIPGGSYRPEDKQNFTLLLQDVRNALNKAGAEDGKQ
YLLTIASGASQRYADHTELKKISQILDWINIMTYDFHGGWEATSNHNAAL
YKDPNDPAANTNFYVDGAINVYTNEGVPVDKLVLGVPFYGRGWKSCGKEN
NGQYQPCKPGSDGKLASKGTWDDYSTGDTGVYDYGDLAANYVNKNGFVRY
WNDTAKVPYLYNATTGTFISYDDNESMKYKTDYIKTKGLSGAMFWELSGD
CRTSPKYSCSGPKLLDTLVKELLGGPISQKDTEPPTNVKNIVVTNKNSNS
VQLNWTASTDNVGVTEYEITAGEEKWSTTTNSITIKNLKPNTEYTFSIIA
KDAAGNKSQPTALTVKTDEANTTPPDGNGTATFSVTSNWGSGYNFSIIIK
NNGTTPIKNWKLEFDYSGNLTQVWDSKISSKTNNHYVITNAGWNGEIPPG
GSITIGGAGTGNPAELLNTVISEN
>BC3750 UDP-N-acetylglucosamine 4,6-dehydratase
MLNKIILITGGTGSWGHELIKQLLEKSPKEIRVFSRNETVQFEMQQQFIN
DHRLKFIIGDIRDKDQLVYACQGVHYVFHLAALKHVPVCEYYPYEAIKTN
IHGTQNVIEASTQMQVEKVIYVSTDKAADPSNTYGMTKAIGEKLMVHANI
QTKKTKFICVRGGNVLGTSGSVVPLFKQQIKRSSEVGITDANMTRFFLTV
EDAVGLLFKAVYQGRGGEIFVMKMPACKITDLAEILIEDSKKENIKVKEV
GIRPGEKLSEMLLSEVESKTSISFDQNYFVVLPTIPIEGLQEYYSSYPLV
DVKSFSSQQDLLAKHEVKQMLLKGGFLR
>BC4693 Deblocking aminopeptidase
MNKETLQLFRTLTELQGASGFEHDVRRFMKQELSKYADEIVQDGLGSVFG
LKKGDETGPRVLVAGHMDEVGFMVTQITKNGMLRFQTLGGWWSQVLLAQR
VQVMTKNGPVIGVVGSIPPHLLSDAQRAKPMDIKNMLIDIGADSYEDAIE
IGVKPGQQIVPICPFTPMANEKKIMAKAWDNRYGCGLAIELLKELKDETL
PNTLYSGATVQEEVGLRGAQTAANMIQPDIFYALDASPANDASGDKTQFG
QLGKGALLRIYDRTMVTHRGIREFILDTAETNNIPYQYFISQGGTDAGRV
HTSNSGIPSAVIGVCARYVHTHASILHVDDYAAAKELITKLVRTTDKTTL
ETIKNNA
>BC0413 Exo-alpha-1,4-glucosidase
MTMNKTWWKEAVAYQIYPRSFMDSNGDGIGDLQGIIAKLDYLKDLGIDVI
WICPMYKSPNDDNGYDISDYQDIMDEFGTMADFDALLDEVHKRDMKLIID
LVINHTSDEHPWFIESRSSKDNPKRDWYIWHDGKDGAEPNNWESIFNGSA
WEYDEETEQYYLHLFSRKQPDLNWENKEVREVLYDTVNWWLDKGIDGFRV
DAISHIKKEEGLKDMPNPKGLKYVPSFDKHMNVKGIQPLLEELKENTFSK
YDIMTVGEANGVKIEDAELWVGEEQGKFNMVFQFEHLSLWDAEKKKDLDV
VGLKKVLTKWQKGLENKGWNALYIENHDKPRIVSTWGDDKQYWRESATAL
GAMYFFMHGTPFIYQGQEIGMTNVQLPNIEDYDDVAIKNLYREKIAEGVP
HQDMMEIIWASCRDNSRTPMQWNDEMNAGFTTSTPWFSMNPNYKEINVEK
QKNEEKSIFNFYKKMIALKKEHDVLNYGTYDLLLEDDPQIYAYTRTLQDE
KVIVISNISKEEAVYNEGSFALERKRLLLNNYEVAEHEEVTTIALKPYET
RVYRIS
>BC4038 Methylthioribose salvage protein (putative aldolase)
MKQLFRQWYDLSEIKKELTTRNWFPATSGNISIKVSHEPLTFLITASGKD
KTKTTPDDFLLVDHVGVPVLETELRPSAETILHTHIYNNTNAGCVLHVHT
TDNNVITNLYSDAVTLQNQEIIKALDIWEEGATIHIPIIENHAHIPTLGE
NFRKHIQGDSGAVLIRNHGITVWGRDSFDAKKRLEAYEFLFQFHIKLLSI
QGGVSNGANSYS
>BC3958 Myo-inositol-1(or 4)-monophosphatase
MQEVWKDIDAHAKRWIRDAGEHLMASMKKALIIETKSNAADLVTNMDREI
EQFLIGKIKETFPNHNILGEEGYGDEITSSDGVVWLIDPIDGTMNFVHQK
RNFAISIGIYENGIGKIGLIYDPVHDELYHAVKGSGAFCNDISIPPLEKG
TVEQGIVALNAIWLTDNPLLNMESMMALVKKARGTRSYGCAALEMVYVAT
GRIDAYVTPRLSPWDFGGGQIIVEEVGGKVTTFSGAPLSIIEKSSVLVAK
PGVYEEVLSFI
>BC2022 Oxidoreductase
MNKRTALILGASGLVGQEITRLLFESDYYDSVTIFVREPMQLQHEKLQQK
QVDFSVLEEYKEFFAVDDVFSCLGTTIKKAKTKANFKKVDYEYTLRAACL
AEKQGVQNFLVVSSMGANPKSFFFYSQVKGKMEEELQKLVIGGIHIFRPS
LLVGNRQEFRFGEQMAEKLSRIIPFIFKGAFKKYKPISAKDVAKGMYITA
LREESGIHTYNSNEITTIE
>BC5215 PTS system, lichenan oligosaccharide-specific IIA component
MDTIETKAFHLILHGGNARSCSMEAIDCAKRGEFTEAEAKLQEALEELKE
AHRVQTELIQKEAGGEKTEVTLLMVHAQDHLMNAITVKELASEFVELYRK
MSVDE
>BC1729 Multi-TM2 domain protein
MNKNPFLALVLGLIPGLGHLYLKKLGRFILYSGGSLFLFSFAVFCTIVVR
ERDIAFLSLFLLAVLWVINLLDLVITIIKQTKKQEAGELINSSKESERFY
IILLSIIPGLGHFQLGLMQRGLTFLVACAGLGSMIIFVTLLTSQGSFLIF
LITLPVLWIYNFFDVVQQLQKKERDEQLIDRTIFEDFEEHREQGKKSKTF
ASILAMFPGAGHMYLGLQRRGLQLMAAFLLSIYLLDLLRLSAFLFLVPII
WFYSFFDALQQTAKYGKERVQDEPIIDYFINHQRWIGIGLITLGGYYLLN
QTVLPILNDYFVTIFNIHLSELYYRYFQTSIVALLLIGGGFKLLLGNKEN
KGGTSE
>BC0398 Benzoate transport protein
MNIMQPSAPPHLESTETIFPSSITKLVVFICWLAILADGYDLGIYGAVLP
KLLEDKSWALSPAHAGTIASYALLGMFIGAILVGTITDLIGRKWTLICCL
ALFSITMGLAAIAPSPELFGLSRFIGGIGLGGVIPTASALTVEYSPKKRQ
SFIYALMFTGYPLGIVLGAILSMLMLEDFGWRIMFGIGMIPLLLIPFIIR
YLPESIQFLLSRNRQEEVNQILNRFQIEFHVKDKTHQDPSTIRKKNGFFT
LFSKEYIKATLLFWITYIMGMFLIYGLNTWLPQMMRQAGYPLGSSLSFLL
MLNITAAIGALFAGAIADRIGAKIVISISYLMAAICIGLLTIKPSVTIIY
LLIGLAGIGSVGITQILNAYVTQYFPSHIRATSLGWGLGLGRVGAIAGPI
LVGIIMTMQYDLAWNFYLFSFAGLIAAISVFFIPTK
>BC5418 Transporter, MFS superfamily
MGKVKEISKRKLLGIAGLGWLFDAMDVGMLSFVMVALQKDWGLSTQEMGW
IGSINSIGMAVGALIFGILSDKIGRKSVFIITLLLFSIGSGLTALTTTLA
MFLVLRFLIGMGLGGELPVASTLVSESVEAHERGKIVVLLESFWAGGWLI
AALISYFVIPKYGWEVAMVLSAIPALYALYLRWNLPDSPRFQKVEKRPSV
IENIKSVWSGEYRKATIMLWILWFCVVFSYYGMFLWLPSVMVLKGFSLIK
SFQYVLIMTLAQLPGYFTAAWFIERLGRKFVLVTYLIGTACSAYLFGVAD
SLTVLIVAGMLLSFFNLGAWGALYAYTPEQYPTVIRGTGAGMAAAFGRIG
GILGPLLVGYLVASEASLSLIFTIFCGSILIGVFAVIILGQETKQRELV
>BC3759 6-phospho-beta-glucosidase
MIDLLSWLNGYKKQYGFIFVDHNDNLKRKKKLSFHWYKRVVETRGEEL
>BC4642 ATP-NAD kinase
MADRRNLFFFYGDDKATLVEKMKPIYRILEENGFTILDHPKNANAIVSVG
DDATFLQAVRKTGFREDCLYAGISTKDEISFYCDFHIDHVDTALQEITKN
EIEVRKYPTIQVDVDGSTSFHCLNEFSLRSSIIKTFVVDVHVDDLYFETF
RGDGLVVSTPTGSTAYNKSLHGAVVDPLIPCFQVSELASLNNNTYRTLGS
PFILNHERTLTLKLRPDGNDYPVIGMDNEALSIKQVEKAVVRLSDKQIKT
VKLKNNSFWEKVQRTFL
>BC3314 Quinolone resistence NorA protein
MQSEKLWTKDFLGTCFSSLFLFLTFYMLMTTLPVYVIDGLKGKPEEIGLV
ATVFLISSVLCRPFTGKWLDDLGRKKILFISLSLFLAATVMYFGAQSLFL
LLALRFLHGIGFGMATTATGTIVTDVAPAHRRGEALAYFGVFMSLPMVIG
PFLGLTIISHFSFTVLFIVCSVFSLLAFLLGLLVDIPHEAPVSKQKREKM
KWKDLIEPSSIPIALTGFVLAFSYSGILSFIPIYAKELGLSEIASYFFIL
YALVVVISRPFTGKIFDRFGENVLVYPAIIIFTIGMFILSQAQTSFWFLG
AGMLIGLGYGTLIPSFQTIAISAAPNHRRGSATATYFSFFDSGIGFGSFI
LGIVAAKSSYHNMYFIAAIIVAFTLLLYYGLHGRKQKFKKQPTDGKISA
>BC4738 Multidrug resistance protein B
MPRKVWLLVAGMIINVTGASFLWPFNTIYLHDHLGKSLSVAGMVLMINSL
TGVIGNLLGGVLFDKWGGYKSTLVGIVITLVSILGLVFFHGWPLYVEWLA
LIGFGSGMVFPSMYAMVGTVWPEGGRRAFNAMYVGQNVGIAIGTACGGLV
ASYRFDYIFLANFILYFVFFLIAFIGFRGMEDKKEPGVQKEVETKKGWSL
TPGFKALLIVCVAYALCWVTYVQWQGAIATHMQELNISLRHYSLLWTING
AMIVCAQPLVSMLIRWMKRSLKQQIMIGIFIFAASFIVLSQAQQFTMFLV
AMVTLTIGELFVWPAVPTIANILAPKDKLGFYQGVVNSAATVGKMFGPVV
GGAIVDLYNMEVLFIAIMVMLVVALIATSIYDKRVKVEETVEEKIAV
>BC4841 2-keto-3-deoxygluconate permease
MDIYLLIVTLLAIAIVILGVSWWKWHAFISLTVASLFLAIMSGLNLTKIV
TAYETGVGSVLGHLVGILALGTILGKMMSDSGAGMQVADFFIRFFGVKKL
PWAMLFAGFVIGIPVFFEVGIVILLPLVISIRKTTKQNILLIALPVIAGL
SIVHGLVPPHPGAMTAIGIYNANLGKVLLYSLIIALPTAIIAGPIFAKWV
HKRVIPENEPELIRVTTVSTDLPSRKVSFFIILLPVVLMILSVVAPYISL
PKKLTEFFVFIGSPVIALLISCFAAFYLLGIKQGINKKMIKKLTDESLLP
VGSIILIIGAGGGFKQILIESGVGTAIAQMAEHISLSPIVLAFMVAGLIR
IATGSATVALTTAAGIVSPVIQHMSGVNLELLVIATGAGSLMFSHVNDAG
FWLVKEYLGLTVKETFKTWTVLETLLSFIAFGFALLLNMFL
>BC0774 Sucrose-6-phosphate hydrolase
MSKYKTILQSNKDELHSLYEIANQDSWKPIYHIHPPFGLMNDPNGVSYYN
DEYHVFYQWYPFGPIHGMKHWGHVRSKDLINWERMPVAIIPTESYESHGA
YSGSAIVKDGLLHLLYTGNIKKPDDSRDAKQCMASMDSQYTMTKYSNNPV
IDIIPDGYTKHVRDPKVWKHNDMYYMLLGAQRENKTGTLLLYKSQDLYNW
HFQGEITTNLKEFGFMWECPDYFQLSGKDVLLFSPQGIEKDGENFHNVYN
VVYAIGHFDIKNLYFHVDSYYEADKGFDFYAPQTLEDSTSRRLLFAWAGS
SEITYPSDDYMWAHCLTLPRELTLEDNILKQKPVSELTKLRTTKKDISGD
ITAGLNVLSTLDDEDSYELIVTLKTEDAKRFGLSLFHNEEECFPITFNRE
QGTISIDRGNFYHQFGGEYGFERCKKIDIQDTIELQIFVDKSIVEIFLYD
GSTVFTSRVFPRKDMKHHIAIFSDAKLNFTITQYKLKRGIV
>BC5368 Transcriptional regulator pfoR
MAILQGLALLLVVLCLFTLFSYRAPYGMKAMGALANAAIASFLIEAFHRY
IGGEMFHNDFLQSVGEASGSMSGVAAAILVALAIGVSPVYAVLIGIATSG
FGILPGFFAGYVCAFVVKFLEKKLPAGVEFLAILFIAAPISRGMAMLMDP
LVNATLGKIGSMISVATTESPIIMGIMLGGLITVISTSPLSSMALTAMLG
LTGLPMAIGSLAVAASAPMNFIFFKRLKICSKKDTIAVAIEPLTQADVVS
ANPIPIYATNFVGGALAGIITSLFQLVNNAPGTASPIPGLLVLFGFNDVV
KVTIAAILCGIVTTIVGYIGSIVFRKYPIRSADEIRGVTSGEKVA
>BC3372 6-phosphogluconate dehydrogenase
MQVGLIGLGKMGLNLGKNLMDHKHEVVAFDLNTSAVEEMKEYGATGTSSL
SELVQSLQSPRILWVMVPHAVVDSVIDEVTPLLSKGDILIEAGNSHYKES
IRRYEQLKEDGIHFMDAGTSGGMEGARNGACYMIGGDQEAWDIVEPIFRD
TAVENGFLYAGKAGSGHFLKMVHNGIEYGMMAAIGEGFEILEKSEFDYDY
EKVSRVWNNGSVIRSWLMELTENAFSKDAKLDEIKGVMHSSGEGKWTVET
ALDLQTATPVIAMSLLMRYRSLDNDTFTGKVVAALRNEFGGHAVEKK
>BC2283 Quinolone resistence NorA protein
MERLWTKSFIQMTFAMLFLFTGFYLLVPTLPLFIKEIGGNESQVGLMMGM
FTIAAVVIRPIIGGMLDQYGRRSFIIFGLIFFGLTMYSYNIASTIVLLAV
LRVIHGVTWAVSTTAVGTAITDIIPDSRRGEGMGWYGMAMTIAMAIGPMI
GLWVVQNYSFDGLFLLATLLSFMAVVLSLITKIPFTPQKEKGKIQLFEKS
VLTITIVVFFLSFAYGGITTFLPLFASSIHVNPGTFFLVYAIALTIVRPI
SGKLLDKYGEVFIILPALCITILAIVVLTISNGLIGVIIAATLYGIGFGS
AQPALQAAMLTIVDPSKRGVANASFFTAFDLGIGLGAILLGVVSQMFGYR
ILFSGSAISALIALIIFVFFVKQRLGKKEFA
>BC5372 Chloramphenicol resistance protein
MESKQKLGRLITVVATFLAFSGIGVVDPILPIIAEKIGASHWQVEMLFTA
YILTMAIMMLPAGIFASRFGDKRMMTIGLAIVTVFAFICGMSQTIAQLSL
FRAGWGLGNAMFFATAMTLLIALSKEVHEAVGLYEAAIGLGMAGGPLLGG
ILGGHSWRYPFFATSILIFLAFILVFFFVKEPERKVKRKAAGVGELLNLV
KYKPFMQGAISGMLYYYGFFVVLAYSPLIMHLSAIQLGFVFCGWGLALAY
GSAILAHKLEGKYEPKTLLKGSLLVFAIFLIALFFVKIMWLQITLIVLSG
LASGLNNALYTSYVMDISPYERSVTSGVYNFVRWLGGAIAPILSGIIGHT
VSPQSPFLVGGIVVLVGCIMILIPIRKPVEIETKALS
>BC4048 Phosphoenolpyruvate-protein phosphotransferase
MTLNIQGIAASSGIAIAKAFRLENPEFNIEKKSITNEAAEIARLDAALEK
AKTELEAIKDHAFAELGADKAAIFEAHLLVLNDPELVNPVKDKVNSEKVN
AEFAMDEVASMFISMFENMDNEYMKERAADIRDVTKRVLAHLLGINFSNP
GTISEEVIIIAEDLTPSDTAQLNRKYAKGFTTDIGGRTSHSAIMARSMEI
PAVVGTKVVMEKIQNGDIVIIDGLDGEVIVNPSEETLRSFEEKKAKFEEQ
KAEWAKLKDQATVTSDGHHVELVANIGTPNDVQGIIDNGGEGVGLYRTEF
LYMGRDNLPTEEEQFEAYKAVLEGVKEGQPVVVRTLDIGGDKELPYLHLP
KEMNPFLGYRAIRLCLDEQDVFRTQLRALLRASVYGNLKIMFPMIATLDE
FRQAKAILLEEKAKLVEAGTTVSDSIEVGMMVEIPASAVLADQFAKEVDF
FSIGTNDLIQYTMAADRMNEQVSYLYQPYNPSILRLVKMVIDAAHKEGKW
AGMCGEMAGDSLAIPLLLGLGLDEFSMSATSILPARTQLSKLSKAEMETL
AEKALMMSTAEEVVELVKSI
>BC3456 Bicyclomycin resistance protein
MKKVSVPSLLLMIVLVAFPQISETIYTPSLPDISKALHVSNNEVQLTLSV
YFAGFALGVFFIGWLSDIIGRRRAMLLGIVVYGAGSFLCYIANSIEVLLV
SRFIQAFGASVGSVVTQTILRESVEGHKRHVMFAQISAVIAFTPAIGPLI
GGFLDQMFGFKIVFLSLVVMSIGIFLYTFFSLPETKTDSVTNKINVFSVF
KKLITNPKVVTYGLLIGGANGVLFSYYAEAPFIFIEYFQLSPSMYGFLGI
VVASASIIGAKVSKRLLATYRPEKIIYIGCLVMTVGAILLTVITALGLNQ
NIIYMIGFLIAMFILLLGIGVALPNCLSLALVDFQDVIGTAGALFSLGYY
VIVTMTIWGMSQLHTGSLLVMPLYFLVIVVIMVVFTRVFIFGKQTSKSI
>BC2995 hypothetical protein
METKKIFKPFAVWSLEKEEAYLRKMHQQGWALQKYNVMYTFKKTEPKDVV
YKADFRLEYKDSTEKQKEYIQIYEMCGWKHVTSFAKWNYFCKEVEEENEL
PDIYSEKETRIQKLTELLQFFVIMFVTIMPALYLCFLGPSESRIPYIFKG
MIGFIGCMYLYIFINVYWKIKKLKNEIL
>BC4079 Acetoin transport permease protein
MFQKALWVHTYKQSKYIIWLFWLVSFYVLSYKYYLAAAEQLKYFHEHNEW
KYIYRYNYQLSLPDAIMVQGGLLIILACILIGWERQNQSSDILWSMPFKR
THLFITKWLFGVCNIVAIVILNWGLFAIMKKTTFHNKYQIFSPFHTYFLY
MVIILVAIYTLALCIGTIAGNMISQGFFSVAILGFPFILPTLIAGAISIH
TVGLTSNHTVYTEENVDRYGSGIEKVSILAPVRGFNINFNYDPQRAYTDQ
QGVRHDEPNFTYIPSATKLTGPIANMLILFPLGMYLCTRSPNEQNGNFVL
YPKLKTLCMICCVIFIGMFGGMAAGGSHSIVNYYIGFIGTSTIVYLLLSR
LLKLKFSWRVK
>BC0809 PTS system, diacetylchitobiose-specific IIC component
MMNGFMSFMEQKIMPTTQKIAGQRHLLAIRNGVISTLPLTIVGSFFVIFL
NLPIDAYMEWIAPFRHILDIPFRFTVGLMALYAAFGVGASLANFYQLNQL
SAGLLSVLAFLLASVEPIQITKAVPGVIDAGRYISVGTLSATSLFGAIVT
ALIAVEIYHFMIKHNISIKLPDSVPPAVSNSFAALIPTLAVILLFWGIRY
GLKFDVNTTITYLIAPLKSVLVGNNLFGGLLTVFLIVFFWSFGIHGPAIL
GPIIRPMWDSAILENMEVFTATGNAHQLPNLFTEQFIQWFVWIGGSGSTL
ALVIMFMFSKSKFLKELGRLSFVPGLFNINEPIIFGAPIVMNPILIIPFV
ITPLVTTTVSYFAVVSGMIPLMMAKLPFTMLAPIAAVISTDWTIMAGVLV
LVNFVISFVIYYPFFKMYEKQQLAGEEKTECSEQLSS
>BC0361 Polysaccharide deacetylase
MRKYAAIALCTSAILAGCNTSNVSQEPKKEKKVQEVAIQKEALQEQGKIS
YTPITHESTNTSIHITDLKDSLNEVQYKIWRTADGKERAKSFSSKEKEKQ
FTIPFDIKEFEGKRGEFQIEATGMKEDGKTIPLTKSIITFEQKVPVLMYH
AIDDYHGQGIKDLFVSPANFEAQMKHLKDNGYTLLTFERWGDINKVNKPI
FVTFDDGMKNNMNAFRVLQKLKDDTFKPAATEYMIVDNVDVEGALSTSEI
KEMVDSGIFSVQSHTATHADLPKITNYEEELKGSKEKLEKITGKPVIAIA
YPFGHVDDKVVTETKKYYQFATTTKPGQFITKGEPDELLKMKRVRIHHTT
TVEQFASSIK
>BC5422 hypothetical protein
MLANQARVRFEHFLLFFIILQPVLDLLTSLSITLLKSNATVGILVRFLIM
AVGGIYILIQAKEKENRKFLIYLILLAGVLGVGFINNKIVKDPIVLSEEV
KFVAKALYIYIMLGSYILALKSLKKTVNISDKVRNSIVYSTLIINAIMVI
SISTSTDFGSYEWMKVGSRGWFYAGNELGSILAIIFPIVVLYSIQKTKSW
KHILYWIPSLLMIYSLIQVGTKVGMGSIGVTLAAAIGIIVLQLLFDRKNP
NKKSLALNAVIAIILLAGVVGTFKQTPLAQNMGIHNNYLTEQNVAQQDQK
EQEIKEKLKKEQELKEKEEKHHKVEKPEEKAKIEVEVKKELEKEQKKENQ
ENLIFSGRQVYEERHKQFFKEAPMSQKLLGMGYAGNFKYNEQKQPDPKLI
EMDFHDWFYDFGIIGFVLLMIPIYLLRAKNSTSICYEI
>BC1983 hypothetical Cytosolic Protein
MKYSLCTISFRHQLISFTDIVQFAYENGFEGIELWGTHAQNLYMQERETT
ERELNFLKDKNLEITMISDYLDISLSADFEKTIEKSEQLVVLANWFNTNK
IRTFAGQKGSKDFSEQERKEYVKRIRKICDVFAQNNMYVLLETHPNTLTD
TLPSTIELLEEVNHPNLKINLDFLHIWESGADPIDSFHRLKPWTLHYHFK
NISSADYLHVFEPNNVYAAAGSRIGMVPLFEGIVNYDEIIQEVRNTDLFA
SLEWFGHNSKEILKEEMKVLINRKLEVVTS
>BC4271 Transporter, MFS superfamily
MKWKHIIGDVEVNRDLVLLLLIGGLYTLAISLSNTFVNIYLWKQTQNYVN
LGLYNLASVVLQPLTFLVGGKLAKRIDRSILLRIGVGTLAIFFIVVLVAG
KSASQYILLMGALLGVGYGFYWLAFNLLTFEITEPETRDFFNGFLGLLTS
FSGMIGPIAAGYTISRMEKWSGYTVIFFLSLALFAIAVVLSFFLSKRECE
GRYEIVQVLKERRIDKNWGKITRAHFFQGLREGTFIFVISVYVYLATNSE
FALGKYSLVNSAVSFVCYYLVARMLKKEWRKKAILLGGIILYAVVFLVIF
NVTYTKLLIYAACIAIAYPILLVPYGSMTYDVIGRAKNAREWRVEYVVVR
ELWLNAGRICSILSFLCAVLFFPPEKSLPYLLCILGAGHFLIYFAVKNVK
YDERNASKASVVTQGNAQNQTEPEG
>BC0806 Transcription antiterminator, BglG family
MHQRLISILEEFLEEKSMLNRAFLAGRLHVSTKTIQKDIKLLNDILEENG
AKIESQRGTGYELEIIQKKKFEDFCVSLFQKQTEKIPTSYEERIAYILQR
VLMTEGYVKLSELAEEMYVSKSTVNLIMKDVTDICGRYKLQIEKRPYYGI
RIVGEEFNIRSCLSQYGLPRYDHTPFHEQFEQTETYLSLPHISLIRSIIL
KYIEGGTIYLSDIEIDNLVIHIAIALKRFQSQHYMKGLHAEQSELIIKKE
YTIAKQILGDLEKALKFSFPEEEVLYVTMHLLSTAVTTRNRYENIEELLG
KDIYAFMQHILFKVAEERNLIFYYDEELLFGFGIHLKTLLNRLKYKLNTR
NPLLAEVKKNYPYAFEIAVLVGDIIGEYTGESIPESEIGYIAIHFGGAMS
RLQEQNQKKRCLLVCATGQGSAQLLKYKILSQFRDKLEIVGITGYYQLKV
EDLYKEKIDCIISTIHIPSGLPVPVIKVNSIFDDKEIKSIGQRLFTHVNT
SVQPYIKEDLIFLNYSASTKEDVIQFLCEKAAEKRYVPENFYASVMEREN
TSPTAVGNSVAIPHPMQLLSEETFLMFCTLEKAVDWGDKKVQVIILFSVK
RNNNEDLQRLYDFLYDIMSSQTTIEKLTQTEVIEDFQEILLSF
>BC2807 hypothetical protein
MKRNLKTSTIIILILTIIALEVGIALYDHNLSLDTIYFAAILICIVLLFG
TRVSGEKENTSKRGRRKKAVIFWPSILLSIACFAVISYIRVGYVSVPGII
GFSCFVTYGGFVLISILKGKNKM
>BC3745 Phosphoglycerate mutase
MSTYIYMVRHGESPKLEGNERMRGLTERGHMDARRVTDILKAERIDTFIS
SPYNRAMLTIEESANFHEKEIVVYENLKECMFSSEDQVISDKEVYPLVQK
MFSNPDFARTEGESYADCQRRVVKVLKEILMDFRGCKIVIGTHGLVMTLM
MNYFDKQYGFEFLMNTSKPDIYKMEFKEEQLMNVERLWKAE
>BC1786 Multidrug resistance protein B
MASWKRNLMICWLGCFTTAAGMSLVIPFLSFYIEELGVTGTSSIAQWSGL
AFGVTFLMGAIVSPIWGKLGDIHGRKLMLIRASLGMAIIMTLMGFVTDVY
QLVALRFLMGAVSGFLSTAMTFIAAETPKEHSGWAISTISTGGVSGSLLG
PLLGGYLSELIGMRHVFLVTGAFLFLSFLIVFFFLHEENHSAQAKKIQPK
KVWTMVPAKHLIISLFVTTFIIQLANMSVQPIVTLYVKNLVGPHTAHIET
IAGAVMSATGLAVILAAPRLGRLSDHIGPQKTLVVALFAAGIIFIPQAFV
TSAWQLLILRFLLGIAQAGLLPSVQTLLKQHTPTHVTGRIFGYNQSFQFL
GNMIGPVLGGQIAAHAGFQYVFLSTSSLLFIACIWVYFHNKNEEVSEKRH
LEVS
>BC5216 PTS system, lichenan oligosaccharide-specific IIC component
MDALASGALSLVTFLLATPFQVAYIIPSTKESVLVEGAIPAALMGSQGLF
VAMIIALISTELYRFIVQKKIIIKMPETVPPAVTRSFAALVPGFIVVTVI
WILRLIIENTSFGSIHNIVGQILQEPLSVLGASLWGAIIAVILVHVLWSC
GIHGATIVGGVMSPVWLSLMDQNRVAFQAGQDVPNTITAQFFDLWIYMGG
SGATLALVVGMLLFARSQQLKSLGRLSIAPGIFNINEMVTFGMPIVMNPL
LLIPFILVPVVLTIVSYFAMEWGWVARPSGAAVPWTTPILFSGYLGSGGK
ISGVILQLVNFALAFFIYLPFLKIWDKQKLAEEKGE
>BC1960 Peptidoglycan N-acetylglucosamine deacetylase
MYYFYSPEMFAPYQWGLERDVSYAYMPYNSFYYGDYINSLPYAYIPQNYE
VQMKADDRGSWTPFSWVEKYAYAFSGPYNKAEVALTFDDGPDLEFTPKIL
DKLKQHNVKATFFLLGENAEKFPNIVKRIANEGHVIGNHTYSHPNLAKVN
EDEYRNQIIKTEEILNRLAGYAPKFIRPPYGEILENQLKWATEQNFMIVQ
WSVDTVDWKGVSADTITNNVLGNSFPGSVILQHSTPGGHLQGSVDALDKI
IPQLKTKGARFVTLPSMFQTSKERK
>BC0184 Glycerate kinase
MKVVIASDSYKESLKAIEVCGAIERGFRAIFPNAEYVKIPIGDGGEGTVE
SLVDATGGRIISISVTGPLREGIQAFYGISKDKKTAFIEMAAASGLQHVP
VEKRNPLITTTKGTGELILHALDQGVEYIILGLGGSATNDGGAGMLEALG
VRFINGKGEVIDPSGGTLHSIVTIDFSRMDPRLKGVKIEAACDVDNPLVG
MQGASFVFGRQKGANIEMMKELDENLQHYANMLKRYVSFDVSEIPGAGAA
GGMGAAVISVLKGDLRRGIEIVLDYTNFDKHIEDAHLIITGEGRIDKQTA
YGKAPVGVAGRAKRFSVPVIAIGGSVSSDCSAVYEKGIDAVFSITTRPMT
LEEAYKVAEENIEMTTKNIATVWKIASEKHF
>BC3879 Transporter
MGVELALLHALYVICLLTIITFFILRKDTTIICIDFIFLLTLTATSSIPL
AVSGIFQSFIYAITELLPTILIISIIVSMSNLLVHTGINDTMISPFTKMI
RTPTLAYWIIGLLMMTISFFFWPSPAVALMGAILLPVAVRVGLPPIGVAI
AMNLFGHGIALSGDFVIQGAPKLTADAAGLPVSSVVSASVPLVIVMGIVT
TSIAFFFLRKEFHTGLSIQESIPSTDSSKTLTSLSPRIKKWLAICIPIVY
IIDILCMIQFKLQGSDATALIGGTTVIMIIIISLIAYKGNGLNKTTDYFI
EGLQFGFKIFGPVIPIAALFYLGDSGFVKIIGDYLPKGSHGIINDLGIAL
SQTVPLNQYVSGGTLTIVGVITGLDGSGFSGISLAGSIANLFGTALGHGT
ATLTALGQIAAIWTGGGTLIPWALIPAAAICKVDPFELARRNFLPVVIGL
IVTMIVAMFTL
>BC0454 Transporter, Drug/Metabolite Exporter family
MKTEKFFTHPIGVFIAAIVATFLWGSAFPFIKLSYVELGIQPQEVGEQIL
FAGYRFFLSGFMLLLFFKVLGKDMSFKKGTGKQLIQIGLFQTFLQYICFY
IGMSYSSGIEGAIISGTSSFFQILLAHFLYKDDALNMRKIIGVSIGFCGV
VLVNMPSDGSLSFHFGIGSLLLLSAAMLYSYGNILAKEGSKTLDVGYMTA
YQMMFGSIGLLCIGALQVGVMPFTFSLHALLMLIYLSFLSAAGFCIWNTI
MKYNKVGKVSMYMFFIPVFGVLLSSMILGEAIHSFVLLGLACVAAGIIVV
NRTPAKQKIEKEKQVA
>BC1974 Peptidoglycan N-acetylglucosamine deacetylase
MEKALKIKQIVVVLIAIAAVAIGYYMFQSITSPAKAVAKQENVVQLASEQ
PKVEMNKTAPSRFNGKERKVAYLTFDDGPGKYTAELLNTLKQHDAKATFF
LIGANVKEFPDLVKRENAEGHYVGMHSMTHNFAKLYKNGEYVNEMKEDQG
LIANIIGKSPKLTRPPYGSMPGLNEGLRNKVVEGGFKVWDWTIDSLDWRY
NKMPVDAAAAQIAQNVLTNATKPQEVILMHDIHPQSVAAVPAILKGLKEK
GYEFEAYHEESHFPVNFWHDNRM
>BC3445 hypothetical protein
MKRFLNTLLQFVVLSIVLHLLFDIVGWLVFNAPIKNKQIIISLITISWVM
YMYRDNFFQKFTSN
>BC3369 Gluconokinase
MVSTKYMIGVDIGTTSTKSVLFSTDGSVIASHGIEYPLYSPTPEIAEQDP
EEIFRAVINTIKETVQSSSVQPNDILCVSFSSAMHSIIAVDEKGKPLTRC
ITWADNRSVSWAEKIKNDMNGHEIYLRTGTPIHPMSPLSKLVWLQNEQAE
LFAKSYKFISIKEYVFYKLYKDYVIDYSIASATGMFNLKSLKWDEEALHV
AGITDDKLSKLVPTTHSLTGLDEELAKEMNVLVSTPFVVGASDGVLSNLG
VNAIDPGVVAVTIGTSGAIRAVTNRPVTDPKGRIFCYALTEDHWVIGGPV
NNGGMIFRWARDQLGTSEIELAKRLGKDPYEVLTEIAAKVSPGSDGLLFH
PYLAGERAPLWNANARGSFFGLGLHHKKEHLIRAVLEGVIYNLYTVLLAL
KELIGEPKKIQATGGFARSELWRQMMADIFHQDVYVPESFESSCLGAAIL
GLYSLGEVDTLHVVSEMVGANFHHEPNMESVEKYKDLTPIYIRLSRQLEE
EYESIAAYQKKWV
>BC2554 hypothetical protein
MNMIELKSIIHSYKLKRKIAKDLYGKRDELTLLLNEFNKMKCTVTSEKKK
NNILSRLQLIYQNMKLDKQYPLSVAFDSKLLERLEKEPLHTIEDGVTCLH
LMLDVNYEKIKQYGSSTSRSFVPLSQSSICLADCICLTGVVVGLLGAISF
GGLLLSICSIT
>BC0739 hypothetical protein
MPRNIPLIIEYVAFLGLICCLIIYNTNIVFLSIIIAFVALEIMMESFQVQ
LKQKIAHIYNAIFLLSALITNIISNGFYLSTVFPVFFMAVLLFVARYINV
PYNQKQKQEA
>BC5135 Enolase
MSTIIDVYAREVLDSRGNPTVEVEVYTESGAFGRAIVPSGASTGEHEAVE
LRDGDKSRYLGKGVVNAVNNVNEIIAPEIAGFDVTDQAGIDRAMIELDGT
PNKGKLGANAILGVSMAVAHAAADFVGLPLYRYLGGFNAKQLPTPMMNII
NGGSHADNNVDFQEFMILPVGAPTFKESIRMGAEVFHALKAVLHDKGLNT
AVGDEGGFAPNLGSNREALEVIIEAIEKAGYKAGENVFLGMDVASSEFYN
KETGKYDLAGEGRTGLTSAEMVDFYEELCKDFPIISIEDGLDENDWDGHK
LLTERIGDKVQLVGDDLFVTNTQKLAEGIEKGISNSILIKVNQIGTLTET
FEAIEMAKRAGYTAVVSHRSGETEDATIADIAVATNAGQIKTGSMSRTDR
IAKYNQLLRIEDELGEVAVYDGVKSFYNIKR
>BC5442 Transporter, MFS superfamily
MNVTTDVQQTTEETKAKRYKTLFGSALGYAAEGLDMLLLSFVLVYILKEF
HLSPVEGGNLTLATTIGMLIGSYLFGFIADLFGRIRTMAFTILLFSLATA
LIYFATDYWQLLILRFLVGMGVGGEFGIGMAIVTETWSKEMRAKATSVVA
LGWQFGVLIASLLPAFIVPHFGWRAVFLFGLIPALLAVYVRKSLSEPKIW
EQKQRYKKELLQKEAAGKLTTTEAEQLKHIKKFPLRKLFANKKVTITTIG
LIIMSFIQNFGYYGIFTWMPTILANKYNYTLAKASGWMFISTIGMLIGIA
IFGILADKIGRRKTFAIYYIGGTVYCLIYFFLFTDSTLLLWGSALLGFFA
NGMMGGFGAILAENYPAEARSTAENFIFGTGRGLAGFGPVIIGLLATGGN
LLGALSLIFIIYPIGLITMLLCVPETKGKVLD
>BC3087 Phosphoenolpyruvate synthase
MSSFVLDFQEIEKTQLFLVGGKGLNLGELSNIQGIQVPEGFCVTTVGYEQ
AIGKNGAFQTLLNQLAMLKIEERDRIGEISKQIREVIMAVEIPVDVVESV
AHYLSHFGDEHAYAVRSSATAEDLPYASFAGQQDTYLNVIGKENILQHIK
KCWASLFTDRAVIYRMQNGFDHNQVSICVVIQKMVFPEASGILFTADPIT
SNRKVLSIDASFGLGEALVSGLVSADNYKVKEDEIVEKVIATKKLAIYGR
KEGGTERKKIAPNQQKFQTLTEQQILQLARIGRQIEAYFGCPQDIEWCLV
DDTIYIVQSRPITTLYPIPEVNDGENHVYISVGHQQMMTDAMKPLGLSFF
LLTTSAPMCKAGGRLFVDATQRLASPASRDYLINTLGKSDPLIRDALTTV
IERENFIKLLSDDEKEKDLSKNVPPASSQQQPENDPEIVTNLIKNSELSI
EELKRNMQTKSGVDVLDFILEDIQQLKKVLFNSQSIAIIMAGMNASSWIN
EKMEQWLGEKNAADVLSQSVQHNITSEMGLALLDVADVIRPYPEVIAYLQ
HVEDDSFLDELIQFKGGEKVRDAIDAFLNKYGMRCSGEIDITKTRWSEQP
ATIIPMILNHIRDFEYGASKRKFEEGLQEALKKEKELLERLQHLPDGEQK
VEETKRMICNLRNFIGYREYPKYGMIHRYFIYKQALLKEAEKLVQNNVLN
EIEDIYYLTFEELHEVVRTNKLDYKIIHKQKNAYKLYEKLTPPRVITSDG
EIITGKYKRENLPAEAIVGLPVSSGVVEGRARVILNMEDANLEDGDILVT
AFTDPGWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKLI
KDGQRIRVHGTEGYIEVL
>BC0569 SN-glycerol-3-phosphate transport system permease protein ugpE
MIVKQWKQNFLLYMLLIISAVMVFFPVLYAFLISFMTPDDIQMRRLFPTQ
FTFDNFINIFQKVPLFTYLYNSLIVSTVVMIGQLIVSSLAAYAFVFLQFK
GRNLIFFLFISTMLIPWEATMVPNFLTIQNFGWINSFAGMTVPFFATAFG
IFLLRQHFMTLPNELKEAAFIEGIGNIRFLFSVVIPYCKTSFITLGVYSF
LTTWNMYLWPLLVTTDEKVRTVQIGVKQLQSQEVATDWGSVMAGVTVIVI
PTLILLFLGQKQLQQGLTKGAIK
>BC2534 hypothetical Membrane Associated Protein
MFSNIELVLDAKASLAEGPCWNGKKQLLYWVDIMERKLCIYNPTANTNRV
IVLNQQIGCVVPYLEDVLLLAMENGFYSINVNTEKLTHIFDPEPHLIENR
FNDGKCDPAGRFWAGSTDTYGMNAAGSLYCLHHNLSVEKKVSHVNTSNGI
AWSPDHTYFYFIDTPTKKVVRYQYNIRTGDIHNPSDVINFSENDGLPDGM
TIDEEGCLWIAHWGGSKITRWNPFTGEQILSIPIPALYVTSCTFGGPNLT
DLYVTTARTRMSDNELKEYPHAGGIFRIQTNVKGCPTYSFCNKNIGAETM
>BC2799 Macrolide glycosyltransferase
MARVLFINAGSEGHINPTLQVVDELISRGEEVVYFSIEAFRERIEKTGAT
VRTIDDQKFIKAFLSGGRNYLQERINGLLHTADIVIPSVLEQIEGEHFDY
IIHDSMFGCGHLIAQILKLPAINSCTSFAQDEKSFEQMLGHLSKNIPVEI
YDKIQNDFQNLTKGIAEKYGVEIKSSYEVFCNPAPLTIVYTIKEFQPFGD
TFDEIYKFVGPSISAQMKNRDVDFTSIEEKSPIYISLGTVFNEAIDFYKL
CMKAFENSEHTIVMSIGSKTKISDLGEIPKNFIVKNYVPQTELLTYTKLF
ITHGGMNSAHEGLYNGVPLVVIPQSADQPVVAKQVESLGAGIKLQMQGLT
ADQLSESVEMVLNNPSFKEVALNLKKSFQKSGGYKEAVDEIFIFVGQ
>BC0467 Spore coat N-acetylmuramic acid deacetylase
MKYKWLYMGLIFSIMMALVPVSALAYTNTPHNWGIPRPKNETVPDAGKLY
TDLLQKNGGFYLGDTKKKDIYLTFDNGYENGYTGKILDVLKEKKVPATFF
VTGHYIKTQKDLLLRMKDEGHIIGNHSWSHPDFTAVNDEKLREELTSVTE
EIKKVTGQKEVKYVRPPRGVFSERTLALTKEMGYYNVFWSLAFLDWKVDQ
QRGWQYAHNNVMTMIHPGSILLLHAISKDNAEALAKIIDDLREKGYHFKS
LDDLVKGNQP
>BC4036 Ribulose bisphosphate carboxylase large chain
MSGIIATYLIHDDSHNLEKKAEQIALGLTIGSWTHLPHLLQEQLKQHKGN
VIHVEELAEHEHTNSYLRKKVKRGIIKIEYPLLNFSPDLPAILTTTFGKL
SLDGEVKLIDLTFSDELKKHFPGPKFGIDGIRNLLQVHDRPLLMSIFKGM
IGRNIGYLKTQLRDQAIGGVDIVKDDEILFENALTPLTKRIVSGKEVLQS
VYETYGHKTLYAVNLTGRTFDLKENAKRAVQAGADILLFNVFAYGLDVLQ
SLAEDDEIPVPIMAHPAVSGAYSASKLYGVSSPLLLGKLLRYAGADFSLF
PSPYGSVALEKEEALAISKYLTEDDASFKKSFSVPSAGIHPGFVPFIVRD
FGKDVVINAGGGIHGHPNGAQGGGKAFRTAIDATLQNKPLHEVDDINLHS
ALQIWGNPSYEVKL
>BC4867 1,4-alpha-glucan branching enzyme
MNVINCEEVKRDEFHTEKYYESYNIFGAHVVTEDEIQGVRFTVWAPHAKA
MSVVGDFNEWDYEQHKMLQVTEEGIWSLFIPHIEEGEIYKYAIETLAGDV
ILKADPYAVYAEVRPNTASVVFDIKGYEWNDKNWNRKKKKKSIYKEAMTV
YELHFGSWKKKEDGTLYSYREMVEELIPYVVEHQFTHIEIMPLVEHPYDR
SWGYQGTGYYAATSRFGTPHDLMHFVDECHKYGIGVILDWVPGHFCKDAH
GLYLFDGTPTYEYKDKDVQENPVWGTVNFDLGKREVRNFLISNALFWMRY
FHIDGFRVDAVANMLYWNKEGQEQSNEHAVSFLRELNEAVFAEDEDFLMT
AEDSTAWPLVTTPTYEGGLGFNYKWNMGWMNDVLKYMECAPEYRKHIHEK
MTFSLLYAYSENFILPLSHDEVVHGKKSLLNKMPGDYWDKFAQLRLLYGY
FFTHPGKKLLFMGGEFGQFDEWKDLEDLDWNLHDFEMHRYMHDYFKELIA
LYKRSKPLWQLDHSPEGFQWIDANNNEQSIFSFIRQGDKQEDALVIVCNF
TKATYENYKVGVPDFEYYNEILNSDAQQYGGSGQVNKKRLKTILEPYHNQ
AAHVEITIPPFGVSILRPVKTRKGSKKQDGSKTKVRSNVTSRGKR
>BC4583 NAD(P)-dependent glyceraldehyde-3-phosphate dehydrogenase
MTRVAINGFGRIGRMVFRQAIKESAFEIVAINASYPSETLAHLIKYDTVH
GKFDGTVEAFEDHLLVDGKMIRLLNNRDPKELPWTDLGVEVVIEATGKFN
SKEKAILHVEAGAKKVILTAPGKNEDVTIVVGVNEDQLDITKHTVISNAS
CTTNCLAPVVKVLDEQFGIENGLMTTVHAYTNDQKNIDNPHKDLRRARAC
GQSIIPTTTGAVKALAKVLPHLNGKLHGMALRVPTPNVSLVDLVVDVKRD
VTVEAINDAFKTVANGALKGIVEFSEEPLVSIDFNTNTHSAIIDGLSTMV
MGDRKVKVLAWYDNEWGYSRRVVDLVTLVVEELAKQENVQHI
>BC0635 Spore germination protein KA
MREKKEQQESTGQKHMFPSLPENINYIENKLSHSDDIKKLDLPFQNGKGI
IIYIESLADPNLIHQLALEPLLTRSDLSLDKAFSTLNMKKETNLNYGVQL
LLQGKSLYFHEHVDSFFIFETALSLKRDIAEPDNEGIVRGPHTGFVEDLA
TNLASIRKLIKSPNIVVKYFTLGEEMHTKVAIAYMQNIANDDLVTEVKRR
LETIKTDALMPPGYIQEFIEDTSFSPFPQQLNTERPDRTAANLMEGRVAI
LSDGDPTALIVPVTLFAFYQSPDDYNNRWIVGSFVRMIRLVSFLIAFLLP
AIYIATVAFHPDVLPLELVYTIKASLEKVPLPPIFEALLMELIFELLREA
GIRLPSRVGQTIGIVGGLVIGDAIVKAGLVSYTMIIVVALTAISSFLVPS
NDMSSAVRILRFPLMILAAIFGYVGISFGLIITFVHLCQLHSFHTPYLSP
VAPMRIKDMKDSFVRLPIWSFWERPHDPKPKKMQRQHVTREDEDGDKHAK
>BC4507 Aquaporin
MLKKAIAEFIGTFVLVLFGTGVAVTGGGIEGIGILGIAMAFGLSIVAMAY
SIGTISGCHINPAVSVAMFINKRMNAMELCYYVLAQILGGLLGTATLVTI
LKSAKTPLDNLGQNGFGTLGLSGAFLVEFILTFVFILVIVAVTGKKGSSS
LAGLVIGFTLVLIHLLGIPLTGTSVNPARSIAPALFVGGEALSQLWVFIV
APILGGIFAAIVGKFILNTEK
>BC1948 hypothetical Multidrug-Efflux Transporter
MNSYMLLFIFGIILANYSQILLKKATLQQYDSRIKEYVNPYVIIGYSLFV
INAGLNVIAMKGMALKQASALESLSYIIILIFGWYFLGEKITKRKLIGNM
IIIVGVIVYCIQ
>BC0380 L-fuculose phosphate aldolase
MLLQKEREEIVAYGKKMISSGLTKGTGGNISIFNREQGLVAISPSGLEYY
ETKPEDVVILNLDGEVVEGERKPSSELDMHLIYYRKREDINALVHTHSPY
AKTIASLGWELPAVSYLIAFAGPNVRCAPYETFGTKQLAEAAFEGMIDRR
AVLLANHGLIAGANNIKMAFTVAEEIEFCAQIYYQTKSIGEPKLLPEDEM
ENLAKKFEGYGQQ
>BC4202 hypothetical Membrane Spanning Protein
MNGRSFTFAIFVLIIGLAIFGLVSSVITNPMGVLRNIGYMLLVVGIFYLL
YKMFTNSSGSANSQSSYKRAAKQSNRKHGKQNVAPLGNSFFKSNTSNDKS
KKGNSSTLKRKRKQSHLTVIEGKKSKKKDRASF
>BC0171 Chitooligosaccharide deacetylase
MFFFFITSKRNFKHISLIVILSLFTAWLLFLKTYSHESAFSTATGPKVIY
KGDTAKKQVAFTFDISWGDKKAIPILDTLKEKEIKNATFFLSAAWAERHP
DIVERIMKDGHEIGSMGYNYTSYTSLETNEIRRDLLRAQDVFTKLGVKQV
KLLRPPSGEFNKATLKIAESLGYTVVHWSNNSNDWKNPGVNNIVSTVSNN
LKGGDIVLLHASDSALQTNRALPLLLQKIKSDGYEQISVSQLISNTSTKS
EDVK
>BC0225 Transporter, Drug/Metabolite Exporter family
MRRGQMIIGALACLIASMSWGAMFPVADHALEYIDPFYFSLIRYGAVAIM
LIVLLLVKEGKQAFCLEGRGKLLVFFGTMAFTVYNVLIFLGQMLMGKSGV
MVASIMEALMPMISICILWGYKHIKPKKYMITSMVIAFVGAVFVITKGDM
SFFVTLKDNMFPLAFIFIGVVGWVIYTMGGQTCSDWSTLRYSTLTCVFGT
TVTGIITVIITSLGYISVPSMGTISIVKYDLLFMMTLPGIVALLAWNYGV
KILSSINGILFINFVPITTLAIMMMQGYQITMFDIIGTVLVIAALIRNNV
CQRKEENINKRVLQEEQLRQAV
>BC1762 Fosmidomycin resistance protein
MHAVSHKKTVETPTIYRILFAISFGHFLNDSMQAVVPALFPILEKTMNLS
YMQVGWIAFALNMTSSIMQPVFGMYSDKKPSPFLLPLGMFSSMLGMIGLA
FAPNFIIVIISVLFIGLGSAVFHPEGARVAYMAAGAKRGLAQAIYQVGGN
TGNSLAPIFTALIFVPLGQIGSLGFTAFAAVGIALLIFVSNWYKNELATG
AVRRKKRAALEAENAIVSTHIKFVIILLVFLTFVRSWYGAGIGNFYQFYL
IEHYGLSIKNAQYFVFAFMIAGVLGTFFGGPLADRFGKKNIIVFSMLGSA
PLALLLPHVSLVWVVPLFLCIGFISSSSFSVIVVYAQELVPGKVGMVSGL
IVGLAFGLGALGAVVLGKLADIYSLQFIMLLCSCLPLIGLTSWLLPSDKK
TIE
>BC0808 PTS system, diacetylchitobiose-specific IIB component
MYILLCCAAGMSTSMVVRKMQEEAKKQGKNYKIKAVDSELVKLEIKEADV
VLIGPQVKYLFPAVEFLANSYNIPVAIIDQRDYGMCDGLKVLKQAEQLVL
A
>BC5258 Phosphoglycerate transporter protein
MFKWLKPAPAIERLPADMIDHVYRLLRIRVLIGISVGYAAYYLVRSNFTL
SSTYLVQEYGFSTAEIGLLGSVMAIVYGFSKFFMGNLSDKAFAQRFIAVG
LFLSGLVNICFGFASSFGMIVTLLVVNGIVQGMGAPPCSIVMTKWFSKKE
RGTKTGLWNISHNVGGMLVPPLVGIGVGIFGENHWQGGVFIFPAIIAMVI
AVLVWINAKDTPESEGLPPIDEYRNDYENLEKADNANKMSPKEILMKYVV
KNKFVWFLCIANAFVYLIRFGVINWVPLYLTTVKGFSKAEAHAAYAIFEG
MAIPSSLIVGFLSDKLFKGKRMPLCIISMVGVVIGTFIYWQATSVLVVSI
AVSIIGCLIYVPQFLIGLSAMELVPKFAVGTTVGMCGLFGYVGGSLVANA
AIGVIVDSSGWDGCFILLLTGAILSTVFLFIVQRGHERKDPKVA
>BC2397 ATPase family protein
MKYMIGVDGGGTKTEAIAFDKDGNELVRATSGFGNILIDFEEALVHIMEA
INQCQKSLINGHCVCVCLGLAGISGANTNELTLRLKKKYGTKIEIFNDAM
IAHAAALKGKDGILTIGGTGAICIGKKGEVYQYSGGWGHILGDEGSGYWI
ALQALKKMAIQFDQGISLCPLSLNIQRQFQLLTPSHIKSLVYTSSKDKIA
AIAPLVIQEARDGNDDAHEIMMQAGKELARITVNVYNKLNFKHSTPIAAS
GSILRLVPEIFAVFKKCCEESMKEITFVSQAEMAVKGTYYLMRDIYF
>BC1759 Tetracycline resistance protein
MLDKAGALIDNHVYTEEEQQKLYKRTLIIVSISQMFGGAGLAAGITVGAL
LAQQMLGTDAFAGLPTAMFTLGSALAAFIVGKLSQRYGRRIGLATGFIVG
GFGAIGVVMAALTNSIILLLISLLIYGAGTATNLQARYAGTDLADKKQRA
TAVSITMVMTTFGAVAGPNLVGVMGSFAHSIGVPKLAGPFILSAAAFILA
GLVLFVMLRPDPLIIANIIERYKQEHTYKGQPITEEAKENKRGITVGAIV
MILTQIVMVAIMTMTPVHMGHHGHGLSAVGLVIGFHVGAMYLPSLVTGML
IDKIGRTTMSIAGGVILLAAGVIAAIAPSDSLLLLIVALSLLGLGWNLGL
ISGTAQIVDSTTPSTRAKTQGKIDVFIALAGASGGAMSGMVVANSSYAAL
SLAGGVLALLLIPVVIWSRKGARN
>BC0757 Bicyclomycin resistance protein
MKKSKLTFILYVVCISALLGSFAQNIYTPILPMIQNSFHTSLYLVNVTVS
LFTFVLAIMQLVYGPLIDTKGRKSVLIPSLVISTIGSIGCAFSANIYLFL
FFRAVQAIGIAAIPVVSATIIGDLFEGKERGEAMSLYQMLLALAPAMAPL
IGGYLGSINGHLSVFLFLSTLGIILLIINISLLPETKPNIIKQSKAQKNY
SLILKNKTGFSITLIGFIQFCIYFCFLVFLPSILTNSFHLTVDKIGLMFV
PMSLSIMLGSFCYKFLQKRLTTKQALFITSFFNVICVVLFSFTYNINIPF
IIIVTSLYGFSMGLSMPTHTTLLTEEFVQERATAIGMYNFIRYLGMGTGP
LIGGFLLFNQNYFWIFFLGAIIFLLVILYTMKMLSFHSVQKAK
>BC4864 Glycogen synthase
MNILFAVSECVPFVKSGGLADVAGALPKELKKLGVDVRIILPNYSLIPQK
LRDGCTLHKVINVPLGWRNQYCGILKGEQDGITYYLIDNEYYFKRDSLYG
HYDDGERFSYFSKAVLECIPHLDFEVDVLHSHDWHTAMVNFLLREKYQDN
PLYERIKTVYTIHNLQFQGVFPPEVIYDLLELGDEYFHSEQLEFYGNVNF
MKGGIIASDQITAVSPTYKEEIQYEFFGEKLDGLLRKYNDKLSGIVNGID
TSVYNPETDSYIKAQYDAESLYEKSENKRALQRYFGLPEKEDTPIISMVT
RLTKQKGLDLVRTVFREIMEEDVQCIILGSGDSEYEQFFEWMAYEYPEKV
KVYIGFNEELAHQVYAGSDLFLMPSLFEPCGLGQLIALAYGTIPIVRETG
GLNDTVHSYDEETGEGNGFSFTNFNAHDMLHTIHRAIEFYHDKPVWEQLV
KQAMTEDYSWEQSALAYKELYKSLME
>BC0622 L-threonine 3-dehydrogenase
MKKILVTGSLGQIGSELVMKLRDVYGASNVIATDIRETDSEVVTSGPFET
LDVTDGQKLHDIAKRNEVDTIIHLAALLSATAEKNPLFAWNLNMGGLVNA
LEAARELNCKFFTPSSIGAFGPSTPKDNTPQDTIQRPTTMYGVNKVAGEL
LCDYYHQKFGVDTRGVRFPGLISYVAPPGGGTTDYAVEIYYEAIKKGAYT
SYIAEGTYMDMMYMPDALQAIISLMEADPSKLVHRNAFNITAMSFEPEQI
AASIRKHIPTFTMDYAVDPARQTIADSWPNSIDATAAMKEWGFKAEYDLD
KMTTDMLAKLKKKLTAELVMN
>BC0775 PTS system, sucrose-specific IIBC component
MDMKQIATQVIQNIGGKENIVRATHCATRLRLILKDDTKINAAEIENIDG
VKGAFATTEQYQIIFGTGIVNKVYDEFSKLIGIAELDSTTSNDIPKKKMN
PIARLAKTLSNIFVPIIPAIVASGLLMGLLGMLKAFKLVPGDHSLIQLLD
MFSSAAFIILPILIGVSAAKEFGGNIFLGAVVGGILTHPSLTNPWTLSNA
KPTVLHFLGMDIDMIGYQGTVLPILLCVYVMSTIEKELRKRVPNSLDLLV
TPFLTIIITGFLSLIIIGPIGYKIGDGITYLLNTIYQFAGPVAGLIFGGL
YSTIVLTGLHHSFHAIEAGLLANKDIGVNFLLPIWSMANVAQGGATLAVY
FKTKNKKTKEIAIPAAASAFLGITEPAIFGVNLKLGKPFIAAAIGGAIGG
AYVVWMQVAANAYGLTGIPMLTIVAPLGMMNMIHYIIGFAIAVITAFVAT
FILYKESK
>BC2175 D-beta-hydroxybutyrate permease
MELVIILLALSLLMFVAYRGFSVILFAPIFALFAVFLTEPSYVLPFFSNI
FMEKMVGFIKLYFPVFLLGAIFGKVVEMSGIADSIAKTIIELVGEKRTIL
AIVLMGAILTYSGVSVYVVVFAVYPFAAKLFRQANIPKRLIPGTIVLGAV
TFTMDALPGSPQIQNVIPTTFFKTDIYAAPILGIVGAIFVLTVGLLYLES
RRKKAKAEGEGYFGFNDGNTEMAASLQVEQKNMPLTNNIEITRAQQLITF
IPLILVGVMNKVFTIMIPKWYPSGFDFSAIGMKAFGKVELSAVVGIWSVE
LALIIGILTTLLLYWKRVVTGFQAGLNTSIGGALLATMNTGAEFGFGGVI
AALPGFAIMRDGISATFTNPLVNGAVTTNILAGITGSASGGMGIVLSAMG
DKFIAAANQFDIPLEVMHRIVSMASGGMDTLPHNGAIITILTVTGLTHKQ
SYKDIFAITILKTVAVFLVIAFYTLTGLY
>BC5447 Acetamide transporter
MGYVGLLLSGAALFLNSLVILGKAEMKSAGVFNLFVGALQIIIPFYLIMI
SDQSNWTVYSYAATFLFGLTYLYVGVTFIKGMDSSGLGWFCIWVAIIALF
YMVVSFVQFHDVVNALTWFMWALLWYLFFVLNTQKKNINQYLGRIAFVQS
WVTLTLPSLFYFMGVWGEGFVYELWVYVSVISILYFCYCIYKYRVR
>BC3749 UDP-2-acetamido-2,6-dideoxy-hexulose 4-reductase
MKKNASLLITGANGFTGRHACHYFLEQGFHVIPMFQNRAHREKIRNGITC
NLTNKSEVMKVMKQIKPDYVLHLAGRNSVIESWTAALEYIEINVIGTLYL
LEAIKQEASHCRTLVIGSALQADSMNEMKISNPYSLSKTMQVIIAEAWGG
LMDSNIIIAKPSNLIGPGVSNGICSILAKKIIDIESGRSKAIIEVNSLKD
SRDFLDVRDAVKAYHVLLRDGINGKQYNIGSGVKRSLLDVLEQYKELTQL
NFFIEETEKSGSDSNESLATEEIKNLGWIPEIEFHQSLKDVLEYAKCSDI
CMQ
>BC2673 Tetracycline resistance determinant tetV
MMGSLRLHIENKNRNQELRNICLYSIAKTVSLFGSSIYSFALGLYVLQIT
GSALNFAITLILGTIPMIVMNPFAGVIADKVDKKKLVVCMDVLSGCLLIT
VYILSNYYGLNLFIIYTTTFLMTVFTTCFGIGLEAVKPNMVTKERLMSIN
SISKIIDSISLILGPMLGGIVFAVFDMKTFIIINGISFILSAISILFINF
KLCEQNINEECSIREINFIEDIKEGYSYLLERKSLKNTFSILISLNFFLG
FAVTVPLPYIINTVLNLNSKQFGMIQGTFPIGMIVGAILVKKITDCYSYS
YLLKKISFMLAIFMIVLGIPVLFKSIVVNNLVYVTTYCMIMFFLGFMIAQ
IDIPLMYFMQNEIPEEYRGRVLSIGLSLGKIMQPIALAISGLLLNFIPAY
TLPIAGGIVFFTLNKILANKFNLEIHSKDYSV
>BC0188 Phosphoglucosamine mutase
MGKYFGTDGVRGVANKELTPELAFKIGRFGGYVLTKDTDRPKVIIGRDTR
VSGHMLEGALVAGLLSTGAEVMRLGVISTPGVAYLTKALDAQAGVMISAS
HNPVQDNGIKFFGSDGFKLTDEQEAEIEALLDKEVDELPRPTGTNLGQVS
DYFEGGQKYLQYIKQTVEEDFSGLHIALDCAHGATSSLAPYLFADLEADI
STMGTSPNGMNINEGVGSTHPEGLAELVKEKGADIGLAFDGDGDRLIAVD
EKGNIVDGDQIMFICAKYMKETGQLKHNTVVSTVMSNLGFYKALEANNIT
SDKTAVGDRYVMEEMKRGGYNLGGEQSGHIILLDYITTGDGMLSALQLVN
IMKMTKKPLSELAGEMTKFPQLLVNVRVTDKKLALENEKIKEIIRVVEEE
MNGDGRILVRPSGTEPLIRVMAEAPTQEVCDAYVHRIVEVVKAEVGAE
>BC5071 Macrolide-efflux protein
MKHMSENNWKTKIILFLTAQTISLLGSSLVQYAIIWYITLTTSSGVMLTI
STVCGFLPQIAISLFAGVWIDRYDRKKMIMLSDGIIAIATLVLAILFLTG
YKSIWLLFIVLLIRSAGTGVQTPAVNALIPQIVPKEYLMKVNGINSSITS
LIMFLSPAASAAILSIASIETTFFIDVITAMIGISIMLIIQVEGHVNAEN
KQKSNLQGIKEGFSYLKENVFIKRLIVLLIIIMILISPAAFLTPLMVTRS
FGAEMWRLTASEMTFSAGAAAGGVLIAAWGGFRNRMHTTALACALYGLLM
IGLGIAPIFIMYLVFNFLIGITMPCFNTPVTVLLQEKVEPSMHGRMFSLV
QIANSCALPLGMIIFGPLSDMFSVEILLIYAGIFVLFCAMYIVLSKRFEV
>BC3368 6-phosphogluconolactonase
MKMKNNKEFIGYVGTYTKENSEGIYKFTLETEAKKISNVTLAAKLDNPTY
VTINRNNEYLYSVVKEGESGGVAAYSMDSHTGELKAKNRQVVEGASPCHI
SVDSGNHTVVTANYHKGTIESFEVNEENGTVNPAASIMTHEGSGPNKERQ
EKPHAHYAGYTPDEKYVVGVDLGIDKIITYEVKDSILTEVNRLSVNPGSG
PRHITFHPNGKYAYVMTELSSEVIVLTYNPTEGSFTELQYISTVPEEFDE
NNQGSAIHISSDGCFVYAGNRGHNSIAVYSVDQNSGQLTFVEHTSTEGNW
PRDFVLDPTEKFLVATNEKSHNLVLFSRDESTGKLTLLQSDVVVPEPVCV
KFLNI
>BC3361 CDP-4-dehydro-6-deoxy-D-gulose 4-reductase
MKKVVVTGGSGWIGKYVVHSLIQKGYEVHATYNKNNPSHLPCHWHKVNLL
RDDEVKQFISDVQPSHLIHLAWEAVPPACYVSINNYYWLKSSISLIQHFT
TCGGKRVVVAGTGAEYEWFNGVLFEDSSLLSYKTPYSLCKNALHSWLETY
AQQTGLSMCWGRIFHMYGPHEQGNRLVSNIITSLLKNEEALCTHGKQSRD
FLHVSDVADALVTVLEHGVTGTINIASGQSVQIKELASIIAKKIGKEHLI
KLDAIPFSKDEPLFVGVSVERLKTEVNWETNIRFKYRNRRNNFMVGIIYT
KT
>BC2530 dTDP-glucose 4,6-dehydratase
MKIFVAGATGVIGRSLLPMLIKNGHTVFAMIRNTSQVEAMKRLGAIPVIA
DVLNREAVFSVLEETNPDVVIHQLTSLSSWNFEDNAKIRTKGTRNLVDAA
KNVGVQKIIAQSISWAYEPGDTFATEKDSLHITASMPRQVTVNGILKLEK
AVTELPESVILRYGTLYGPGTWYAENGLIANQVRNNEIIASDGISSFIHV
EDAARATMLSLNWPSGIVNIVDNYPATSKEWLPIYAAAIGAHKPKVQDGK
NSWERGASNNKARKEYGWTPLFPSWSEGFNNLIGK
>BC5274 UDP-N-acetylglucosamine 4,6-dehydratase
MILLDSFIVLTAVYLSYWFIHPNVLNKIPMTVVISSITLLCSHHVFAAIY
KLYNKAWEYASIGELKQIFKAITLSILVTAIVQQIINHDIYVRILAIAWM
LHLLLIGGSRFVWRMFRDTYITKATDKKRTLIIGAGSAGTMVVRQLQHNK
EADLYPIAFVDDDRNKQKLEIYNVPVIGTTNHIQEIVEDNDIEHIIIAIP
SLNRGQINEIFEKCRKTKAKTQIVPMLEDLLDGKVSVNEFRDVQVEDLLG
REPVQLDDKGIGEKIQDKTVLITGAGGSIGSEICRQILKYKPAKMVLLGH
GENSIYHIEMELRTKYKEQAEFVTEIADIQDRNKIFEIMKKHKPFVVYHA
AAHKHVPLMERNPEEAVKNNIIGTKNVAEAADTFGINTFVMVSTDKAVNP
TNVMGATKRVAEMVVQHMAMISQTRFVAVRFGNVLGSRGSVIPLFKKQIQ
SGGPVTVTHPDITRYFMTIPEASRLVIQAGSLARGGELFVLDMGEPVKIA
DLAKNLIQLSGYSIEEIGIEYSGLRPGEKMYEELLNDNEIHKEQVFPKIH
IGKAVLKDFESIQQFIDEFEQMSQESIRKTLLDFANNKVEVNS
>BC1780 Dihydroxy-acid dehydratase
MIKKGFDKAPHRSLLKATGLKDEDFDKPFIAICNSFIEIIPGHKHLNEFG
KLVKEAVRAAGMVPFEFNTIGVDDGIAMGHIGMRYSLPSREIIADSVETV
VNAHWFDGMICIPNCDKITPGMMMAALRINIPTVFVSGGPMAAGKTSKGE
VVDLSSVFEGVGAYQSGKISEEELKDIEDHGCPSCGSCSGMFTANSMNCL
CEVLGLALPGNGSILAIDPRREELIKQAAEKLKILIERDIKPRDIVTEEA
IDDAFALDMAMGGSTNTVLHTLALAQEAGLDYDMNRIDAVSRRVPHLCKV
SPASNWHMEDIDRAGGISAILKEMSRKEGVLHLDRITATGQTLRENIAEA
EIKDKEVIHSLENPHSEEGGLRILKGNLAKDGAVIKSGATEVKRFEGPCV
IFNSQDEALAGIMLGKVKKGDVVVIRYEGPRGGPGMPEMLAPTSAIAGMG
LGAEVALLTDGRFSGASRGISVGHISPEAAAGGMIALLEQGDIVCIDVEE
RLLEVRVSDEELEKRKKEWKRPEPKVKTGWLGRYAQMVTSANTGAVLKIP
HFD
>BC0807 PTS system, diacetylchitobiose-specific IIA component
MADMQTPFALILHGGNARSAALEAIAFARQGDFGNAGEKMKLASEEISAA
HRIQTDLIQEEARGNHAEISLLLVHAQDHLMNAITVKELAEEFIALHKRV
EEKVTV
>BC3000 Proline/betaine transporter
MQQNNDLNFEPQDVNIVNPKQARKAVIATGIGNAMEWFDFGLYAYLAVIL
SQLFFSGVDNSGLQLVLTFGTFAAAFLVRPIGGVFFGRIGDKYGRKIVLS
TTIILMALSTLFIALLPTYEQIGVWAPILLLVARMIQGFSTGGEYSGAMV
YIAESSPDKKRGILGSGLEIGTLSGYIAASVIVTILMLLLTDEQMLSWGW
RIPFLIAAPIGLVGLYLRRHLDESPIFEEMEKAQEESEDNEQFSFMDIIK
YHKKDFLLSTVIVAFFNITNYMILSYIPSYLTQVLKVEETTGLLIISITM
ALMIPLALYFGKLSDKIGNKRVVQIGLLGLTVFAIPAFLLIGNGHIAAIF
AGIFVLGFFLSVYEGTLPSLLPSLFFTDVRYRALSISFNISVSIFGGTTP
LVCSYLVHATGNPLAPAFYLAGVSIIGLVVFSVLFVTTSGRALKGSYPTV
ETKKEAHQIAKEDPEETLWWHEESLEIEAGKNASI
>BC0977 ATP synthase protein I
MIRMALRSFNIQMYCLLGVMLLGWLVTPFSAQFVGISIGLLVSMYCAWIL
GRRIEKFGDSIVKKEKAPMLGMINRFAAAILGAIIMYEIEHHEFMWTFAA
GIMSGYFLVIINLGYYSMRDEKG
>BC2224 Gluconate permease
MGEMVVGIVLAAVVILLLLITVVKWHPFVALILTAIGVGLAMGMPLIGTS
PKDPGIIDSIKLGLGNTLGFLAIVLALGTMLGKMMAESGGAERIANTLIN
RFGKKRVHWAMMFVAFLVGIPVFFQVGFVLLIPLVFTIALETGVSLITIG
IPLVAGLSVVHGLVPPHPAAMAAVGIFKADVGKTILYALIVGLPTAIISG
PLYGKWIGARIHKEVPLDIAEQFVEKDNKKELPSFWNTLFTILLPVFLML
GASIAEVALNKTSQLAQVLHFIGDPIVALLIATIYSFFSLGYAKGFSKDK
VLQFTNDCLGPIANILLVIGAGGAFNKVLLDSGIGTTIADMAKESHISPI
LLGWGIAALIRIATGSATVSMMTAAGIVAPIAASTPGVNVELLALATGAG
SLILSHVNDSGFWMIKEYFGMTVKETLLTWTAMETILSVVALGLISILNI
FV
>BC2042 putative NAD-dependent dehydrogenase
MGATGRVGSNIINLALKDSAEVTALARDLNRIEIQHERLRVIEGNVLNEN
DIKKAIEGSDIVISALGTDQNGTLAKSMPQIIKEMEEDGIRGIITIGTAG
ILQARTDLNLYRFQSTESKRKTTTAAEDHLAAYKVLSNSNNLCWTVVCPT
HLIDGEATEVYRTEKDILPEGGSKITVGDTAHFAWDLCKKNIYENSRVGI
AY
>BC2394 PTS system, diacetylchitobiose-specific IIC component
MNKFVTFLDKNLSGPMARLSEQRHLQAIRDGVISALPFIIVGSFFLIVAF
PPLPKDSFISVWALKNQTSILIPYRLTMFIMSLYIAFGIGYNLAKSYKLD
ALSGAQLAVCSLLLTLTPELIDKKGFMLPMTNLGGHGLFVTMIVSILSVE
ILRFCKKKNVMIKMPEQVPPSVSRSFEALIPAAFVIIIMSLVTVVFSIDL
HHVVDKLAAPLVKAGDSYFGVMIPVFLITFFWSFGIHGVSVVGTVARPLW
EVYLGKNGEAVASGADQLPFISPEPLYQWFIWIGGSGATLGLVLAMIVFG
RSKYSKALSRTCIVPGIFNINEPVIFGLPIVLNPILIIPFIITPLVTATV
AYSATAMGFVTPTHIMPPWTLPAPIGAYLATGGDWRAIVLVFINIAISFL
IYLPFFKMYDKNMLEIEKNGDGESVNP
>BC4716 Glucose uptake protein
MMDIFLAILPAIFWGSIVLFNVKLGGGPYSQTLGTTFGALIFSIVVYIFM
KPVLTPTVIGVGVVSGLFWALGQANQLKSIDLMGVSRTMPISTGLQLVAT
TLFGVIVFHEWSTTISVVLGILALVCIIIGVILTSLQSEEEKNAEQAANF
KRGIVILLISTVGYLVYVVVIRLFNVDGWSALLPQAVGMVLGGILLTFKH
HPFNKYAIRNIIPGLIWAAGNMFLFISQPRVGVATSFSLSQMGIIISTLG
GILILGEKKTKRQLTGIVVGIVFIIAAGIMLGIAKS
>BC5335 Fructose-bisphosphate aldolase
MPLVSMKEMLNKALEGKYAVGQFNMNNLEWTQAILAAAEEEKSPVILGVS
EGAARHMTGFKTVVAMVKALIEEMNITVPVAIHLDHGSSFEKCKEAIDAG
FTSVMIDASHHPFEENVETTKQVVEYAHARNVSVEAELGTVGGQEDDVIA
EGVIYADPAECKHLVEATGIDCLAPALGSVHGPYKGEPNLGFAEMEQVRD
FTGVPLVLHGGTGIPTADIEKAISLGTSKINVNTENQIEFTKAVREVLNK
DQEVYDPRKFIGPGRDAIKATVIGKIREFGSNGKA
>BC2610 Macrolide-efflux protein
MSTNVVTKQNNGVSQVLKNRFVQGILASALFLQIGIWVRNFAVLLYVMEM
TKGDAFAISMISVAEFAPIFIFSFIGGTFADRWKPKKTMIWCETLSSISV
FAVLITLMFGTWKIVFFVTLISAILSQFSQPSGMKLFKQHLSTEQIQLAM
SIYQTIFAIFMVLGPILGTFIFHSFGIYISIIITGISFLLAAVVLLFLPK
DLENDVEKKDITLLQEMKDGIKYVKKKKALTLLGLCFMAAGLGIGLIQPL
GIFIVTEQLGLSKESLQWLLTVNGAGMIVGGALAMVFAKNVAPQKMLIIG
MLGQAIGIGIIGYSTNLWVTLTAQLFSGLALPCIQIGINTLIIQNSDTDF
IGRVNGILSPLFTGSMVVTMSIAGSLKEMFSLSMMYEGTALLFIIGLLFI
LPIYNLKPVIAVESEISGKGSAVQNES
>BC4217 ABC transporter permease protein
MKQLILKDFIIQWKFLIWYILYPVFFYMALTDTENLFIIMSVIITIGATV
KTFEADSKNESEVIVNSLPILRKQIVYAKYIVAIIILFISVTVGCFTMGM
KSGVNLFEFLETTMVASISFILLYLSFVLPISFWLGYKKTIFITIVIFMA
PIVVLEALFQINLEQIQLYNSLLFISSMCMFIASTFVSVKIYEKREF
>BC0438 hypothetical protein
MEGGNTMDWLDGFGIFYIIGGITIILVFAISYLLKKRFPDKQFDIIFALS
LILLCLASFPVTMIVIGGWEGMGYGFIGFFVLLGTLIGMIAHQLVKITRK
SYV
>BC0656 Glycerol-3-phosphate transporter
MFFTQLFKPAPHAERLPADRVDSEYRKLRLQVFLGIFIGYAGYYFVRKNF
SLAMPYLIEQGFSKGELGVILSAVSIAYGLSKFLMGIVSDRCNPRYFLAA
GLFLSGIINIIFGSFSFITTSIILMFVLQFLNGWVQGMGWPPCGRTMVHW
FSISERGTKMSIWNVAHNVGGALMPSLVTLGLYFFADDWKSIFYFPGILS
ILVGIYVLITMKDTPQSCGLPSIEEHTGEYPPDEKVKDRERELSVKEILF
KYVLNNKFLWYIAIANVFVYFVRYGVVDWAPTYLVEEKSFTHSSSRTAYA
LYEWAGIPGTLLCGWMSDKLFKGRRAPAGILFMVGVFIAVLVYWLNPPGN
PMVDSIALVAIGFLIYGPVMLIGLHALDLAPKKAAGTAAGLTGFFGYLGG
AAFASAAMGFIVDAFGWDGGFILLLASCVLAMFFLALTLNTGSVKSKQA
>BC0312 UDP-glucose 4-epimerase
MRKNNYLIVGGNSFIGINLALGLLEQGQNVKVFSRHINNFPQNIISEVEF
IKGDLENVEDIYKALVNIDIIIYLAATSNVATSIEDVFGDINSSLFFLNF
MESVKDFRIKKIILASSGGTVYGEPEYLPIDEKHPLRPLSPYGITKVSLE
NYLYFYKRKYGIDYVVCRYSNPYGKYQNPLKKVGAINCFLYQHLSNERIH
IYGNPEEIIRDYIYIDDLVEITIQLAQLNQLKSCVYNIGSGKGLSLKRII
VELEKITERKVDFICYKQKQENVQKIILNIDKIKQELNWEPKIDFKHGIR
LNKLWIEEFLYSKK
>BC5153 Catabolite repression protein crh
MVQKRVQVSLKNGLQARPAALFVQEANRFHADIFIEKDGKTVNAKSIMGI
MSLAIGTGSMITITTEGSDAEEALEALAAYVQ
>BC4054 Glucosamine-6-phosphate isomerase
MNILVVKTPEELAEAGYKLIEEVVKTKENPTLGMATGSSPLGIYAEMRKN
KLDTSRVTTVNLDEYVNLPHEDKNSYHYFMQEQLFDHLPFKQTYVPNGMA
SDLEEECKRYESILAANPVDLQILGIGENGHIGFNEPGTPFNSPTNIVEL
TESTRQANLRFFEKEEDVPTHAITMGIGSIMKAKQVLLVAMGSKKAEAVK
ELLQGEYSEECPATVLQRHPNVTVIADQEALSLCSEAIADEHRQVFTISD
LLSDSRVGETAN
>BC1150 IG hypothetical 15940
MVHMHITAWALGLILFFVAYSLYSAGRKGKGVHMGLRLMYIIIIVTGFML
YMSIVKTATGSMHMWYGLKMLAGILVIGGMEMVLVKMSKNKPTGAVWGLF
IVALVAVFYLGLKLPIGWKVF
>BC3370 Gluconate permease
MNMYLLMITLLSIVIVILGVSWWRWHAFISLTVASLFLAIMSGMPMDKIV
SAYETGVGSVLGHLVGILVLGTILGKMMAESGAGMQVAEFFIKSFGIKNL
PWAMLIAGFIIGIPVFFEVGILILLPLVISIHKTTKQNILLIALPAIAGL
SVVHGLVPPHPGAIVAIGIYKANLGKVLLYSLIITFFAAIIAGPIFAKWI
HKRVIPENEPELIRVNTKSTKLPGIGVSFLVILLPVMLMVLAAAAPYVPL
STTLMKIITLIGSPIIALLIACFAAFYFLGFRQGIDKKAIKKVTEDSLLP
IGSIVAIIGAGGGFKQILIDSGVGNAIAQMSEHLALSPIVLAFIVAGLIR
IATGSATVALTTAAGIVSPIIENTTGVNLELLVIATGAGALMFSHVNDAG
FWMVKEYLGLTVKETFKTWTVLETLLSFIAFGGVLLLDMFV
>BC4536 hypothetical protein
MLNGLWLNLVSGFIVMLISGILYYRKPGRKWLFSVLVIGMLSFVTAGIRM
LVA
>BC4409 hypothetical protein
MDGTKKLSTAIGFGIVTLLILASITSMIMALLLKFTNINEGTLTVTIFIL
ALLSMLMSGFTAGKKAQGKGWLVGFTTGLTFTILVFLVNYLGFSQTLSNS
QLLYQLALMGASTLGGIFGVNMSKQSN
>BC5318 Ribose 5-phosphate isomerase
MKVVIASDHGGMNIRKELVNLLEELNIEYIDLGCECEAGSVDYPDFAFPA
AEMVANGEVDRGILVCGTGIGMSIAANKVNGIRCALVHDTFSAKATREHN
DTNMLAMGERVIGAGLARDIAKIWLTTDYEGGRHENRVGKIKTYETK
>BC1704 Transporter, Drug/Metabolite Exporter family
MDSNRLKGIIMVIIGACLWGLSGTAAQQLFQYDNVSTEWLVTIRLLISGI
ILLIISSFGTRKKEIFGIWKQKSDAIKMILFGLFGMLAVQYTYFASIKEG
NAAVATLLQYLAPIFITVYLLFKWNVRPSKIDFISITLSLVGTFLLLTNG
SVHNLAVSTPAIIWGILSGLSLAFYSLYSKELLEKWSSSVIVGWGMITGG
IGVTIVHFISTNEFILLSTMKYVKLSTLPLITFVVIFGTLIAFYLYLDSI
RYLTPKETTLFGCTEPLAAIISSVLILHVPFQSFQLLGAFCVIVMVLILS
QKPDEGKQKLKLVHAKKENIQ
>BC0318 Transporter, Drug/Metabolite Exporter family
MKEICMLLVAVILWGTAIAPTKWALESIQPFTLLFIRLFFAGGICMIFSF
KELQKSVVHKKVPWKRMSLLAFTGVAGYFMFTSYGISLTSGLHVSIIDAA
LPLVTILFSALFLKEEIRLNYWIGIILGAIGVLFITIPSKSANQEVSLIG
DILILLSTFLFAFYTVLLKRPKQEQYLSNEVFTTLTLIIGAVILLPFALV
EIFYYGLPKVETWKTVLSVIYLVIGATILAYWFWNKALERVSASVSGLYL
NALPLISIITSIILLNESLTWRVIMGASLVLIGVGWADKQKLCNLLKGNK
VENRDC
>BC0660 Ribokinase
MPNIAVVGSISMDLVAVSKKRPKAGETVIGEAFHTIPGGKGANQAVAAAR
LGANVAMVGAVGNDDYGTVVRKNLENERIFIDYVVPVTDRTTGIAHIVLA
EEDNSIVVVQGANALVNKSVVDRSKDLLVKADMVVLQLEIPLETVKYVLA
ICEEHNIPVMLNPAPAQVLSEEILEKATYITPNEHECRIVLDDFTSPIED
LLAKYPNKLLMTEGSNGVRFHNGTEIVHVPSIAVDVVDTTGAGDTFNGAL
AVALSEGETLQKAIRFANIAGGLSVTKLGAQGGMPTRDRVREVQVIVG
>BC0631 PTS system, trehalose-specific IIBC component
MGKDYRKTAEEVLQYIGGKDNIEQAAHCVTRLRIALKDESKIDNDKLQSV
SLVKGAFHNAGIFQVVIGPGDVDRVYAELITLAGMKESTVADVKDSGNQK
LNPAQKFVKIFSDVFMPILPAIVTAGLLMGINNLLGAKDLFFDGKNLLDV
YPNLGGLWDLINMMANTAFVFLPALVGWSATKRFGGSPILGIVMGLMLVH
PALLNAWDYGKAATGLEGQKIEYFNILGLFQIEKVGYQGQILPVLVAAFV
LSKVEIFLKKHVPNAIQLLVVPITTIVVTGVLALGIIGPVTRHIGDLLTV
GLVGVYETVPVVGAVLFGALYAPLVITGMHHMFIAIDLQLIAQHGGTFIW
PMIALSNIAQGSAALAMFWISKNQNDKSMASTSAISAYFGITEPAMFGVN
LRNKFPFYAAIIGSAVAAIFITLNGVLAPAIGIGGLPAFISIIPKSIPMF
IVGMIIAVVIPFTLTWLFAKRVKQK
>BC1768 Chitooligosaccharide deacetylase
MKKKIIITIVTLFFIITALFGTYKLMNARSFQLFGDLTQRVETNEKVIAL
TFDDGPTNNVKQILPLLDKYNAKATFFLIGNELEQNLSLGEAIAQSGHQL
GNHTYSHNRMVFKTPSFIKDEIEKTNSLIRQTGFTDEIDFRPPNGKKLIG
LPYYLNKNNIETITWDLEPDTFYKSAADKIKYVNKNVKPGSIILLHSMYD
ESNENLQTIEGILDSLSKKGYQFVTVNELQKRAK
>BC1034 Glycerol uptake facilitator protein
MWRDTMSAFLGELIGTALLIVLGGGVCAGVSLKKSFAKDSGWIVITMGWG
LAVAVAAYAVGSISGAHLNPALTIGLAFKGAFPWSDVPGYIVAQMIGAII
GAVIVYLHYLPHWKETEDPGTKLGVFATGPAIPNTFANLLSEMIGTFVLV
FGILAIGANKFADGLNPFIVGFLIVSIGLSLGGTTGYAINPARDLGPRIA
HFFLPIAGKGGSNWKYAWIPVVGPILGGSLAGLFHQVVFEGKQNSALIYV
IIATVIVLAISYMTSKKSGSNTNSRKVA
>BC2946 Integral membrane protein
MNDFTVVLIKFISCIIAFSIGLALFFPATFVQIISFSLFVTIVSYMFVDK
IILNRIGNTGAIMSDFLLTYLSVWIFGNILLDNYMQIAWGSILSAIVFTL
SEVIVHRFSNSHTRHNNDNIRINRRFAYGTEFAEEQNILDKDKKK
>BC5397 hypothetical Membrane Spanning Protein
MLSTPIGRLRAIGLVEGISFLLLLFVAMPLKYFAGFATAVKITGMAHGVL
FILFIFAVIQVTIVHRKSILWALGAFVSSVIPFGTFVLDAKLKNEQQ
>BC4971 Phosphoglycerate mutase
MKKIIIIRHCSAIGQKRDDELTTDGKDQANTLATFLLENHLQIDHIISSP
FVRAIDSIRPYALQANLSIQEDERLTERILSNIPMDDWMQKLESTFTNID
IAFSGGESTKQATDRALSLIQDVLQLNHTTTLLVTHGNLLTLILKHFDHT
IGFNEWRTLTNPDIYEITIDEQCIIKRLWEASSK
>BC0482 PTS system, N-acetylglucosamine-specific IIBC component
MLQFLQRIGKALMLPIAVLPAAGLLLRLGQPDVFDIPVMAQAGAAVFDNL
ALIFAIGIAIGLSVDGSGAAGLAGAIGYLVMKNSIDALSKGYSTAELQGK
LGKVQDLIGNSANVDPSKLADTMTQVSKAAELSTKVDMKVLGGIIVGVIA
GLLYNKFHKIKLPEWLGFFAGKRFVPIVTSVVMLILGILFAQIWPTIQNG
IDALAHGIVNLGAIGSGLFGLLNRLLIPIGLHHVMNTYFWFVFGDFTNAA
GNVVNGDIARFLAGDKTAGMFMTGFFPVMMFGLPAACFAMIAAAKPEKRK
AVTGMLAGLALTSFLTGITEPIEFSFMFLSPVLYGIHAVLTGLSLFITTS
LGIHDGFSFSAGAIDYALNFGIATKPVLLAGIGLIYAAIYFIVFYFLIKK
FDLKTPGREDDDELVEDGDAPVAGSIGETYVAALGGKENLTVIDNCATRL
RLQVKDAGQVNEAALKRAGAKGVMKLSNTSVQVIVGTNVESVADDMKKHV
>BC3663 Transporter, Drug/Metabolite Exporter family
MLRYSLLVLLGACSYGILAIFVKLAYAEGFSLGEVIGSQYLFGWIILLAI
TLLFSRHRVPLKQALLLFVAGTSASFTGIFYYASLKTVPASIAIILLFQF
VWVGIIIEAVATKTLPSREKVISVIFLLVGTFLSSGLLEQSAGAFDTTGI
ILGLLSAVTFATYIFVSGKVAVEVPSLPRGVLLMTGALTLVMIVFPPTFI
FNGAISQGLWKYGLGLGTFSIVIPSIAFTIGIPKIGSGLATILGAAELPV
TTIMSVFVLKEAVLSSQWFGVSLILIGIAIPQIAYAMRGRYRKHHTHKKV
AA
>BC3516 CDP-abequose synthase
MIASFKNKTFLITGGYGFIGSHLARRLLNLQAKIVLFIRTPSNSWRLKDI
LKYIETYEIDIRDKKQVQDAIKKINPDYIFHLAAYGVNSAHTDYIHAIET
NVIGTCNIIQAAKLVNCKKIINFGSSSEYGNKMEPIHENMLLTPVDIYGS
TKAAATILAHQIASENNINLITLRPFGIFGEGEEPHKIFSYIILRVLQNK
DVNLTLCNQLRDYCYIENVIDACILAVENTTVQNEIFNIGSGTIHPLKHY
VELLFKHLKTNSRPNYGAISSRTNERWVPEADVQKIKNSLSWEPRINIEE
GIIKTVNWYKNNKHLYLTP
>BC0663 Ribose transport system permease protein rbsC
MAKKGNVLQQLGSLIGLVLIIVVITALNPAFIEIPNLFNILRQVSINALI
AFGMTFVILTGGIDLSVGSILALSSALVAGMMASGMDPFLAMAVGLLAGL
VMGIVNGIIIAKGKVAPFIATLATMTIFRGLTLVYMDGRPITGLGDHLMF
QMFGRGYFLGIPVPAVTMMIAFAVLYFILKKTTFGRRTFAIGGNEEAAAL
SGINVTRIKVMIYGLSGILAALAGIVLTSRLDSAQPTAGTSYELDAIAAV
VLGGTSLSGGRGWIVGTFIGVLIIGVLNNGLNLLGVSSFFQQVVKGLVIL
LAVLIDRRKEA
>BC0632 Trehalose-6-phosphate hydrolase
MKDWHKSVVYQIYPKSFNSYYNRETGDIKGVTEKLDYLKELGVDYIWLTP
IYQSPQNDNGYDVSDYYSIDPSYGTMEEFEELLAEAKVRNIEIMLDIVVN
HSSTEHKWFKEAKEDKNSPYRNYYIWRDEKNNWQSKFGGSAWKYDEKTEQ
YYLHLFDETQADLNWENEKLREEVYDMMRFWLDKGVTGFRLDVINLISKD
QCFLNDEGSTATSDGRKYYTDGPRVHEYLQEMNRNVFAGKDVITVGEMSS
TTIDNCIKYSNPERNELSMTFSFHHLKVDYPNGDKWTKADFDFIKLKEIM
SSWQIEMQKGGGWNALFWCNHDQPRIVSRFGDDGKYRNESAKMLATAMHM
LQGTPYIYQGEEIGMTNPKFESIEQYRDVESLNIYDIKLKEGLSKEEIIG
ILKQKSRDNSRTPMQWNEEMNSGFTTSTPWISAAENFKEINVEKALEDKE
SVFYHYKKLIELRKTYDVITEGEYAILDKNDPKIWAYTRTTESEVLLVIN
NFYGEEITYSVPAHVQLDGMKQEVLLSNYKDASKDIAKLNLRPYESIVYR
YTK
>BC4919 Phosphoglucomutase
MNWKQEFSRWLSYAQLDAELKEQLENMKQDEKKIEDSFYKNLEFGTGGMR
GELGAGTNRLNVYTVRKATKGLASFIEKLGEEAKKRGVVVAYDSRHKSPE
FAMEVAATLGARGITTYVFESLRPTPVLSFAVRHLHTVSGIVLTASHNPP
EYNGYKVYGEDGGQLPPKEADELISYVNAVEDELTVEVADVEQLKADGLL
HIIGQEVDDAYAAELNNVIINKEMVQKVGKDLKIVFTPLHGTSNISVRRG
LKEVGFTDVTVVKEQELPDPNFSTVKSPNPEEHAAFEYAIRDGEKVGADV
LIATDPDADRLGVAVRNHNGEFQVLTGNQTGALMLDYLLSQKKENGTLPE
NGVVLKTIVTSEIGRTIAKAYGLDTIDTLTGFKFIGEKIRQYEESGQYEF
QFGYEESYGYLIRPFCRDKDAVQSVLFACEVAAYYKSQGKTLYDGLLEVF
EKYGFFREDLVSLTLKGKDGAEKIQEMMATFRENPPKEVAGLTVVAVEDY
KASIVTSLQDGHKEEIHLPKSNVLKYQLEDGSWFCLRPSGTEPKIKFYFG
VKDSSLQNSEQKLLTIKEDIMNRL
>BC4863 Glycogen phosphorylase
MFTHVESFKSTFLEKLETMYGKSFKDSTTRDQYNTLGHMVREYMNSQWIA
TNESYRSGEQKQMYYLSIEFLLGRLLGSNILNLGIRDVCEQGLSELGISL
QELEEVEADAGLGNGGLGRLAACFLDSLASLNLPGHGCGIRYKHGLFDQK
IVDGYQVEFPEQWLLHENVWEVRRYDQAVEVSYFGSVEPLEIDGRLEFRH
TNAEVIMAVPYDVPVVGYETSTVNTLRLWNAEPVPFPQNCKDILKYKRET
EAVSEFLYPDDTHDEGKILRLKQQYFLVSASLQNIVRMHRERYGDLRQLH
EKIAIHINDTHPVLAIPELMRILLDEEKLAWEEAWHITTQTISYTNHTTL
SEALEKWPIHIFKPLLPRIYMIIEEINERFCHELWEQYPYEWDRIEAMAI
IAHDLVKMAHLAIVGSHSVNGVAKIHTEILKQREMRLFYEFYPDKFNNKT
NGIAHRRWLMKANPQLTNLISEAIGTEWKKEPIKLQELQLVQYDASFQEK
FAEVKQERKEILAERIHNTMGITIDPNSIFDVQVKRLHAYKRQLLNVLHI
LYLYNRLKEDASFTFYPRTFIFGAKASPGYYYAKKIIKLINELARKVNND
PYVSQYMKVIFLENYRVSLAEDIFPAADVSEQISTASKEASGTGNMKFMM
NGAITLGTLDGANVEIKDRVGEDNCFIFGLTAEEVLHYYQNGGYRASDYY
HHNRHIKKVVDQLTNGFFAQSGAEFEAIYDSLVIQNDEYFVLRDFGPYAE
RQEAVGRAYENRTKWLEMSILNIAQSGHFASDRTILQYSNEIWGIGNAVK
QF
>BC0901 Deblocking aminopeptidase
MAHHTKETMELIKELVSIPSPSGNTAKIINFIENYVSEWNVETKRNNKGA
LILTVKGKNDAQHRLLTAHVDTLGAMVKEIKPDGRLSLSMIGGFRWNSVE
GEYCEIETSSGKTYTGTILMHQTSVHVYKDAGEAKRDEKNIEVRIDERVF
SADEVRELGIEVGDFVSFDPRVQITESGYIKSRHLDDKVSVAILLKLIKR
LQDENVTLPYTTHFLISNNEEIGYGGNSNIPEETVEYLAVDMGALGDGQA
SDEYTVSICAKDSSGPYHYALRKHLVELAKTNHIEYKVDIYPYYGSDASA
AIRAGFDVKHALIGAGIDSSHAFERTHESSIAHTEALVYAYVMSNLIEE
>BC0658 Multidrug resistance protein B
MEQQENQNRKLLLIGLVIAMLFAALDGTIVGTAMPRIVGDLGGLSLMTWL
TTAYMLTSTTVVPIAGKLADLLGRRNVYITGLVIFMIGSALCGMANGMTE
LIIFRGIQGLGGGIMMPMAMIIIGDMFTGKERAKWQGIFGALYGLASVIG
PQVGGWIVDAVNWRWVFYINLPVGILATIFIAMGLKSHKQTGPIKIDIAG
IFTMILGVVSLLLALTFGGKDYAWDSWQIIGLFALAVIGIVSFVIVETKA
EEPILPMHFFKNRTFTILNAIGFFMSIGMFGAIMFVPFFMQGIVGVSAAE
SRTIMTPMMITMIVMSIIGGQLVLKVGVKPQIIAGMLIMAGGFWLLTTMD
MHTTKLTATSYMMVIGLGMGLVMPTLTLALQESFPKKDLGVVTSSSQFFR
QIGGTFGITILGSIMNNTSGTTLTNKLVPVLDTFPKEAGQMVTKFKDMIH
TDPQGLYSMLFSPEALKQMPEAFANSIVPILKNSLVDSLHTVFLTGLVFI
VVGAIFTIFLQKIKLSDRKKDAEEPAVEEKEKTVSYS
>BC3191 Transporter, Drug/Metabolite Exporter family
MKPIKANLMILLVTMTWGTSYLFMKIGLETVPSFSLVALRFGIAFFVCAA
VFFKQFRSIHFVTLKYGFILGFLLFVVSASVILGLKTTSASNAGFLASLT
VIFIPLLSIVLFKDRLSYRLIISSLVAMTGIGLLTLNNQLTLNSGDLLCI
LAALFYAFHIIVTGRAAKVANTLQLGILQLGFAGGFGVLSALIFEEPQLP
STKESWIAVLVLSIFCSAFAYIIQAMAQKYTTPTHTGLIFSLEPVFSALF
AYLFMNEVLSLKGYIGALLILSGVILAEIKVKRKSTLLL
>BC0979 Dihydroxyacetone kinase
MKKIMNDVQNIVQDMLHGFYFEHNDKVNYDETNNIIYVKDIEKMKQDVAI
ISGGGSGHEPADIGYVGKGMLTAAVNGSIFTPPTVEQIAAATRLMPKDKS
ILFIIKNFKDDVENFLAAKQIAKEEGRKIDHIIVNDDVSIEDDASFNKRR
RGVAGTVFVQKILGAAALEGHSLEELTTLGRSITKNLHTLGVALSPVNDP
VKGKASFTLNDDEVFYGVGIHGEKGYRKEALSSSEILAIELMNKLKSIYR
WRKGDNFAILINGLGATPLMEQYIFANDIRRLCELEGLQVTFVKVGTLLT
SLDMKGVSLSLLKVEDLDWVKWLKADVRVGNW